Document:

Exhibit 10.9

 

SECURITIES PURCHASE
AGREEMENT

 

THIS SECURITIES
PURCHASE AGREEMENT (the “Agreement”) is made as of the 12th day of May, 2015 by
and between RealBiz Media Group, Inc., a Delaware corporation (the “Company”), and Himmil Investments,
Ltd., a British Virgin Islands company (the “Investor”).

 

WHEREAS, the
Company and the Investor are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”), and Rule 506(b)
of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission
(the “Commission”) under the 1933 Act (without limiting any other such exemption which may apply to the
transactions contemplated by this Agreement);

 

WHEREAS, the
Company has authorized the issuance of (i) a senior convertible note, in the original principal amount of $500,000, in the form
attached hereto as Exhibit A (the “Note”), which Note shall be convertible into shares of the
Company’s common stock, $.001 par value per share (the “Common Stock”), in accordance with the
terms of the Note, and (ii) a warrant to acquire up 675,000 additional shares of Common Stock, in the form attached hereto as Exhibit
B (the “Warrant”);

 

WHEREAS, Investor
wishes to purchase, and the Company wishes to sell at the Closing (as defined below), upon the terms and conditions stated in this
Agreement (i) the Note (and the Common Stock issuable upon conversion thereof, collectively, the “Conversion Shares”),
and (ii) the Warrant (and the Common Stock issuable upon exercise thereof, collectively, the “Warrant Shares”).

 

WHEREAS,
the Note, the Conversion Shares, the Warrant and the Warrant Shares are collectively referred
to herein as the “Securities” and the offering contemplated hereby is referred to herein as the “Offering”;

 

WHEREAS, the
parties have agreed that the obligation to repay the Note shall be an unsecured obligation of the Company; and

 

WHEREAS, at
the Closing, the parties hereto shall execute and deliver a Registration Rights Agreement, in the form attached hereto as Exhibit
C (the “Registration Rights Agreement”), pursuant to which the Company has agreed to provide certain
registration rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement), under the 1933
Act and the rules and regulations promulgated thereunder, and applicable state securities laws.

 

    	 

    	 

    

 

NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and in consideration of the
premises and the mutual agreements, representations and warranties, provisions and covenants contained herein, the parties hereto,
intending to be legally bound hereby, agree as follows:

 

1.           
Purchase and Sale of Note and Warrant.

 

1.1           
Purchase and Sale of Note and Warrant. Subject to the satisfaction (or, where legally permissible, the waiver) of
the conditions set forth in Section 4.1, the Company shall issue and sell to the Investor, and the Investor shall purchase from
the Company on the Closing Date (as defined below), the Note and the Warrant (the “Closing”).

  

1.2           
Form of Payment. On the Closing Date, (i) the Investor shall pay the Purchase Price (as defined below) (less the
amounts withheld pursuant to Section 12.12) to the Company for the Note and the Warrant to be issued and sold to the Investor at
the Closing, by wire transfer of immediately available funds in accordance with the Company’s written wire instructions and
(ii) immediately following the Company’s receipt of such amount, the Company shall deliver to the Investor (x) the Note and
(y) the Warrant, in each case, duly executed on behalf of the Company and registered in the name of the Investor or its designee.

 

2.           
Purchase Price. The purchase price for the Note and the Warrant to be purchased by the Investor (the “Purchase
Price”) shall be $500,000.

 

3.           
Closing Date. Subject to the satisfaction (or, where legally permissible, the waiver) of the conditions to the Closing
set forth in Section 4.1, the date and time of the Closing (the “Closing Date”) shall be 10:00 a.m. (New
York City time) on a date that is no later than the second (2nd) Trading Day after the Effective Date. The Closing shall
occur electronically.

 

4.           
Closing Conditions; Certain Covenants.

 

4.1           
Conditions to the Closing.

 

(a)             
Conditions of the Company to the Closing. The obligation of the Company to sell and issue the Note and the Warrant
to the Investor at the Closing is subject to the fulfillment, to the Company’s reasonable satisfaction, prior to or at the
Closing, of each of the following conditions:

 

(i)              
Representations and Warranties. The representations and warranties of the Investor contained in this Agreement (x)
that are not qualified by “materiality” shall have been true and correct in all material respects when made and shall
be true and correct in all material respects as of the Closing Date with the same force and effect as if made on such dates, except
to the extent such representations and warranties are as of another date, in which case, such representations and warranties shall
be true and correct in all material respects as of such other date and (y) that are qualified by “materiality”
shall have been true and correct when made and shall be true and correct as of the Closing Date with the same force and effect
as if made on such dates, except to the extent such representations and warranties are as of another date, in which case, such
representations and warranties shall be true and correct as of such other date.

 

(ii)            
Registration Rights Agreement. The Investor shall have duly executed and delivered the Registration Rights Agreement
to the Company.

 

    	2

    	 

    

 

(iii)            
No Injunction. No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered,
promulgated, threatened or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of or which would materially modify or delay any of the transactions contemplated by the Transaction Documents.

 

(b)            
Conditions to the Investor to the Closing. The obligation of the Investor to purchase the Note and the Warrant to
be issued to the Investor at the Closing is subject to the satisfaction, or (where legally permissible) the waiver by the Investor,
on the Closing Date, of each of the following conditions:

 

(i)              
Representations and Warranties. The representations and warranties of the Company contained in this Agreement (x)
that are not qualified by “materiality” or “Material Adverse Effect” shall have been true
and correct in all material respects when made and shall be true and correct in all material respects as of the Closing Date with
the same force and effect as if made on such dates, except to the extent such representations and warranties are as of another
date, in which case, such representations and warranties shall be true and correct in all material respects as of such other date
and (y) that are qualified by “materiality” or “Material Adverse Effect” shall have been true and
correct when made and shall be true and correct as of the Closing Date with the same force and effect as if made on such dates,
except to the extent such representations and warranties are as of another date, in which case, such representations and warranties
shall be true and correct as of such other date.

 

(ii)            
Performance of the Company. The Company shall have performed, satisfied and complied in all material respects with
all covenants, agreements and conditions required by this Agreement and the Registration Rights Agreement to be performed, satisfied
or complied with by the Company at or prior to the Closing Date. The Company shall have delivered to the Investor on the Closing
Date a written certification by an executive officer of the Company to the foregoing substantially in the form attached hereto
as Exhibit D.

 

(iii)            
No Suspension of Trading in or Notice of Delisting of Common Stock. Trading in the Common Stock shall not have been
suspended by the Commission, the Trading Market or the FINRA (except for any suspension of trading of less than fourteen (14) days,
which suspension shall be terminated prior to the Closing Notice Date), the Company shall not have received any final and non-appealable
notice that the listing or quotation of the Common Stock on the Trading Market shall be terminated on a date certain (unless, prior
to such date certain, the Common Stock is listed or quoted on any other Trading Market), trading in securities generally as reported
on the Trading Market shall not have been suspended or limited, nor shall a banking moratorium have been declared either by the
U.S. or New York State authorities (except for any suspension, limitation or moratorium which shall be terminated prior to the
Closing Notice Date), there shall not have been imposed any suspension of electronic trading or settlement services by the Depository
Trust Company (“DTC”) with respect to the Common Stock that is continuing, the Company shall not have
received any notice from DTC to the effect that a suspension of electronic trading or settlement services by DTC with respect to
the Common Stock is being imposed or is contemplated (unless, prior to such suspension, DTC shall have notified the Company in
writing that DTC has determined not to impose any such suspension).

 

    	3

    	 

    

 

(iv)            
Compliance with Laws. The Company shall have complied with all applicable federal, state and local governmental laws,
rules, regulations and ordinances in connection with the execution, delivery and performance of this Agreement and the other Transaction
Documents (as defined below) to which it is a party and the consummation of the transactions contemplated hereby and thereby, including,
without limitation, the Company shall have obtained all permits and qualifications required by any applicable state securities
or “Blue Sky” laws for the offer and sale of the Securities by the Company to the Investor).

 

(v)            
No Injunction. No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered,
promulgated, threatened or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of or which would materially modify or delay any of the transactions contemplated by the Transaction Documents.

 

(vi)            
No Proceedings or Litigation. No action, suit or proceeding before any arbitrator or any court or governmental authority
shall have been commenced or threatened, and no inquiry or investigation by any governmental authority shall have been commenced
or threatened, against the Company or any Subsidiary, or any of the officers, directors or affiliates of the Company or any Subsidiary,
seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents, or seeking material damages
in connection with such transactions.

 

(vii)          
Listing of Securities. All of the Conversion Shares and Warrant Shares that may be issued pursuant to the Note and
Warrant, respectively, shall have been approved for listing or quotation on the Trading Market as of the Closing Date, in each
case, without regard to any limitations on conversion or exercise set forth in the Note or Warrant, respectively, subject only
to notice of issuance.

 

(viii)        
No Material Adverse Effect. No condition, occurrence, state of facts or event constituting a Material Adverse Effect
shall have occurred and be continuing.

 

(ix)            
Opinion of Counsel. On the Closing Date, the Investor shall have received an opinion from outside counsels to the
Company, dated the Closing Date, in the form mutually agreed to by the parties hereto prior to the date hereof.

 

(x)            
Note and Warrant. At the Closing, the Company shall have tendered to the Investor the Note and Warrant.

 

(xi)            
Registration Rights Agreement. The Company shall have duly executed and delivered the Registration Rights Agreement
to the Investor.

 

(xii)          
Current Public Information. All reports, schedules, registrations, forms, statements, information and other documents
required to have been filed by the Company with the Commission pursuant to the reporting requirements of the 1934 Act, including
all material required to have been filed pursuant to Section 13(a) or 15(d) of the 1934 Act, shall have been filed with the Commission
under the 1934 Act.

 

    	4

    	 

    

 

(xiii)        
Effectiveness of Registration Statement. The registration statement on Form S-1 as contemplated by the Registration
Rights Agreement has been declared effective by the Commission.

 

4.2           
Limitations on Future Issuances. So long as any amounts due under the Note remain outstanding, the Company may not,
directly or indirectly, without prior approval from Investor, (i) enter into any agreement or other contractual arrangement, except
for a registered secondary offering, unregistered private placements or equity grants to employees or other service providers,
not containing any variable pricing, price resets, “true up” provisions or similar provisions pursuant to which the
pricing of the securities offered may change in the future, to effect any financing agreement or other arrangement involving the
sale of any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive
additional shares of Common Stock at a price that is based upon and/or varies with the trading prices of the Company’s Common
Stock at any time after the initial issuance of such securities or is subject to reset upon the occurrence of specified or contingent
event or events, (ii) enter into any agreement, including, but not limited to an equity line of credit or other committed equity
facility, where the Company may sell securities at a future determined price, and (iii) the Company and/or its affiliates shall
not directly or indirectly, solicit, initiate or enter into any agreement to effect an “Exchange Transaction” (as such
term is defined in Section 3(a)(9) or Section 3(a)(10) of the 1933 Act.

 

4.3           
Securities Law Disclosure; Publicity. The Company shall (a) by 9:00 a.m. (New York City time) on the Trading Day
immediately following the Closing Date, issue a press release in form and substance reasonably acceptable to the Investor disclosing
the material terms of the transactions contemplated hereby (the “Press Release”) and (b) by the fourth
Trading Date following the Closing Date, issue a Current Report on Form 8-K (the “Current Report”) disclosing
the material terms of the transactions contemplated hereby, and including the Transaction Documents as exhibits thereto, within
the time required by the 1934 Act. From and after the issuance of the Press Release, the Company represents to the Investor that
the Company shall have publicly disclosed all material, non-public information delivered to the Investor as of such time by the
Company or any of its subsidiaries, or any of their respective officers, directors, employees or agents in connection with the
transactions contemplated by the Transaction Documents. The Company shall afford the Investor and its counsel with a reasonable
opportunity to review and comment upon, shall consult with the Investor and its counsel on the form and substance of, and shall
give due consideration to all such comments from the Investor or its counsel on, any press release, Commission filing or any other
public disclosure made by or on behalf of the Company relating to the Investor, its purchases hereunder or any aspect of the Transaction
Documents or the transactions contemplated thereby, prior to the issuance, filing or public disclosure thereof, and the Company
shall not issue, file or publicly disclose any such information to which the Investor shall object. For the avoidance of doubt,
the Company shall not be required to submit for review any such disclosure contained in periodic reports filed with the Commission
under the Securities Exchange Act of 1934, as amended (the “1934 Act”) if it shall have previously provided
the same disclosure for review in connection with a previous filing.

 

    	5

    	 

    

 

4.4           
Legends. The Securities may only be disposed of in compliance with state and federal securities laws. In connection
with any transfer of Securities other than pursuant to an effective registration statement or Rule 144 (as defined below), to the
Company or to an affiliate of the Investor or in connection with a pledge, the Company may require the transferor thereof to provide
to the Company an opinion of the Company’s counsel, the form and substance of which opinion shall be reasonably satisfactory
to the Company, to the effect that such transfer does not require registration of such transferred Securities under the 1933 Act.
The Investor understands that the certificate or other instrument representing the Note and the Warrant and the stock certificates
representing the Conversion Shares and the Warrant Shares, respectively, except as set forth below, shall bear any legends as required
by applicable state securities or “Blue Sky” laws in addition to a restrictive legend in substantially the following
form (and a stop-transfer order may be placed against transfer of such stock certificates):

 

[NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE][EXERCISABLE]
HAVE BEEN] [THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE
OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF
COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED
UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE
FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED
BY THE SECURITIES.

 

    	6

    	 

    

 

The Company shall use
its reasonable best efforts to cause its transfer agent to remove the legend set forth above and to issue a certificate without
such legend to the holder of the Securities upon which it is stamped, or to issue to such holder by electronic delivery at the
applicable balance account at DTC, unless otherwise required by state securities or “blue sky” laws, at such time as
(i) such Securities are registered for resale under the 1933 Act, (ii) in connection with a sale, assignment or other transfer,
such holder provides the Company with an opinion of counsel, in a form generally acceptable to the Company’s legal counsel
and the Transfer Agent, to the effect that such sale, assignment or transfer of the Securities may be made without registration
under the 1933 Act, (ii) if the holding period (as determined under Rule 144) for such Securities is at least six months, but less
than one year, such holder provides the Company and its legal counsel with reasonable assurance in writing that the Securities
are being sold, assigned or transferred pursuant to Rule 144 or Rule 144A or (iii) if the holding period (as determined under Rule
144) for such Securities is at least one year, such holder provides the Company and its legal counsel with reasonable assurance
in writing that the Securities can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A. In furtherance of the foregoing,
the Company agrees that, following the Effective Date or at such time as such legend is not required pursuant to this Section 4.4,
the Company shall, no later than three Trading Days following the delivery by the Investor to the Company or the Transfer Agent
of a certificate representing Conversion Shares or Warrant Shares issued with a restrictive legend (such third Trading Day, the
“Legend Removal Date”), either: (A) issue and deliver (or cause to be issued and delivered) to the Investor
a certificate representing such Conversion Shares or Warrant Shares, as applicable, that is free from all restrictive and other
legends or (B) cause the Transfer Agent to credit the Investor’s or its designee’s account at DTC through its Deposit/Withdrawal
at Custodian (DWAC) system with a number of shares of Common Stock equal to the number of Conversion Shares or Warrant Shares,
as applicable, represented by the certificate so delivered by the Investor. If the Company fails on or prior to the Legend Removal
Date to either (i) issue and deliver (or cause to be issued and delivered) to the Investor a certificate representing the Conversion
Shares or Warrant Shares, as applicable, that is free from all restrictive and other legends or (ii) cause the Transfer Agent to
credit the balance account of the Investor or its designee at DTC through its Deposit/Withdrawal at Custodian (DWAC) system with
a number of shares of Common Stock equal to the number of the Conversion Shares or Warrant Shares, as applicable, represented by
the certificate delivered by the Investor pursuant hereto (a “Delivery Failure”), and if on or after
the Legend Removal Date the Investor purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the Investor of shares of Common Stock that the Investor anticipated receiving from the Company without
any restrictive legend, then the Company shall, within three Trading Days after the Investor’s request, pay cash to the Investor
in an amount equal to the Investor’s total purchase price (including brokerage commissions, if any) for the shares of Common
Stock so purchased, at which point the Company’s obligation to deliver a certificate or credit the Investor’s or its
designee’s account at DTC for such shares of Common Stock shall terminate and such shares shall be cancelled(the “Buy-In
Remedy”). For the avoidance of doubt, with respect to any given Delivery Failure, the Investor shall be entitled,
at the election of the Investor, to recovery either pursuant to this Buy-In Remedy or Section 3(c)(ii) of the Note, but not both.

 

4.5           
Sales of Stock

 

(a)             
Investor hereby agrees that, for so long as Investor owns any Notes, such Investor shall not maintain a Net Short Position
(as defined below).

 

(b)            
For purposes hereof, a “Net Short Position” by a person means a position whereby such person has executed
one or more sales of Common Stock that is marked as a short sale (but not including any sale marked “short exempt”)
and that is executed at a time when the Investor has no equivalent offsetting long position in the Common Stock (or is deemed to
have a long position hereunder or otherwise in accordance with Regulation SHO of the 1934 Act). For purposes of determining whether
the Investor has an equivalent offsetting long position in the Common Stock, all Common Stock (A) that is owned by the Investor,
(B) that may be issued as Interest Shares pursuant to the terms of the Notes issuable to the Investor on the Closing Date or, after
the Closing Date, then held by the Investor or (C) that would be issuable upon conversion or exercise in full of all Securities
issuable to the Investor on the Closing Date or, after the Closing Date, then held by the Investor (assuming that such Securities
were then fully convertible or exercisable, notwithstanding any provisions to the contrary, and giving effect to any conversion
or exercise price adjustments that would take effect given only the passage of time) shall be deemed to be held long by the Investor.

 

4.6            Reservation
of Shares. So long as any Notes or Warrants remain outstanding, the Company shall take all action necessary to at all times
have authorized, and reserved for the purpose of issuance, no less than the sum of (i) 100% of the maximum number of shares of
Common Stock issuable upon conversion of all the Notes then outstanding (assuming for purposes hereof, that the Notes are convertible
at the Conversion Price (as defined in the Notes) and without regard to any limitations on the conversion of the Notes set forth
therein), and (ii) 100% of the maximum number of Interest Shares issuable pursuant to the terms of the Notes then outstanding from
the Closing Date through the twelve month anniversary of the Closing Date (determined as if issued on the Trading Day immediately
preceding the Closing Date without taking into account any limitations on the issuance of securities set forth in the Notes) and
(iii) 100% of the maximum number of Warrant Shares issuable upon exercise of all the Warrants then outstanding (without regard
to any limitations on the exercise of the Warrants set forth therein).

 

    	7

    	 

    

 

5.           
Representations and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure
Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure
contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and
warranties to the Investor as of the Closing Date:

 

5.1           
Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and
in good standing under the laws of the State of Nevada. The Company is duly qualified to transact business and is in good standing
in each jurisdiction in which the failure to so qualify would have a Material Adverse Effect.

 

5.2           
Capitalization. As of the date hereof, the authorized capital stock of the Company consists of (i) 250,000,000 shares
of Common Stock, of which, 106,338,852 are issued and outstanding and 11,458,119 shares are reserved for issuance pursuant to
Convertible Securities (as defined below) (other than the Notes and the Warrants) and (ii) 66,816,653 shares of preferred stock,
of which 66,816,653 are issued and outstanding. A complete capitalization table of the Company as of the date hereof is attached
hereto as Schedule 5.2 (including, without limitation, all outstanding Convertible Securities). No shares of Common Stock are
held in treasury. All of such outstanding shares are duly authorized and have been, or upon issuance will be, validly issued and
are fully paid and nonassessable. In addition, 131,542,744 shares of the Company’s issued and outstanding Common Stock on
the date hereof are as of the date hereof owned by Persons who are “affiliates” (as defined in Rule 405 of the 1933
Act and calculated based on the assumption that only officers, directors and holders of at least 10% of the Company’s issued
and outstanding Common Stock are “affiliates” without conceding that any such Persons are “affiliates”
for purposes of federal securities laws) of the Company or any of its Subsidiaries. To the Company’s Knowledge, except as
disclosed in the Public Reports, no Person owns 10% or more of the Company’s issued and outstanding shares of Common Stock
(calculated based on the assumption that all Convertible Securities (as defined below), whether or not presently exercisable or
convertible, have been fully exercised or converted (as the case may be) taking account of any limitations on exercise
or conversion (including “blockers”) contained therein without conceding that such identified Person is a 10% stockholder
for purposes of federal securities laws). (i) None of the Company’s or any Subsidiary’s capital stock is subject to
preemptive rights or any other similar rights or any Encumbrances suffered or permitted by the Company or any Subsidiary; (ii)
except as disclosed in  Schedule 5.2 (ii), there are no outstanding options, warrants, scrip, rights to subscribe to, calls
or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable
for, any capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by
which the Company or any of its Subsidiaries is or may become bound to issue additional capital stock of the Company or any of
its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities or rights convertible into, or exercisable or exchangeable for, any capital stock of the Company or any of its
Subsidiaries; (iii) other than as set forth on Schedule 5.2(iii), there are no outstanding debt securities, notes, credit agreements,
credit facilities or other agreements, documents or instruments evidencing Indebtedness of the Company or any of its Subsidiaries
or by which the Company or any of its Subsidiaries is or may become bound; (iv) there are no financing statements securing obligations
in any amounts filed in connection with the Company or any of its Subsidiaries; (v) except as set forth on Schedule 5.2(v), there
are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any
of their securities under the 1933 Act (except pursuant to the Registration Rights Agreement); (vi) there are no outstanding securities
or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no
contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound
to redeem a security of the Company or any of its Subsidiaries; (vii) there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by the issuance of the Securities; (viii) neither the Company nor any Subsidiary
has any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement; and (ix)
neither the Company nor any of its Subsidiaries have any liabilities or obligations required to be disclosed in the Public Reports
which are not so disclosed in the Public Reports, other than those incurred in the ordinary course of the Company’s or its
Subsidiaries’ respective businesses and which, individually or in the aggregate, do not or could not reasonably be expected
to have a Material Adverse Effect.

 

    	8

    	 

    

 

5.3           
Authorization; Enforcement. All corporate action on the part of the Company, its officers, directors and stockholders
necessary for the authorization, execution and delivery of this Agreement, the Note, the Warrant and the Registration Rights Agreement
(the “Transaction Documents”) and the performance of all obligations of the Company hereunder and thereunder,
and the authorization (or reservation for issuance), sale and issuance of the Note and the Warrant, and the Common Stock into which
the Note and the Warrant are convertible or exercisable, as applicable, have been taken on or prior to the date hereof. Each of
the Transaction Documents has been duly executed by the Company and, when delivered in accordance with the terms hereof and thereof,
will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws
of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions
may be limited by applicable law.

 

5.4           
Valid Issuance of the Conversion Shares and Warrant Shares; Reservation of Shares. Each of the Note and Warrant has
been duly authorized and, when issued and paid for in accordance with this Agreement, will be duly and validly issued, fully paid
and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer under this Agreement
and under applicable state and federal securities laws. Upon conversion in accordance with the Note or exercise in accordance with
the Warrant (as the case may be), the Conversion Shares and the Warrant Shares, respectively, when issued and delivered in accordance
with the terms of this Agreement and the Note or the Warrant, as applicable, for the consideration expressed herein and therein,
will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company, other than
restrictions on transfer under this Agreement and under applicable state and federal securities laws. The Company has reserved
from its duly authorized capital stock a sufficient number of shares of Common Stock for issuance of the Conversion Shares as required
by Section 8 of the Note and Warrant Shares as required by Section 1(g) of the Warrant.

 

    	9

    	 

    

 

5.5           
Offering. Subject to the truth and accuracy of the Investor’s representations set forth in Section 6 of this
Agreement, the offer and issuance of the Securities as contemplated by this Agreement are exempt from the registration requirements
of the1933 Act, and the qualification or registration requirements of state securities laws or other applicable blue sky laws.
Neither the Company nor any authorized agent acting on its behalf will take any action hereafter that would cause the loss of such
exemptions.

 

5.6           
Public Reports. The Company is current in its filing obligations under the 1934 Act, including without limitation
as to its filings of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K (collectively,
the “Public Reports”). The Public Reports do not contain any untrue statement of a material fact or omit
to state any fact necessary to make any statement therein not misleading. The financial statements included within the Public Reports
for the fiscal year ended October 31, 2014 and for each quarterly period thereafter (the “Financial Statements”)
have been prepared in accordance with generally accepted accounting principles (“GAAP”) applied on a
consistent basis throughout the periods indicated and with each other, except that unaudited Financial Statements may not contain
all footnote required by generally accepted accounting principles. The Financial Statements fairly present, in all material respects,
the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein, subject in
the case of unaudited Financial Statements to normal year-end audit adjustments.

 

5.7           
Compliance With Laws. The Company has not violated any law or any governmental regulation or requirement which violation
has had or would reasonably be expected to have a Material Adverse Effect on its business and the Company has not received written
notice of any such violation.

 

5.8           
Violations. The consummation of the transactions contemplated by the Transaction Documents and all other documents
and instruments required to be delivered in connection therewith will not result in or constitute any of the following: (a) a violation
of any provision of the articles of incorporation, bylaws or other governing documents of the Company; (b) a violation of any provisions
of any applicable law or of any writ or decree of any court or governmental instrumentality; (c) a default or an event that, with
notice or lapse of time or both, would be a default, breach, or violation of a lease, license, promissory note, financing arrangement
for debt or equity instruments, conditional sales contract, commitment, indenture, mortgage, deed of trust, or other agreement,
instrument, or arrangement to which the Company is a party or by which the Company or its property is bound; (d) an event that
would permit any party to terminate any agreement or to accelerate the maturity of any indebtedness or other obligation of the
Company; or (e) the creation or imposition of any lien, pledge, option, security agreement, equity, claim, charge, encumbrance
or other restriction or limitation on the capital stock or on any of the properties or assets of the Company.

 

    	10

    	 

    

 

5.9           
Consents; Waivers. No consent, waiver, approval or authority of any nature, or other formal action, by any Person,
firm or corporation, or any agency, bureau or department of any government or any subdivision thereof, not already obtained, is
required in connection with the execution and delivery of the Transaction Documents by the Company or the consummation by the Company
of the transactions provided for herein and therein.

 

5.10         
Sarbanes-Oxley Act. The Company is in compliance with any and all applicable requirements of the Sarbanes-Oxley Act
of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission
thereunder that are effective as of the date hereof.

 

5.11         
Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public
board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against
or affecting the Company, the Common Stock or any of the Company’s officers or directors in their capacities as such.

 

5.12         
Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial
statements included within the Public Reports, except as specifically disclosed in a subsequent Public Report filed prior to the
date hereof: (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result
in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade
payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not
required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution
of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of
its capital stock and (v) the Company has not issued any equity securities to any officer, director or affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its
Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would be required to be
disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been
publicly disclosed at least one Trading Day prior to the date that this representation is made.

 

5.13         
Intellectual Property. The Company has, or has rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights as described in the Public Reports as necessary or required for use in connection with their respective businesses
and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”).
None of, and the Company has not received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this
Agreement. The Company has not received, since the date of the latest audited financial statements included within the Public Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights
of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of
the Intellectual Property Rights. The Company has taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.

 

    	11

    	 

    

 

5.14         
Registration Rights. Other than the Investor or as set forth in the Public Reports, no Person has any right to cause
the Company to effect the registration under the 1933 Act of any securities of the Company.

 

5.15         
Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided the Investor or its agents
or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company
understands and confirms that the Investor will rely on the foregoing representation in effecting transactions in securities of
the Company. All of the disclosure furnished by or on behalf of the Company to the Investor regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is
true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.
The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do
not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.
The Company acknowledges and agrees that the Investor does not make nor has made any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in Section 6 hereof.

 

5.16         
No Integrated Offering. Assuming the accuracy of the Investor’s representations and warranties set forth in
Section 6, neither the Company, nor any of its affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the 1933 Act which would require
the registration of any such securities under the 1933 Act, or (ii) any applicable shareholder approval provisions of any Trading
Market on which any of the securities of the Company are listed or designated.

 

5.17         
Seniority. As of the Closing Date, no Indebtedness or other claim against the Company is senior to the Note in right
of payment, whether with respect to interest or upon liquidation or dissolution, or otherwise, other than indebtedness secured
by purchase money security interests (which is senior only as to underlying assets covered thereby) and capital lease obligations
(which is senior only as to the property covered thereby).

 

    	12

    	 

    

 

5.18         
Bankruptcy Status; Indebtedness. The Company has no current intention or expectation to file for reorganization or
liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. Schedule 5.18
sets forth as of the date hereof all outstanding secured and unsecured Indebtedness (as defined below) of the Company or any Subsidiary,
or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, “Indebtedness”
means (x) any liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred
in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness
of others, whether or not the same are or should be reflected in the Company’s consolidated balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course
of business; and (z) the present value of any lease payments in excess of $100,000 due under leases required to be capitalized
in accordance with GAAP. The Company is not in default with respect to any Indebtedness.

 

5.19         
Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for
soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another
to purchase any other securities of the Company.

 

5.20         
No Disqualification Events. None of the Company, any of its predecessors, any affiliated issuer, any director, executive
officer, other officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of
the Company's outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is
defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at the time of sale (each, an “Issuer
Covered Person”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i)
to (viii) under the 1933 Act (a “Disqualification Event”), except for a Disqualification Event covered
by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject
to a Disqualification Event.

 

6.           
Representations and Warranties of the Investor. The Investor hereby represents, warrants and covenants that:

 

6.1           
Authorization. The Investor has full power and authority to enter into this Agreement, to perform its obligations
hereunder and to consummate the transactions contemplated hereby and has taken all action necessary to authorize the execution
and delivery of this Agreement and the Registration Rights Agreement, the performance of its obligations hereunder and thereunder
and the consummation of the transactions contemplated hereby and thereby.

 

6.2           
No Public Sale or Distribution. The Investor is (i) acquiring the Note and the Warrant, and (ii) upon conversion
of the Note will acquire the Conversion Shares and (iii) upon exercise of the Warrant will acquire the Warrant Shares for its own
account, not as a nominee or agent, and not with a view towards, or for resale in connection with, the public sale or distribution
of any part thereof, except pursuant to sales registered or exempted under the 1933 Act. The Investor is acquiring the Securities
hereunder in the ordinary course of its business. The Investor does not presently have any contract, agreement, undertaking, arrangement
or understanding, directly or indirectly, with any Person to sell, transfer, pledge, assign or otherwise distribute any of the
Securities.

 

    	13

    	 

    

 

6.3           
Accredited Investor Status; Investment Experience. The Investor is an “accredited investor” as that term
is defined in Rule 501(a) of Regulation D. The Investor can bear the economic risk of its investment in the Securities, and has
such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of an investment
in the Securities.

 

6.4           
Reliance on Exemptions. The Investor understands that the Securities are being offered and sold to it in reliance
on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company
is relying in part upon the truth and accuracy of, and the Investor’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Investor set forth herein in order to determine the availability of such exemptions and
the eligibility of the Investor to acquire the Securities.

 

6.5           
Information. The Investor and its advisors, if any, have been furnished with all materials relating to the business,
finances and operations of the Company and materials relating to the offer and sale of the Securities which have been requested
by the Investor. The Investor and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither
such inquiries nor any other due diligence investigations conducted by the Investor or its advisors, if any, or its representatives
shall modify, amend or affect the Investor’s right to rely on the Company’s representations and warranties contained
herein. The Investor understands that its investment in the Securities involves a high degree of risk. The Investor has sought
such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its
acquisition of the Securities. The Investor is relying solely on its own accounting, legal and tax advisors, and not on any statements
of the Company or any of its agents or representatives, for such accounting, legal and tax advice with respect to its acquisition
of the Securities and the transactions contemplated by this Agreement.

 

6.6           
No Governmental Review. The Investor understands that no United States federal or state agency or any other government
or governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability
of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

6.7           
Validity; Enforcement; No Conflicts. This Agreement and each Transaction Document to which the Investor is a party
have been duly and validly authorized, executed and delivered on behalf of the Investor and shall constitute the legal, valid and
binding obligations of the Investor enforceable against the Investor in accordance with their respective terms, except as such
enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and
remedies. The execution, delivery and performance by the Investor of this Agreement and each Transaction Document to which the
Investor is a party and the consummation by the Investor of the transactions contemplated hereby and thereby will not (i) result
in a violation of the organizational documents of the Investor or (ii) conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which the Investor is a party, or (iii) result in a violation of
any law, rule, regulation, order, judgment or decree (including federal and state securities or “Blue Sky” laws) applicable
to the Investor, except in the case of clause (ii) above, for such conflicts, defaults or rights which would not, individually
or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Investor to perform its obligations
hereunder.

 

    	14

    	 

    

 

6.8           
Organization and Standing. The Investor is a company duly organized, validly existing and in good standing under
the laws of the British Virgin Islands.

 

6.9           
No Disqualification Events. None of the Investor, any of its predecessors, any affiliates of the Investor, any director,
executive officer, other officer of the Investor, (each, an “Investor Covered Person” and, together, “Investor
Covered Persons”) is subject to any of the "Bad Actor" disqualifications described in Rule 506(d)(1)(i) to (viii)
under the 1933 Act (an “Investor Disqualification Event”), except for an Investor Disqualification Event covered by
Rule 506(d)(2) or (d)(3). The Investor has exercised reasonable care to determine whether any Investor Covered Person is subject
to a Disqualification Event. The Investor has complied, to the extent applicable, with its disclosure obligations under Rule 506(e).

 

6.10         
Brokers or Finders. The Investor represents and warrants, to the best of its knowledge, that no finder, broker, agent,
financial advisor or other intermediary, nor any purchaser representative or any broker-dealer acting as a broker, is entitled
to any compensation in connection with the transactions contemplated by this Agreement or the transactions contemplated hereby.

 

6.11         
Ability to Perform. There are no actions, suits, proceedings or investigations pending against Investor or Investor’s
assets before any court or governmental agency (nor is there any threat thereof) which would impair in any way Investor’s
ability to enter into and fully perform its commitments and obligations under this Agreement or the transactions contemplated hereby.

 

7.           
Use of Proceeds. The Investor acknowledges that the Company will use the proceeds received from the purchase of the
Note and Warrant for, among other things, (i) costs and expenses relating to the sale of the Note and Warrant to the Investor and
(ii) general working capital purposes.

 

    	15

    	 

    

 

8.           
Rule 144 Availability; Public Information. At all times during the period commencing on the six (6) month anniversary
of the Closing Date and ending at such time that all of the Securities can be sold without the requirement to be in compliance
with Rule 144(c)(1) under the 1933 Act and otherwise without restriction or limitation pursuant to Rule 144 under the 1933 Act,
the Company shall use its reasonable best efforts to ensure the availability of Rule 144 under the 1933 Act to the Investor with
regard to the Conversion Shares and the Warrant Shares (assuming a cashless exercise of the Warrant), including compliance with
Rule 144(c)(1) under the 1933 Act. If, (i) at any time during the period commencing from the six (6) month anniversary of the Closing
Date and ending on the first anniversary of the Closing Date, the Company shall fail for any reason to satisfy the current public
information requirement under Rule 144(c) under the 1933 Act (a “Public Information Failure”), or (ii)
the Company shall fail to take such action as is reasonably requested by the Investor to enable the Investor to sell the Conversion
Shares and the Warrant Shares (assuming a cashless exercise of the Warrant) pursuant to Rule 144 under the 1933 Act (including,
without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to the Company’s
transfer agent as may be reasonably requested from time to time by the Investor and otherwise fully cooperate with Investor and
Investor’s broker to effect such sale of securities pursuant to Rule 144 under the 1933 Act) (a “Process Failure”),
then, in either case, in addition to the Investor’s other available remedies, the Company shall pay to an Investor, in cash,
as liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities,
an amount in cash equal to two percent (2.0%) of the aggregate Purchase Price of the Investor’s Securities on the day of
a Public Information Failure or Process Failure, as applicable, and on every thirtieth (30th) day (pro rated for periods totaling
less than thirty days) thereafter until (a) in the case of a Process Failure, the date such Process Failure is cured, or (b) in
the case of a Public Information Failure, the earlier of (1) the date such Public Information Failure is cured and (b) such time
that such public information is no longer required for the Investor to transfer the Conversion Shares or the Warrant Shares (assuming
a cashless exercise of the Warrant) pursuant to Rule 144 under the 1933 Act. The payments to which the Investor shall be entitled
pursuant to this Section 8 are referred to herein as “Rule 144 Failure Payments.” Rule
144 Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Rule 144 Failure
Payments are incurred and (ii) the third (3rd) Trading Day after the event or failure giving rise to the Rule 144 Failure Payments
is cured.

 

9.           
Indemnification. In consideration of the Investor’s execution and delivery of the Transaction Documents and
acquiring the Securities thereunder and in addition to all of the Company’s other obligations under the Transaction Documents,
the Company shall defend, protect, indemnify and hold harmless the Investor and each holder of any Securities and all of their
stockholders, partners, members, officers, directors, employees and direct or indirect investors and any of the foregoing Persons’
agents or other representatives (including, without limitation, those retained in connection with the transactions contemplated
by this Agreement) (collectively, the “Indemnitees”) from and against any and all actions, causes of
action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith (irrespective
of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable
attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred by any Indemnitee as
a result of, or arising out of, or relating to (a) any misrepresentation or breach of any representation or warranty made by the
Company or any Subsidiary in any of the Transaction Documents, (b) any breach of any covenant, agreement or obligation of the Company
or any Subsidiary contained in any of the Transaction Documents or (c) any cause of action, suit or claim brought or made against
such Indemnitee by a third party (including for these purposes a derivative action brought on behalf of the Company or any Subsidiary)
and arising out of or resulting from (i) the execution, delivery, performance or enforcement of any of the Transaction Documents,
(ii) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance
of the Securities, or (iii) the status of the Investor or holder of the Securities as an investor in the Company pursuant to the
transactions contemplated by the Transaction Documents. To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
which is permissible under applicable law. Except as otherwise set forth herein, the mechanics and procedures with respect to the
rights and obligations under this Section 9 shall be the same as those set forth in Section 6 of the Registration Rights Agreement.
Notwithstanding anything to the contrary in this Section 9, the Company shall not be obligated to pay an Indemnitee any sums otherwise
due under this Section 9 if the Company has already paid the Indemnitee such sums for the same Indemnified Liabilities under Section
6 of the Registration Rights Agreement.

 

    	16

    	 

    

 

10.           
Reserved.

 

11.           
Reserved.

 

12.           
Miscellaneous

 

12.1         
Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure
to the benefit of and be binding upon the respective successors and assigns of the parties (including transferees of the Securities).
Nothing in this Agreement, express or implied, is intended to confer upon any party, other than the parties hereto or their respective
successors and assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly
provided in this Agreement.

 

12.2         
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or
conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in New York County, New York , for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert
in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT
IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING
OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

12.3         
Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to
be considered in construing or interpreting this Agreement.

 

12.4         
Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a)
upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business
hours of the recipient; if not, then on the next Trading Day, (c) five (5) Trading Days after having been sent by registered or
certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight
courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to (a) in the case
of the Company, to RealBiz Media Group, Inc. Suite 200, 2690 Weston Road, Weston, Florida 33331, Telephone Number: (954) 888-9779,
Fax: (954) 888-9082, Attention: President, with a copy (which shall not constitute notice) to Leslie Marlow, Gracin & Marlow,
405 Lexington Avenue, 26th Floor, New York, New York 10174, Telephone Number (212) 907-6457 or (b) in the case of the Investor,
to Himmil Investments, Ltd., Rodus Building, 4th Floor, Road Town, Tortola, British Virgin Islands, Telephone Number:
(284) 494-8086, Fax: (284) 494-9474, Attention: Arthur C. Price, Director, with a copy (which shall not constitute notice) to Anthony
J. Marsico, Esq., Greenberg Traurig, LLP, 200 Park Avenue, New York, New York 10166, Telephone Number: (212) 801-9200, Fax (212)
805-9362.

 

    	17

    	 

    

 

12.5         
Finder’s Fees. Each party represents that it neither is nor will be obligated for any finders’ fee or
commission in connection with this transaction. The Company shall indemnify and hold harmless each Investor from any liability
for any commission or compensation in the nature of a finders’ fee (and the costs and expenses of defending against such
liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.

 

12.6         
Amendments and Waivers. No provision of this Agreement may be amended other than by a written instrument signed by
both parties hereto. No provision of this Agreement may be waived other than in a written instrument signed by the party against
whom enforcement of such waiver is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercises thereof or of any other right, power or privilege.

 

12.7         
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such
provision shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were
so excluded and shall be enforceable in accordance with its terms.

 

12.8         
Entire Agreement. This Agreement and the documents referred to herein constitute the entire agreement among the parties
and no party shall be liable or bound to any other party in any manner by any warranties, representations or covenants except as
specifically set forth herein or therein.

 

12.9         
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. Signatures to this Agreement transmitted by facsimile,
by electronic mail in “portable document format” (“.pdf”), or by any other electronic means which preserves
the original graphic and pictorial appearance of the Agreement, shall have the same effect as physical delivery of the paper document
bearing the original signature.

 

12.10     
Interpretation. Unless the context of this Agreement clearly requires otherwise, (a) references to the plural include
the singular, the singular the plural, the part the whole, (b) references to any gender include all genders, (c) “including”
has the inclusive meaning frequently identified with the phrase “but not limited to” and (d) references to “hereunder”
or “herein” relate to this Agreement.

 

    	18

    	 

    

 

12.11     
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery
of damages, the Investor and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained
in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation
the defense that a remedy at law would be adequate.

 

12.12     
Fees and Expenses. Each party shall bear its own fees and expenses related to the transactions contemplated by the
Transaction Documents; provided, however, that $20,000 shall be withheld by the Investor from the Purchase Price
at the Closing as a non-accountable and non-refundable document preparation fee (the “Document Preparation Fee”)
in connection with the preparation, negotiation, execution and delivery of the Transaction Documents and business and legal due
diligence of the Company, and shall be paid directly to the Investor’s counsel on the Closing Date by wire transfer of immediately
available funds. For the avoidance of doubt, the Document Preparation Fee (and any portion thereof) shall be non-refundable when
paid. The Company shall pay all transfer agent fees (including, without limitation, any fees required for same-day processing of
any instruction letter delivered by the Company, delivery of any legal opinion, and any conversion or exercise notice delivered
by an Investor), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Investor.

 

12.13     
No Variable Rate Transactions; No Frustration. For so long as the Note remains outstanding, neither the Company nor
any of its affiliates or Subsidiaries, nor any of its or their respective officers, employees, directors, agents or other representatives,
will, without the prior written consent of the Investor (which consent may be withheld, delayed or conditioned in the Investor’s
sole discretion), effect, enter into, announce or recommend to its stockholders any agreement, plan, arrangement or transaction
that would or would reasonably be expected to constitute or involve a Variable Rate Transaction. So long as the Investor or its
affiliates hold any Securities, neither the Company nor any of its affiliates or Subsidiaries, nor any of its or their respective
officers, employees, directors, agents or other representatives, will, without the prior written consent of the Investor (which
consent may be withheld, delayed or conditioned in the Investor’s sole discretion), effect, enter into, announce or recommend
to its stockholders any agreement, plan, arrangement or transaction that would or would reasonably be expected to restrict, delay,
conflict with or impair the ability or right of the Company to timely perform its obligations under this Agreement, the Note or
the Warrant, including, without limitation, the obligation of the Company to timely deliver shares of Common Stock to the Investor
or its affiliates in accordance with this Agreement, the Note or the Warrant.

 

12.14     
Further Transactions. The Company acknowledges that the Investor has made certain concessions on terms in this transaction
to accommodate the Company; however, the Company confirms its understanding that the Investor is not bound by these concessions
in negotiating any future agreements between the parties, should any such negotiations ever occur.

 

12.15     
No Integration. None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act), or any
person acting on behalf of the Company or such affiliate will sell, offer for sale, or solicit offers to buy or otherwise negotiate
in respect of any security (as defined in the 1933 Act) which will be integrated with the sale of the Securities in a manner which
would require the registration of the Securities under the 1933 Act or require stockholder approval under the rules and regulations
of the Trading Market and the Company will take all action that is appropriate or necessary to assure that its offerings of other
securities will not be integrated for purposes of the 1933 Act or the rules and regulations of the Trading Market, with the issuance
of Securities contemplated hereby.

 

    	19

    	 

    

 

13.           
Additional Defined Terms. In addition to the terms defined elsewhere in this Agreement, the Note or the Warrant the
following terms have the meanings set forth in this Section 13:

 

13.1         
“1934 Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder.

 

13.2         
Intentionally omitted.

 

13.3         
“Commission” means the United States Securities and Exchange Commission.

 

13.4         
“Convertible Securities” shall have the meaning as set forth in Section 13.16 below.

 

13.5         
“Effective Date” means the date that the Initial Registration Statement (as defined in the Registration
Rights Agreement) filed pursuant to the Registration Rights Agreement has been declared effective by the Commission.

 

13.6         
Intentionally Omitted.

 

13.7         
“Liens” means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive
right or other restriction.

 

13.8         
 “Material Adverse Effect” means (i) a material adverse effect on the legality, validity or enforceability
of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition
(financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s
ability to perform in any material respect on a timely basis its obligations under any Transaction Document.

 

13.9         
 “Person” means any individual, partnership, firm, corporation, limited liability company, association,
trust, unincorporated organization or other entity, as well as any syndicate or group that would be deemed to be a person under
Section 13(d)(3) of the 1934 Act. For all purposes of this Agreement, violations of the restrictions set forth in this Section
11 by any Subsidiary or affiliate of the Company, or any officer, employee, director, agent or other representative of the Company
or any of its Subsidiaries or affiliates shall be deemed a direct breach of this Section 11 by the Company.

 

13.10     
“Registrable Securities” shall have the meaning set forth in the Registration Rights Agreement.

 

13.11     
“Short Sales” shall mean “short sales” as defined in Rule 200 promulgated under Regulation
SHO under the 1934 Act.

 

    	20

    	 

    

 

13.12     
“Subsidiary” shall mean any corporation or other entity of which at least a majority of the securities
or other ownership interest having ordinary voting power for the election of directors or other persons performing similar functions
are at the time owned directly or indirectly by the Company and/or any of its other Subsidiaries.

 

13.13     
“Trading Day” means any day on which the Common Stock is traded on the Trading Market, provided
that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on the Trading
Market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on the
Trading Market (or if the Trading Market does not designate in advance the closing time of trading on the Trading Market, then
during the hour ending at 4:00:00 p.m., New York City time) unless such day is otherwise designated as a Trading Day in writing
by the Investor.

 

13.14     
“Trading Market” means any of the following markets or exchanges on which the Common Stock is
listed or quoted for trading on the date in question: the OTC Bulletin Board, The NASDAQ Global Market, The NASDAQ Global Select
Market, The NASDAQ Capital Market, the New York Stock Exchange, NYSE Arca, the NYSE MKT, or the OTCQX Marketplace or the OTCQB
Marketplace operated by OTC Markets Group Inc. (or any successor to any of the foregoing).

 

13.15     
“Variable Rate Transaction” means a transaction in which the Company or any Subsidiary (i) issues
or sells any convertible securities convertible or exchangeable into Common Stock of the Company (“Convertible Securities”)
either (A) at a conversion, exercise or exchange rate or other price that is based upon and/or varies with the trading prices of
or quotations for the shares of Common Stock at any time after the initial issuance of such convertible securities, or (B) with
a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such
Convertible Securities or upon the occurrence of specified or contingent events directly or indirectly related to the business
of the Company or the market for the Common Stock, including, without limitation, pursuant to any “weighted average”
or “full-ratchet” anti-dilution provision, or (ii) enters into any agreement (including, without limitation, an equity
line of credit or an “at-the-market” offering) whereby the Company or any Subsidiary may sell securities at a future
determined price.

 

[SIGNATURES ON THE FOLLOWING
PAGE]

 

    	21

    	 

    

 

IN WITNESS WHEREOF,
the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

 

	 	THE COMPANY
	 	 	 
	 	REALBIZ MEDIA GROUP, INC.
	 	 	 
	 	 	 
	 	By:	/s/ William Kerby	 
	 	 	Name: William Kerby
	 	 	Title: Chief Executive Officer

 

 

 

 

 

    	 

    	 

    

IN WITNESS WHEREOF,
the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

 

	 	THE INVESTOR:
	 	 	 
	 	 	 
	 	HIMMIL INVESTMENTS, LTD. 
	 	 	 
	 	By:	/s/ Arthur C. Price	 
	 	 	Name: Arthur C. Price
	 	 	Title: DirectorEX-10.7

 Exhibit 10.7 
  

 
  

 
  

INDENTURE 
 Dated as of
May 12, 2015 
  
  

THE CHEMOURS COMPANY, 
 THE
GUARANTORS PARTY HERETO, 
 U.S. BANK NATIONAL ASSOCIATION, 

as Trustee, 
 ELAVON FINANCIAL
SERVICES LIMITED, UK BRANCH, 
 as Paying Agent with respect to Euro Notes, 

and 
 ELAVON FINANCIAL SERVICES
LIMITED, 
 as Registrar and Transfer Agent with respect to Euro Notes 

 
  

 

							
	ARTICLE I	  
	
	DEFINITIONS	  
			
	Section 1.01		 Definitions
		 	1	  
	Section 1.02		 Other Definitions
		 	37	  
	Section 1.03		 Incorporation by Reference of Trust Indenture Act
		 	38	  
	Section 1.04		 Rules of Construction
		 	38	  
	
	ARTICLE II	  
	
	THE NOTES	  
			
	Section 2.01		 Issuable in Series
		 	39	  
	Section 2.02		 Establishment of Terms of Series of Notes
		 	39	  
	Section 2.03		 Denominations; Provisions for Payment
		 	42	  
	Section 2.04		 Execution and Authentication
		 	43	  
	Section 2.05		 Registrar, Paying Agent and Transfer Agent
		 	44	  
	Section 2.06		 Paying Agent To Hold Money in Trust
		 	45	  
	Section 2.07		 Holder Lists
		 	45	  
	Section 2.08		 Transfer and Exchange
		 	46	  
	Section 2.09		 Mutilated, Destroyed, Lost and Stolen Notes
		 	46	  
	Section 2.10		 Treasury Notes
		 	47	  
	Section 2.11		 Temporary Notes
		 	48	  
	Section 2.12		 Cancellation
		 	48	  
	Section 2.13		 Defaulted Interest
		 	48	  
	Section 2.14		 Global Notes
		 	48	  
	Section 2.15		 CUSIP Numbers, ISINs and Common Code Numbers
		 	51	  
	Section 2.16		 Benefits of the Indenture
		 	51	  
	Section 2.17		 Performance of the Transactions
		 	51	  
	
	 ARTICLE III
	   

	
	 REDEMPTION AND PREPAYMENT
	   

			
	Section 3.01		 Notices to Trustee
		 	51	  
	Section 3.02		 Selection of Notes To Be Redeemed
		 	52	  
	Section 3.03		 Notice of Redemption
		 	53	  
	Section 3.04		 Effect of Notice of Redemption
		 	54	  
	Section 3.05		 Deposit of Redemption Price
		 	54	  
	Section 3.06		 Notes Redeemed in Part
		 	55	  
	Section 3.07		 Optional Redemption
		 	55	  

  
 i 

							
	
	ARTICLE IV	  
	
	 COVENANTS
	   

			
	Section 4.01		 Payment of Notes
		 	55	  
	Section 4.02		 Reports and Other Information
		 	56	  
	Section 4.03		 Compliance Certificate
		 	57	  
	Section 4.04		 Further Instruments and Acts
		 	58	  
	Section 4.05		 Corporate Existence
		 	58	  
	Section 4.06		 Calculation of Original Issue Discount
		 	58	  
	Section 4.07		 Restricted Payments
		 	58	  
	Section 4.08		 Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries
		 	65	  
	Section 4.09		 Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock
		 	68	  
	Section 4.10		 Asset Sales
		 	75	  
	Section 4.11		 Transactions with Affiliates
		 	79	  
	Section 4.12		 Liens
		 	81	  
	Section 4.13		 Offer to Repurchase Upon Change of Control
		 	82	  
	Section 4.14		 Covenant Suspension
		 	84	  
	
	ARTICLE V	  
	
	SUCCESSORS	  
			
	Section 5.01		 Merger, Consolidation or Sale of All or Substantially All Assets
		 	86	  
	Section 5.02		 Successor Corporation Substituted
		 	88	  
	
	ARTICLE VI	  
	
	 DEFAULTS AND REMEDIES
	   

			
	Section 6.01		 Events of Default
		 	88	  
	Section 6.02		 Acceleration
		 	90	  
	Section 6.03		 Other Remedies
		 	91	  
	Section 6.04		 Waiver of Past Defaults
		 	92	  
	Section 6.05		 Control by Majority
		 	92	  
	Section 6.06		 Limitation on Suits
		 	92	  
	Section 6.07		 Rights of Holders to Receive Payment
		 	93	  
	Section 6.08		 Collection Suit by Trustee
		 	93	  
	Section 6.09		 Trustee May File Proofs of Claim
		 	93	  
	Section 6.10		 Priorities
		 	94	  
	Section 6.11		 Undertaking for Costs
		 	94	  
	Section 6.12		 Waiver of Stay or Extension Laws
		 	95	  

  
 ii 

							
	
	ARTICLE VII	  
	
	TRUSTEE	  
			
	Section 7.01		 Duties of Trustee
		 	95	  
	Section 7.02		 Rights of Trustee
		 	96	  
	Section 7.03		 Individual Rights of Trustee
		 	98	  
	Section 7.04		 Trustee’s Disclaimer
		 	98	  
	Section 7.05		 Notice of Defaults
		 	99	  
	Section 7.06		 Reports by Trustee to Holders
		 	99	  
	Section 7.07		 Compensation and Indemnity
		 	99	  
	Section 7.08		 Replacement of Trustee
		 	100	  
	Section 7.09		 Successor Trustee by Merger
		 	101	  
	Section 7.10		 Eligibility; Disqualification
		 	102	  
	Section 7.11		 Preferential Collection of Claims Against the Company and Guarantors
		 	102	  
	
	 ARTICLE VIII
	   

	
	 LEGAL DEFEASANCE, COVENANT DEFEASANCE

AND SATISFACTION AND DISCHARGE
	   

  

			
	Section 8.01		 Option To Effect Legal Defeasance or Covenant Defeasance
		 	102	  
	Section 8.02		 Legal Defeasance and Discharge
		 	102	  
	Section 8.03		 Covenant Defeasance
		 	103	  
	Section 8.04		 Conditions to Legal or Covenant Defeasance
		 	104	  
	Section 8.05		 Deposited Money and U.S. Government Obligations to be Held in Trust; Other Miscellaneous Provisions
		 	105	  
	Section 8.06		 Repayment to the Company
		 	106	  
	Section 8.07		 Satisfaction and Discharge of Indenture
		 	106	  
	Section 8.08		 Reinstatement
		 	108	  
	
	ARTICLE IX	  
	
	AMENDMENTS	  
			
	Section 9.01		 Without Consent of Holders
		 	108	  
	Section 9.02		 With Consent of Holders
		 	109	  
	Section 9.03		 Revocation and Effect of Consents and Waivers
		 	110	  
	Section 9.04		 Notation on or Exchange of Notes
		 	111	  
	Section 9.05		 Trustee to Sign Amendments
		 	111	  
	Section 9.06		 Payment for Consent
		 	111	  

  
 iii 

							
	
	ARTICLE X	  
	
	GUARANTEES	  
			
	Section 10.01		 Guarantees
		 	112	  
	Section 10.02		 Limitation on Liability
		 	113	  
	Section 10.03		 Releases
		 	114	  
	Section 10.04		 Successors and Assigns
		 	115	  
	Section 10.05		 No Waiver
		 	115	  
	Section 10.06		 Additional Guarantees
		 	115	  
	Section 10.07		 Execution of Supplemental Indenture for Future Guarantors
		 	115	  
	Section 10.08		 Non-Impairment
		 	116	  
	Section 10.09		 Benefits Acknowledged
		 	116	  
	
	ARTICLE XI	  
	
	MISCELLANEOUS	  
			
	Section 11.01		 Trust Indenture Act Controls
		 	116	  
	Section 11.02		 Notices
		 	116	  
	Section 11.03		 Communication by Holders with Other Holders
		 	117	  
	Section 11.04		 Certificate and Opinion as to Conditions Precedent
		 	118	  
	Section 11.05		 Statements Required in Certificate or Opinion
		 	118	  
	Section 11.06		 Rules by Trustee, Paying Agent and Registrar
		 	118	  
	Section 11.07		 Legal Holidays
		 	118	  
	Section 11.08		 Governing Law
		 	119	  
	Section 11.09		 No Personal Liability of Directors, Officers, Employees and Stockholders
		 	119	  
	Section 11.10		 Successors
		 	119	  
	Section 11.11		 Multiple Originals; Electronic Signatures
		 	119	  
	Section 11.12		 Waiver of Jury Trial
		 	119	  
	Section 11.13		 Table of Contents; Headings
		 	119	  
	Section 11.14		 Severability
		 	120	  
	Section 11.15		 Submission to Jurisdiction and Venue
		 	120	  
			
	Exhibit A		 Form of Supplemental Indenture for Additional Subsidiary Guarantors
				

  
 iv 

 CROSS-REFERENCE TABLE* 
  

			
	 Trust Indenture Act Section
	 	 Indenture Section

		
	 310(a)(1)
	 	7.10
	       (a)(2)
	 	7.10
	       (a)(3)
	 	N.A.
	       (a)(4)
	 	N.A.
	       (a)(5)
	 	7.10
	       (b)
	 	7.08, 7.10, 11.02
	       (c)
	 	N.A.
	 311(a)
	 	7.11
	       (b)
	 	7.11
	 312(a)
	 	2.07
	       (b)
	 	11.03
	       (c)
	 	11.03
	 313(a)
	 	7.06
	       (b)(1)
	 	N.A.
	       (b)(2)
	 	7.06
	       (c)
	 	7.06, 11.02
	       (d)
	 	7.06
	 314(a)
	 	4.02, 4.03, 11.02
	       (b)
	 	N.A.
	       (c)(1)
	 	7.02, 11.04, 11.05
	       (c)(2)
	 	7.02, 11.04, 11.05
	       (c)(3)
	 	N.A.
	       (d)
	 	N.A.
	       (e)
	 	11.05
	       (f)
	 	N.A.
	 315(a)
	 	7.01(b), 7.02(a)
	       (b)
	 	7.05, 11.02
	       (c)
	 	7.01
	       (d)
	 	6.05, 7.01(c)
	       (e)
	 	6.11
	 316(a) (last sentence)
	 	2.11
	       (a)(1)(A)
	 	6.05
	       (a)(1)(B)
	 	6.04
	       (a)(2)
	 	N.A.
	       (b)
	 	6.07
	       (c)
	 	9.03
	 317(a)(1)
	 	6.08
	       (a)(2)
	 	6.09
	       (b)
	 	2.06
	 318(a)
	 	11.01
	       (b)
	 	N.A.
	       (c)
	 	11.01

  

	*	N.A. means not applicable. 

 This Cross-Reference Table is not part of this Indenture. 

  
 v 

 INDENTURE dated as of May 12, 2015, among THE CHEMOURS COMPANY, a Delaware corporation (the
“Company”), each of the Company’s subsidiaries signatory hereto or that becomes a Guarantor pursuant to the terms of this Indenture (the “Subsidiary Guarantors”), U.S. BANK NATIONAL ASSOCIATION, a national
banking association organized under the laws of the United States, as trustee (the “Trustee”), ELAVON FINANCIAL SERVICES LIMITED, UK BRANCH, a limited liability company registered in Ireland limited liability company registered in
Ireland with the Companies Registration Office (registered number 418442), with its registered office at Block E, Cherrywood Business Park, Loughlinstown, Dublin, Ireland acting through its UK Branch (registered number BR009373) from its offices at
5th Floor, 125 Old Broad Street, London EC2N 1AR, United Kingdom, as paying agent with respect to Euro Notes, and ELAVON FINANCIAL SERVICES LIMITED, a limited liability company registered in Ireland with the Companies Registration Office (registered
number 418442), with its registered office at Block E, Cherrywood Business Park, Loughlinstown, Dublin, Ireland, as registrar and transfer agent with respect to Euro Notes. 

The Company, the Guarantors and the Trustee agree as follows for the benefit of each other and for the equal and ratable benefit of the
Holders of the notes authenticated and delivered under this Indenture (the “Notes”): 
 ARTICLE I 

DEFINITIONS 

SECTION 1.01 Definitions. The following terms shall have the following meanings: 

“Acquired Indebtedness” means, with respect to any specified Person, 

(1) Indebtedness of any other Person existing at the time such other Person is merged with or into or became a Restricted Subsidiary of
such specified Person, including Indebtedness incurred in connection with, or in contemplation of, such other Person merging with or into or becoming a Restricted Subsidiary of such specified Person, and 

(2) Indebtedness secured by a Lien encumbering any asset acquired by such specified Person. 

“Affiliate” of any specified Person means any other Person directly or indirectly controlling or controlled by or under
direct or indirect common control with such specified Person. For purposes of this Indenture, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control
with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by
agreement or otherwise. 

 “Agent” means any Transfer Agent, Registrar, Paying Agent and Custodian. 

“Asset Sale” means: 

(1) the sale, conveyance, transfer or other disposition, whether in a single transaction or a series of related transactions, of property
or assets (including by way of a Sale and Lease-Back Transaction) of the Company or any of its Restricted Subsidiaries (each referred to in this definition as a “disposition”); or 

(2) the issuance or sale of Equity Interests of any Restricted Subsidiary (other than Preferred Stock of Restricted Subsidiaries issued
in compliance with Section 4.09, whether in a single transaction or a series of related transactions; 
 in each case, other than: 

(a) any disposition of Cash Equivalents or Investment Grade Securities or surplus, obsolete or worn-out property or equipment in the
ordinary course of business or any disposition of inventory or goods (or other assets) held for sale or no longer used in the ordinary course of business; 

(b) the disposition of all or substantially all of the assets of the Company in a manner permitted pursuant to Section 5.01 or any
disposition that constitutes a Change of Control pursuant to this Indenture; 
 (c) the making of any Restricted Payment or Permitted
Investment that is permitted to be made, and is made, under Section 4.07; 
 (d) any disposition of assets or issuance or sale of
Equity Interests of any Restricted Subsidiary in any transaction or series of transactions with an aggregate fair market value of less than $75.0 million; 

(e) any disposition of property or assets or issuance of securities by a Restricted Subsidiary of the Company to the Company or by the
Company or a Restricted Subsidiary of the Company to another Restricted Subsidiary of the Company; 
 (f) to the extent allowable under
Section 1031 of the Internal Revenue Code of 1986, as amended, or comparable law or regulation, any exchange of like property (excluding any boot thereon) for use in a Similar Business; 

(g) the lease, assignment or sub-lease of any real or personal property in the ordinary course of business or to the extent required by,
or made pursuant to, customary buy/sell arrangements between joint venture parties set forth in any joint venture or similar binding agreement; 

(h) any issuance or sale of Equity Interests in, or Indebtedness or other securities of, an Unrestricted Subsidiary; 

  
 2 

 (i) foreclosures, condemnations or any similar action with respect to assets or the granting
of Liens not prohibited by this Indenture; 
 (j) any financing transaction with respect to the acquisition or construction of property
by the Company or any Restricted Subsidiary after the Original Issue Date, including Sale and Lease-Back Transactions, and asset securitizations permitted by this Indenture; 

(k) the licensing and sub-licensing of intellectual property or other general intangibles in the ordinary course of business or
consistent with past practice; 
 (l) the sale, discount or other disposition of inventory, accounts receivable or notes receivable in
the ordinary course of business or the conversion of accounts receivable to notes receivable; 
 (m) any surrender or waiver of
contract rights or the settlement, release or surrender of contract rights or other litigation claims in the ordinary course of business; 

(n) any transfer, sale or other disposition of Securitization Assets to a Securitization Special Purpose Entity in connection with a Qualified
Securitization Transaction; and 
 (o) any disposition of assets effected pursuant to the Transactions. 

“Bankruptcy Law” means Title 11, U.S. Code or any similar federal or state law for the relief of debtors or other relevant
law in any jurisdiction of competent authority for the relief of debtors relating to moratorium, bankruptcy, insolvency, receivership, winding up, liquidation, examinership or reorganization or any amendment to, succession to or change in any such
law. 
 “board of directors” means, with respect to a corporation, the board of directors of the corporation, and, with
respect to any other Person, the board or committee of such Person, or board of directors of the general partner or general manager of such Person, serving a similar function. 

“Board Resolution” means a copy of a resolution certified by the secretary or an assistant secretary of the Company to have
been adopted by the board of directors of the Company or pursuant to authorization by the board of directors of the Company, including by an authorized officer, and to be in full force and effect on the date of the certificate, and delivered to the
Trustee. 
 “Business Day” means each day that is not a Legal Holiday. 

“Calculation Date” means the date on which the event for which the calculation of the Consolidated Net Leverage Ratio or the
Fixed Charge Coverage Ratio, as applicable, shall occur. 

  
 3 

 “Capital Stock” means: 

(1) in the case of a corporation, corporate stock; 

(2) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however
designated) of corporate stock; 
 (3) in the case of a partnership or limited liability company, partnership or membership interests
(whether general or limited); and 
 (4) any other interest or participation (including, without limitation, quotas) that confers on a
Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person. 
 “Capitalized
Lease Obligation” means, at the time any determination thereof is to be made, the amount of the liability in respect of a capital lease that would at such time be required to be capitalized and reflected as a liability on a balance sheet
(excluding the footnotes thereto) in accordance with GAAP; provided that any obligations of the Company or its Restricted Subsidiaries either existing on the Original Issue Date or created prior to any recharacterization described below
(i) that were not included on the consolidated balance sheet of the Company as capital lease obligations and (ii) that are subsequently recharacterized as capital lease obligations due to a change in accounting treatment or otherwise,
shall for all purposes under this Indenture (including, without limitation, the calculation of Consolidated Net Income and EBITDA) not be treated as capital lease obligations, Capitalized Lease Obligations or Indebtedness. 

“Cash Equivalents” means: 

(1) United States Dollars; 

(2) (a) Canadian Dollars, pounds sterling, yen, Euros, Brazilian reais, Renminbi and the New Taiwan dollar; and 

(b) such other currencies held by the Company or any Restricted Subsidiary from time to time in the ordinary course of business; 

(3) securities issued or directly and fully and unconditionally guaranteed or insured by the U.S. government (or any agency or
instrumentality thereof the securities of which are unconditionally guaranteed as a full faith and credit obligation of the U.S. government) and European Government Obligations, in each case with maturities of 24 months or less from the date of
acquisition; 
 (4) certificates of deposit, time deposits and Eurodollar time deposits with maturities of 24 months or less from the
date of acquisition, bankers’ acceptances with maturities not exceeding one year and overnight bank deposits, in each case with any commercial bank having capital and surplus of not less than $500.0 million in the case of U.S. banks and
$100.0 million (or the U.S. Dollar equivalent as of the date of determination) in the case of non-U.S. banks; 

  
 4 

 (5) repurchase obligations for underlying securities of the types described in clauses
(3) and (4) entered into with any financial institution meeting the qualifications specified in clause (4) above; 

(6) commercial paper rated at least P-1 by Moody’s or at least A-1 by S&P (or, if at any time neither Moody’s nor S&P
shall be rating such obligations, an equivalent rating from another Rating Agency) and in each case maturing within 24 months after the date of creation thereof; 

(7) marketable short-term money market and similar securities having a rating of at least P-2 or A-2 from either Moody’s or S&P,
respectively (or, if at any time neither Moody’s nor S&P shall be rating such obligations, an equivalent rating from another Rating Agency) and in each case maturing within 24 months after the date of creation thereof; 

(8) investment funds investing at least 95% of their assets in securities of the types described in clauses (1) through
(7) above; 
 (9) readily marketable direct obligations issued by any state, commonwealth or territory of the United States or any
political subdivision thereof having an Investment Grade Rating from either Moody’s or S&P with maturities of 24 months or less from the date of acquisition; 

(10) Indebtedness or Preferred Stock issued by Persons with a rating of “A” or higher from S&P or “A2” or higher
from Moody’s with maturities of 24 months or less from the date of acquisition; 
 (11) Investments with average maturities of 24
months or less from the date of acquisition in money market funds rated AAA- (or the equivalent thereof) or better by S&P or Aaa3 (or the equivalent thereof) or better by Moody’s; and 

(12) Investments in money market funds with average maturities of 24 months or less from the date of acquisition that are rated
“Aaa3” by Moody’s and “AAA” by S&P (or reasonably equivalent ratings of another internationally recognized rating agency). 

Notwithstanding the foregoing, Cash Equivalents shall include amounts denominated in currencies other than those set forth in clause
(1) or (2) above; provided that such amounts are converted into any currency listed in clause (1) or (2) as promptly as practicable and in any event within ten Business Days following the receipt of such amounts. 

“Change of Control” means the occurrence of any one of the following: 

(1) the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a
series of related transactions, of all or substantially all of the assets of the Company and its Restricted Subsidiaries, taken as a whole, to any person, other than to the Company or one of its Restricted Subsidiaries; 

  
 5 

 (2) the Company becomes aware (by way of a report or any other filing pursuant to
Section 13(d) of the Exchange Act, proxy, vote, written notice or otherwise) of the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any person becomes the beneficial
owner, directly or indirectly, of more than 50% of the outstanding Voting Stock of the Company, measured by voting power rather than number of shares; or 

(3) the adoption of a plan relating to the liquidation or dissolution of the Company. 

For the purposes of this definition, the term “person” shall be defined as that term is used in Section 13(d)(3) of the
Exchange Act and the term “beneficial owner” shall be defined as that term is used in Rules 13d-3 and 13d-5 under the Exchange Act. 

For the avoidance of doubt, the consummation of the Transactions shall not constitute a Change of Control. 

“Clearstream” means Clearstream Banking, société anonyme, or any successor thereto. 

“Common Depositary” means, with respect to any Euro Notes issuable or issued in whole or in part in global form, the Person
specified in Section 2.14 as the Common Depositary with respect to Euro Notes, and any and all successors thereto appointed as common depositary hereunder and having become such pursuant to the applicable provisions of this Indenture. 

“Company” has the meaning assigned to it in the preamble to this Indenture. 

“Company Order” means a written order signed in the name of the Company by an Officer. 

“Consolidated Depreciation and Amortization Expense” means, with respect to any Person for any period, the total amount of
depreciation and amortization expense and capitalized fees related to any Qualified Securitization Transaction or a Receivables Facility and amortization of intangible assets, debt issuance costs, commissions, fees and expenses, including the
amortization of deferred financing fees of such Person and its Restricted Subsidiaries for such period on a consolidated basis and otherwise determined in accordance with GAAP (excluding, in each case, amortization expense attributable to a prepaid
cash item that was paid in a prior period). 

  
 6 

 “Consolidated Interest Expense” means, with respect to any Person for any
period, without duplication, the sum of: 
 (1) consolidated interest expense of such Person and its Restricted Subsidiaries for such
period, to the extent such expense was deducted (and not added back) in computing Consolidated Net Income (including (a) amortization of original issue discount resulting from the issuance of Indebtedness at less than par, (b) all
commissions, discounts and other fees and charges owed with respect to letters of credit or bankers acceptances, (c) non-cash interest payments (but excluding any non-cash interest expense attributable to the movement in the mark to market
valuation of Hedging Obligations or other derivative instruments pursuant to GAAP), (d) the interest component of Capitalized Lease Obligations and (e) net payments, if any, made (less net payments, if any, received) pursuant to interest
rate Hedging Obligations with respect to Indebtedness but excluding (i) penalties and interest relating to taxes; (ii) accretion or accrual of discounted liabilities not constituting Indebtedness, (iii) any expense resulting from the
discounting of any outstanding Indebtedness in connection with the application of purchase accounting in connection with any acquisition, (iv) amortization of deferred financing fees, debt issuance costs, commissions, fees and expenses,
(v) any expensing of bridge, commitment and other financing fees and (vi) commissions, discounts, yield and other fees and charges (including any interest expense) related to any Qualified Securitization Transaction or Receivables
Facility); plus 
 (2) consolidated capitalized interest of such Person and its Restricted Subsidiaries for such period, whether
paid or accrued; less 
 (3) interest income for such period. 

For purposes of this definition, interest on a Capitalized Lease Obligation shall be deemed to accrue at an interest rate reasonably
determined by such Person to be the rate of interest implicit in such Capitalized Lease Obligation in accordance with GAAP. 

“Consolidated Net Income” means, with respect to any Person for any period, the aggregate of the net income (loss) of such
Person and its Restricted Subsidiaries for such period, on a consolidated basis, and otherwise determined in accordance with GAAP; provided, however, that, without duplication, 

(1) the cumulative effect of a change in accounting principles and changes as a result of the adoption or modification of accounting
policies during such period shall be excluded, 
 (2) any after-tax effect of income (loss) from abandoned or discontinued operations
and any net after-tax gains or losses on disposal of abandoned or discontinued operations shall be excluded, 
 (3) any net after-tax
gains or losses (less all fees and expenses relating thereto) attributable to asset dispositions or the sale or other disposition of any Capital Stock of any Person other than in the ordinary course of business, as determined in good faith by the
Company, shall be excluded, 

  
 7 

 (4) the Net Income for such period of any Person that is not a Subsidiary or is an
Unrestricted Subsidiary or that is accounted for by the equity method of accounting shall be excluded; provided that Consolidated Net Income of the Company will be increased by the amount of dividends or distributions or other payments that
are actually paid in cash (or to the extent converted into cash) or Cash Equivalents to the referent Person or a Restricted Subsidiary thereof in respect of such period (other than any such proceeds that are used to make a JV Reinvestment), 

(5) solely for the purpose of determining the amount available for Restricted Payments under clause (3)(a) of Section 4.07(a),
the Net Income for such period of any Restricted Subsidiary (other than any Subsidiary Guarantor) shall be excluded to the extent that the declaration or payment of dividends or similar distributions by that Restricted Subsidiary of its Net Income
is not at the date of determination permitted without any prior governmental approval (which has not been obtained) or, directly or indirectly, by the operation of the terms of its charter or any agreement, instrument, judgment, decree, order,
statute, rule or governmental regulation applicable to that Restricted Subsidiary or its stockholders, unless such restriction with respect to the payment of dividends or similar distributions has been legally waived; provided that
Consolidated Net Income of the Company will be increased by the amount of dividends or other distributions or other payments that are actually paid in cash (or to the extent converted into cash) or Cash Equivalents to the Company or a Restricted
Subsidiary thereof in respect of such period, to the extent not already included therein, 
 (6) any after-tax effect of income (loss)
from the early extinguishment of Indebtedness or Hedging Obligations or other derivative instruments shall be excluded, 
 (7) any
impairment charge or asset write-off or write-down, including impairment charges or asset write-offs or write-downs related to intangible assets, physical assets (including commodities and inventory), long-lived assets or investments in debt and
equity securities or as a result of a change in law or regulation, in each case, pursuant to GAAP and the amortization of intangibles arising pursuant to GAAP shall be excluded, 

(8) any non-cash compensation or similar charge or expense or reduction of revenue, including any such charge or amount arising from
grants of stock appreciation or similar rights, stock options, restricted stock or other rights and any cash charges associated with the rollover, acceleration or payout of Equity Interests by management, other employees or business partners of the
Company or any of its direct or indirect parent companies or subsidiaries shall be excluded, 
 (9) any fees, expenses or charges
incurred during such period, or any amortization thereof for such period, in connection with the Transactions, any acquisition, disposition, recapitalization, Investment, Asset Sale, issuance, repayment or amendment of Indebtedness, issuance of
Equity Interests, refinancing transaction or amendment or modification of any debt instrument (in each case, including any such transaction consummated prior to the Original Issue Date and any such transaction undertaken but not completed), any
non-cash expenses or charges recorded in accordance 

  
 8 

 
with GAAP relating to currency valuation of foreign denominated debt and any charges or non- recurring merger costs incurred during such period as a result of any such transaction including,
without limitation, any non-cash expenses or charges recorded in accordance with GAAP relating to equity interests issued to non-employees in exchange for services provided in connection with any acquisition or business arrangement (in each case,
including any such transaction consummated prior to the Original Issue Date and any such transaction undertaken but not completed) shall be excluded, 

(10) all extraordinary, unusual or non-recurring charges, gains and losses (whether cash or non-cash) (including, without limitation, all
restructuring costs, facilities relocation costs, acquisition integration costs and fees, including cash severance payments made in connection with acquisitions, and any expense or charge related to the repurchase of Capital Stock or warrants or
options to purchase Capital Stock), and the related tax effects according to GAAP shall be excluded, 
 (11) inventory purchase
accounting adjustments and amortization and impairment charges resulting from other purchase accounting adjustments in connection with acquisition transactions shall be excluded, 

(12) the following items shall be excluded: 

(a) any net unrealized gain or loss (after any offset) resulting in such period from Hedging Obligations and the application of ASC 815
Derivatives and Hedging; and 
 (b) foreign currency and other non-operating gain or loss and foreign currency gain (loss) included in
other operating expenses including any net unrealized gain or loss (after any offset) resulting in such period from currency translation gains or losses related to currency remeasurements of Indebtedness (including any net loss or gain resulting
from hedge agreements for currency exchange risk). 
 In addition, to the extent not already included in the Consolidated Net Income of such
Person and its Restricted Subsidiaries, notwithstanding anything to the contrary in the foregoing, Consolidated Net Income shall include the amount of proceeds actually received from business interruption insurance and reimbursements of any expenses
and charges that are covered by indemnification or other reimbursement provisions in connection with any Permitted Investment or any sale, conveyance, transfer or other disposition of assets permitted under this Indenture. 

Notwithstanding the foregoing, for the purpose of Section 4.07 only (other than clause (3)(d) of Section 4.07(a)), there shall
be excluded from Consolidated Net Income any income arising from any sale or other disposition of Restricted Investments made by the Company and its Restricted Subsidiaries, any repurchases and redemptions of Restricted Investments from the Company
and its Restricted Subsidiaries, any repayments of loans and advances which constitute Restricted Investments by the Company or any of its Restricted Subsidiaries, any sale of the stock of an Unrestricted Subsidiary or any distribution or dividend
from an Unrestricted Subsidiary, in each case to the extent such amounts increase the amount of Restricted Payments permitted under Section 4.07 pursuant to clause (3)(c) or (3)(d) thereof. 

  
 9 

 “Consolidated Net Leverage Ratio” means, as of the date of determination, the
ratio of (a) the Indebtedness of the Company and its Restricted Subsidiaries as of such date of determination less Unrestricted Cash of the Company and its Restricted Subsidiaries as of such date of determination (in each case, determined after
giving pro forma effect to such incurrence of Indebtedness, and each other incurrence, assumption, guarantee, redemption, retirement and extinguishment of Indebtedness as of such date of determination) to (b) EBITDA of the Company and
its Restricted Subsidiaries for the most recent four fiscal quarter period ending immediately prior to such determination date for which internal financial statements are available. For purposes of determining the “Consolidated Net Leverage
Ratio,” “EBITDA” shall be subject to the adjustments applicable to “EBITDA” as provided for in the definition of “Fixed Charge Coverage Ratio.” 

“Contingent Obligations” means, with respect to any Person, any obligation of such Person guaranteeing any leases, dividends
or other obligations that do not constitute Indebtedness (“primary obligations”) of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, including, without limitation, any
obligation of such Person, whether or not contingent, 
 (1) to purchase any such primary obligation or any property constituting
direct or indirect security therefor, 
 (2) to advance or supply funds, 

(a) for the purchase or payment of any such primary obligation, or 

(b) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the
primary obligor, or 
 (3) to purchase property, securities or services primarily for the purpose of assuring the owner of any such
primary obligation of the ability of the primary obligor to make payment of such primary obligation against loss in respect thereof. 

“Credit Facilities” means, with respect to the Company or any of its Restricted Subsidiaries, one or more debt facilities,
including the Senior Secured Credit Facilities, or other financing arrangements (including, without limitation, commercial paper facilities or indentures), providing for revolving credit loans, term loans or letters of credit or other long-term
indebtedness, including any notes, mortgages, guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, renewals, restatements or refundings thereof and
any indentures or credit facilities or commercial paper facilities that replace, refund or refinance any part of the loans, notes, other credit facilities or commitments thereunder, including any such replacement, refunding or refinancing facility
or indenture that increases the amount permitted to be borrowed thereunder or 

  
 10 

 
alters the maturity thereof (provided that such increase in borrowings is permitted under Section 4.09) or adds Restricted Subsidiaries as additional borrowers or guarantors
thereunder and whether by the same or any other agent, lender, investor or group of lenders. 
 “Custodian” means (other
than as used and defined in Article VI) the Trustee, as custodian with respect to any Dollar Notes in global form, and the Common Depositary, as custodian with respect to any Euro Notes in global form, or any successor entity thereto. 

“Default” means any event that is, or with the passage of time or the giving of notice or both would be, an Event of Default.

 “Definitive Note” means a certificated Note registered in the name of the Holder thereof and issued in accordance with
Article II hereof. 
 “Depositary” means the Dollar Depositary or the Common Depositary, as applicable. 

“Designated Non-cash Consideration” means the fair market value of non-cash consideration received by the Company or a
Restricted Subsidiary in connection with an Asset Sale that is so designated as Designated Non-cash Consideration pursuant to an Officer’s Certificate, setting forth the basis of such valuation, executed by the principal financial officer of
the Company, less the amount of cash or Cash Equivalents received in connection with a subsequent sale of or collection on such Designated Non-cash Consideration. 

“Designated Preferred Stock” means Preferred Stock of the Company or any parent corporation thereof (in each case other than
Disqualified Stock) that is issued for cash (other than to a Restricted Subsidiary or an employee stock ownership plan or trust established by the Company or any of its Subsidiaries) and is so designated as Designated Preferred Stock pursuant to an
Officer’s Certificate executed by the principal financial officer of the Company on the issuance date thereof, the cash proceeds of which are excluded from the calculation set forth in clause (3) of Section 4.07(a). 

“Disqualified Stock” means, with respect to any Person, any Capital Stock of such Person that, by its terms, or by the terms
of any security into which it is convertible or for which it is putable or exchangeable, or upon the happening of any event, matures or is mandatorily redeemable (other than solely as a result of a change of control or asset sale and other than
redeemable for Capital Stock of such Person that is not itself Disqualified Stock) pursuant to a sinking fund obligation or otherwise, or is redeemable at the option of the holder thereof (other than solely as a result of a change of control or
asset sale and other than redeemable for Capital Stock of such Person that is not itself Disqualified Stock), in whole or in part, in each case prior to the date that is 91 days after the maturity date of the Notes; provided,
however, that if such Capital Stock is issued to any plan for the benefit of employees of the Company or its Subsidiaries or by any such plan to such employees, such Capital Stock shall not constitute Disqualified Stock solely because it may
be required to be repurchased by the Company or its Subsidiaries in order to satisfy applicable statutory or regulatory obligations. 

  
 11 

 “Distribution Date” means the date that the shares of the Company’s common
stock are distributed to DuPont’s stockholders pursuant to the separation and distribution. 
 “Dollar” means a dollar
or other equivalent unit in such coin or currency of the United States of America as at the time shall be legal tender for the payment of public and private debt. 

“Dollar Depositary” means, with respect to any Dollar Notes issuable or issued, in whole or in part, in global form, the
Person specified in Section 2.14 as the Dollar Depositary with respect to Dollar Notes, and any and all successors thereto appointed as dollar depositary hereunder and having become such pursuant to the applicable provisions of this Indenture.

 “Dollar Notes” means Notes that are denominated in Dollars. 

“Domestic Restricted Subsidiary” means any Restricted Subsidiary that is organized or existing under the laws of the United
States, any state thereof, or the District of Columbia other than any such Restricted Subsidiary that is a Subsidiary of a Foreign Subsidiary that is a “controlled foreign corporation” within the meaning of Section 957 of the Internal
Revenue Code of 1986, as amended. 
 “DTC” means The Depository Trust Company or its successors. 

“DuPont” means E. I. du Pont de Nemours and Company, a Delaware corporation. 

“EBITDA” means, with respect to any Person for any period, the Consolidated Net Income of such Person for such period: 

(1) increased (without duplication) by the following, in each case (other than clause (g)) to the extent deducted (and not added back) in
determining Consolidated Net Income for such period: 
 (a) provision for taxes based on income or profits or capital gains, including,
without limitation, state, franchise and similar taxes, and foreign withholding taxes and penalties and interest relating to taxes of such Person paid or accrued during such period; plus 

(b) Consolidated Interest Expense of such Person for such period, together with items excluded from the definition of “Consolidated
Interest Expense” pursuant to clauses (1)(u) through (z) thereof to the extent the same were deducted (and not added back) in calculating Consolidated Net Income; plus 

  
 12 

 (c) Consolidated Depreciation and Amortization Expense of such Person for such period;
plus 
 (d) the amount of any restructuring charges, integration, business optimization and acquisition, investment or
disposal-related costs (whether incurred prior to, or after, the consummation of any such acquisition, investment or disposal), retention charges, stock option and any other equity-based compensation expenses deducted (and not added back) in such
period in computing Consolidated Net Income, including any one-time costs incurred in connection with acquisitions, investments or disposals before or after the Original Issue Date and costs related to the closure and/or consolidation of facilities
or headcount reductions or other similar actions (including severance charges in respect of employee terminations); plus 

(e) any other non-cash charges, including any write-offs or write-downs, reducing Consolidated Net Income for such period
(provided that if any such non-cash charges represent an accrual or reserve for potential cash items in any future period, the cash payment in respect thereof in such future period shall be subtracted from EBITDA to such extent, and excluding
amortization of a prepaid cash item that was paid in a prior period); plus 
 (f) income attributable to non-controlling
interests in Subsidiaries to the extent deducted (and not added back) in such period in calculating Consolidated Net Income; plus 

(g) the amount of net cost savings and operating expense reductions projected by the Company in good faith to be realized as a result of
actions initiated or to be initiated or taken on or prior to the date that is 12 months after the Distribution Date or 12 months after the consummation of any acquisition, amalgamation, merger or operational change or other action, plan or
transaction and prior to or during such period (calculated on a pro forma basis as though such cost savings had been realized on the first day of such period), net of the amount of actual benefits realized during such period from such
actions; provided that (x) such cost savings are reasonably identifiable and quantifiable and (y) no cost savings shall be added pursuant to this clause (g) to the extent duplicative of any expenses or charges relating to such
cost savings that are either excluded in computing Consolidated Net Income or included (i.e., added back) in computing “EBITDA” for such period; provided, further, that the adjustments pursuant to this clause (g) may be
incremental to (but not duplicative of) pro forma adjustments made pursuant to the definition of “Fixed Charge Coverage Ratio”; provided, further, that the aggregate amount of add backs made pursuant to this clause
(g) shall not exceed an amount equal to 15% of EBITDA for the period of four consecutive fiscal quarters most recently ended prior to the determination date (without giving effect to any adjustments pursuant to this clause (g)); plus

 (h) any costs or expense incurred by the Company or a Restricted Subsidiary pursuant to any management equity plan or stock option
plan or any other management or employee benefit plan or agreement or any stock subscription or shareholder agreement, to the extent that such cost or expenses are funded with cash 

  
 13 

 
proceeds contributed to the capital of the Company or net cash proceeds of an issuance of Equity Interests of the Company (other than Disqualified Stock) solely to the extent that such net cash
proceeds are excluded from the calculation set forth in clause (3) of Section 4.07(a); plus 
 (i) the amount of any
earn-out payments, contingent consideration or deferred purchase price of any kind in conjunction with acquisitions; plus 

(j) losses to the extent reimbursable by third parties in connection with any acquisition permitted hereunder, as determined in good
faith by the Company; and 
 (2) decreased by (without duplication) non-cash gains increasing Consolidated Net Income of such Person
for such period, excluding any non-cash gains to the extent they represent the reversal of an accrual or reserve for a potential cash item that reduced EBITDA in any prior period. 

“Equity Interests” means Capital Stock and all warrants, options or other rights to acquire Capital Stock, but excluding any
debt security that is convertible into, or exchangeable for, Capital Stock. 
 “Euro” means the lawful currency of
participating member states of the European Union. 
 “Euro Agent” means Elavon Financial Services Limited, UK Branch, as
initial Paying Agent in respect of the Euro Notes. 
 “Euro Notes” means Notes that are denominated in Euros. 

“Euroclear” means Euroclear Bank S.A./N.V., as operator of the Euroclear system, or any successor thereto. 

“European Government Obligations” means direct, non-callable and non-redeemable obligations denominated in Euros of any
member state of the European Union that is a member of the European Union as of the date of this Indenture and that has a rating of “A” or higher from S&P or “A2” or higher from Moody’s at the time that the relevant
obligation was acquired by the Company or a Restricted Subsidiary. 
 “Exchange Act” means the Securities Exchange Act of
1934, as amended, and the rules and regulations of the SEC promulgated thereunder. 
 “Excluded Contribution” means net
cash proceeds, marketable securities or Qualified Proceeds received by the Company from 
 (1) contributions to its common equity
capital, or 
 (2) the sale (other than to a Subsidiary of the Company or to any management equity plan or stock option plan or any
other management or employee benefit plan or agreement of the Company) of Capital Stock (other than Disqualified Stock and Designated Preferred Stock) of the Company, 

  
 14 

 in each case after the Original Issue Date and in each case designated as an Excluded
Contribution pursuant to an Officer’s Certificate executed by the principal financial officer of the Company on the date such capital contribution is made or the date such Capital Stock is sold, as the case may be, which shall be excluded from
the calculation set forth in clause (3) of Section 4.07(a). 
 “fair market value” means, with respect to any
asset or liability, the fair market value of such asset or liability as determined by the Company in good faith. 
 “Fixed Charge
Coverage Ratio” means, with respect to any Person for any period, the ratio of EBITDA of such Person for such period to the Fixed Charges of such Person for such period. In the event that the Company or any Restricted Subsidiary incurs,
assumes, guarantees, redeems, retires or extinguishes any Indebtedness (other than Indebtedness incurred under any revolving credit facility unless such Indebtedness has been permanently repaid and has not been replaced) or issues or redeems
Disqualified Stock or Preferred Stock subsequent to the commencement of the period for which the Fixed Charge Coverage Ratio is being calculated but prior to or simultaneously with the event for which the calculation of the Fixed Charge Coverage
Ratio is made, then the Fixed Charge Coverage Ratio shall be calculated giving pro forma effect to such incurrence, assumption, guarantee, redemption, retirement or extinguishment of Indebtedness, or such issuance or redemption of
Disqualified Stock or Preferred Stock, as if the same had occurred at the beginning of the applicable four-quarter period. 
 For purposes
of making the computation referred to above, Investments, acquisitions, dispositions, mergers, consolidations and disposed operations (as determined in accordance with GAAP) that have been made by the Company or any of its Restricted Subsidiaries
during the four-quarter reference period or subsequent to such reference period and on or prior to or simultaneously with the Fixed Charge Coverage Ratio Calculation Date shall be calculated on a pro forma basis, assuming that all such
Investments, acquisitions, dispositions, mergers, consolidations and disposed operations (and the change in any associated fixed charge obligations and the change in EBITDA resulting therefrom) had occurred on the first day of the four-quarter
reference period. If since the beginning of such period any Person that subsequently became a Restricted Subsidiary or was merged with or into the Company or any of its Restricted Subsidiaries since the beginning of such period shall have made any
Investment, acquisition, disposition, merger, consolidation or disposed operation that would have required adjustment pursuant to this definition, then the Fixed Charge Coverage Ratio shall be calculated giving pro forma effect thereto for
such period as if such Investment, acquisition, disposition, merger, consolidation or disposed operation had occurred at the beginning of the applicable four-quarter period. 

For purposes of this definition, whenever pro forma effect is to be given to an Investment, acquisition, disposition, merger,
consolidation, disposed operation or any other transaction, the pro forma calculations shall be made in good faith by a responsible 

  
 15 

 
financial or accounting officer of the Company (and may include, for the avoidance of doubt and without duplication, cost savings and operating expense reduction resulting from such Investment,
acquisition, disposition, merger, consolidation, disposed operation or other transaction, in each case calculated in the manner described in the definition of “EBITDA” herein). If any Indebtedness bears a floating rate of interest and is
being given pro forma effect, the interest on such Indebtedness shall be calculated as if the rate in effect on the Fixed Charge Coverage Ratio Calculation Date had been the applicable rate for the entire period (taking into account any
Hedging Obligations applicable to such Indebtedness). Interest on a Capitalized Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by a responsible financial or accounting officer of the Company to be the rate of
interest implicit in such Capitalized Lease Obligation in accordance with GAAP. For purposes of making the computation referred to above, interest on any Indebtedness under a revolving credit facility computed on a pro forma basis shall be
computed based upon the average daily balance of such Indebtedness during the applicable period except as set forth in the first paragraph of this definition. Interest on Indebtedness that may optionally be determined at an interest rate based upon
a factor of a prime or similar rate, a Eurocurrency interbank offered rate, or other rate, shall be deemed to have been based upon the rate actually chosen, or, if none, then based upon such optional rate chosen as the Company may designate. 

“Fixed Charges” means, with respect to any Person for any period, the sum of: 

(1) Consolidated Interest Expense of such Person for such period; 

(2) all cash dividends or other distributions paid (excluding items eliminated in consolidation) on any series of Preferred Stock during
such period; and 
 (3) all cash dividends or other distributions paid or accrued (excluding items eliminated in consolidation) on any
series of Disqualified Stock during such period. 
 “Foreign Subsidiary” means, with respect to any Person, any Restricted
Subsidiary of such Person that is not organized or existing under the laws of the United States, any state thereof, or the District of Columbia and any Restricted Subsidiary of such Foreign Subsidiary. 

“Foreign Subsidiary Holding Company” means, with respect to any Person, (a) any Restricted Subsidiary of such Person
that is a “controlled foreign corporation” for purposes of the Internal Revenue Code of 1986 (a “CFC”) and (b) any Restricted Subsidiary of such Person substantially all of whose assets consist of Equity Interests
and/or Indebtedness of one or more CFCs and intellectual property relating to such CFCs and any other assets incidental thereto. 

“Form 10” means the Information Statement on Form 10 filed by the Company with the SEC on December 18, 2014 (including
all exhibits thereto), as amended or supplemented from time to time through to the date hereof, pursuant to which the Company will conduct the business described in the Offering Circular and in such Form 10. 

  
 16 

 “GAAP” means (1) generally accepted accounting principles in the United
States of America which are in effect on the Original Issue Date or (2) if elected by the Company by written notice to the Trustee in connection with the delivery of financial statements and information, the accounting standards and
interpretations (“IFRS”) adopted by the International Accounting Standards Board, as in effect on the first date of the period for which the Company is making such election; provided, that (a) any such election once made
shall be irrevocable, (b) all financial statements and reports required to be provided after such election pursuant to this Indenture shall be prepared on the basis of IFRS, (c) from and after such election, all ratios, computations and
other determinations based on GAAP contained in this Indenture shall be computed in conformity with IFRS and (d) in connection with the delivery of financial statements (x) for any of its first three financial quarters of any financial
year, it shall restate its consolidated interim financial statements for such interim financial period and the comparable period in the prior year to the extent previously prepared in accordance with GAAP as in effect on the Original Issue Date and
(y) for delivery of audited annual financial information, it shall provide consolidated historical financial statements prepared in accordance with IFRS for the prior most recent fiscal year to the extent previously prepared in accordance with
GAAP as in effect on the Original Issue Date. 
 “Global Note” when used with respect to any Series of Notes issued
hereunder, means, individually and collectively, Notes executed by the Company and authenticated by the Trustee, which shall be registered in the name of the Depositary or its nominee and which shall represent, and shall be denominated in an amount
equal to the aggregate principal amount of, all the Outstanding Notes of such Series or any portion thereof, in either case having the same terms, including, without limitation, the same original issue date, date or dates on which principal is due,
and interest rate or method of determining interest and which shall bear the legend as prescribed by Section 2.14(c). 

“Global Note Legend” means the legend set forth in Section 2.14(c), which is required to be placed on all Global Notes
issued under this Indenture and any global note legend required by a supplemental indenture or Officer’s Certificate with respect to one or more series of Notes in addition to or in replacement thereof. 

“Government Securities” means securities that are: 

(1) direct obligations of the United States of America for the timely payment of which its full faith and credit is pledged; 

(2) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America the
timely payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America, which are not callable or redeemable at the option of the issuers thereof, and shall also include a depository receipt
issued by a bank (as defined in Section 3(a)(2) of the Securities Act), as custodian with respect to any such Government Securities or a 

  
 17 

 
specific payment of principal of or interest on any such Government Securities held by such custodian for the account of the holder of such depository receipt; provided that (except as
required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depository receipt from any amount received by the custodian in respect of the Government Securities or the specific payment of
principal of or interest on the Government Securities evidenced by such depository receipt; or 
 (3) AAA rated money market mutual
funds, where 100% of the holdings are in securities described in clauses (1) or (2) of this definition of Government Securities or repurchase agreements that are fully collateralized by securities described in clauses (1) or
(2) of this definition of Government Securities. 
 “Governmental Authority” means the government of the United States
or any other nation, or of any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or
administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank). 

“guarantee” means a guarantee (other than by endorsement of negotiable instruments for collection in the ordinary course of
business), direct or indirect, in any manner (including letters of credit and reimbursement agreements in respect thereof), of all or any part of any Indebtedness or other obligations. 

“Guarantee” means the guarantee by any Guarantor of the Company’s Obligations under this Indenture and the Notes. 

“Guarantor” means each Subsidiary Guarantor and any other Person that becomes a Guarantor in accordance with the terms of
this Indenture. 
 “Hedging Obligations” means, with respect to any Person, the obligations of such Person under any
interest rate swap agreement, interest rate cap agreement, interest rate collar agreement, commodity swap agreement, commodity cap agreement, commodity collar agreement, foreign exchange contract, currency swap agreement, currency collar agreement
or similar agreement providing for the transfer, modification or mitigation of interest rate, commodity or currency risks either generally or under specific contingencies. 

“Holder” means the Person in whose name a Note is registered on the applicable Registrar’s books. 

“Indebtedness” means, with respect to any Person, without duplication: 

(1) any indebtedness of such Person, whether or not contingent: 

(a) in respect of borrowed money; 

  
 18 

 (b) evidenced by bonds, notes, debentures or similar instruments or letters of credit or
bankers’ acceptances (or, without duplication, reimbursement agreements in respect thereof); 
 (c) representing the balance
deferred and unpaid of the purchase price of any property (including Capitalized Lease Obligations), except (i) any such balance that constitutes a trade payable or similar obligation to a trade creditor, in each case accrued in the ordinary
course of business and (ii) any earn- out obligations until such obligation becomes a liability on the balance sheet of such Person in accordance with GAAP; or 

(d) representing net payment obligations under any Hedging Obligations; 

if and to the extent that any of the foregoing Indebtedness (other than letters of credit and Hedging Obligations) would appear as a liability
upon a balance sheet (excluding the footnotes thereto) of such Person prepared in accordance with GAAP; 
 (2) to the extent not
otherwise included, any obligation by such Person to be liable for, or to pay, as obligor, guarantor or otherwise on, the obligations of the type referred to in clause (1) of a third Person (whether or not such items would appear upon the
balance sheet of such obligor or guarantor), other than by endorsement of negotiable instruments for collection in the ordinary course of business; and 

(3) to the extent not otherwise included, the obligations of the type referred to in clause (1) of a third Person secured by a Lien
on any asset owned by such first Person, whether or not such Indebtedness is assumed by such first Person, the amount of such obligation being deemed to be the lesser of the value of such asset or the amount of the obligation so secured; 

provided, however, that notwithstanding the foregoing, Indebtedness shall be deemed not to include (a) Contingent
Obligations incurred in the ordinary course of business or (b) any obligations under or in respect of operating leases or Sale and Lease-back Transactions (except any resulting Capitalized Lease Obligations). 

“Indenture” means this Indenture, as amended or supplemented from time to time. 

“Independent Financial Advisor” means an accounting, appraisal or investment banking firm of nationally recognized standing
that is, in the good faith judgment of the Company, qualified to perform the task for which it has been engaged. 
 “Interest
Payment Date” when used with respect to any Series of Notes, means the date specified in such Notes for the payment of any installment of interest on those Notes. 

“Internal Revenue Code” means the Internal Revenue Code of 1986, as amended, and the regulations thereunder. 

  
 19 

 “Investment Grade Rating” means a rating equal to or higher than Baa3 (or the
equivalent) by Moody’s and BBB- (or the equivalent) by S&P, or an equivalent rating by any other Rating Agency. 

“Investment Grade Securities” means: 

(1) securities issued or directly and fully guaranteed or insured by the United States government or any agency or instrumentality
thereof (other than Cash Equivalents); 
 (2) debt securities or debt instruments with an Investment Grade Rating, but excluding any
debt securities or instruments constituting loans or advances among the Company and its Subsidiaries; 
 (3) investments in any fund
that invests exclusively in investments of the type described in clauses (1) and (2) (which fund may also hold immaterial amounts of cash pending investment or distribution thereof); and 

(4) corresponding instruments in countries other than the United States customarily utilized for high quality investments. 

“Investments” means, with respect to any Person, all investments by such Person in other Persons (including Affiliates) in
the form of loans (including guarantees), advances or capital contributions (excluding accounts receivable, trade credit, advances to customers, commission, travel and similar advances to directors, officers, employees and consultants in each case
made in the ordinary course of business), purchases or other acquisitions for consideration of Indebtedness, Equity Interests or other securities issued by any other Person and investments that are required by GAAP to be classified on the balance
sheet (excluding the footnotes) of the Company in the same manner as the other investments included in this definition to the extent such transactions involve the transfer of cash or other property. For purposes of the definition of
“Unrestricted Subsidiary” and Section 4.07: 
 (1) “Investments” shall include the portion (proportionate to
the Company’s equity interest in such Subsidiary) of the fair market value of the net assets of a Subsidiary of the Company at the time that such Subsidiary is designated an Unrestricted Subsidiary; provided, however, that upon a
redesignation of such Subsidiary as a Restricted Subsidiary, the Company shall be deemed to continue to have a permanent “Investment” in an Unrestricted Subsidiary in an amount (if positive) equal to: 

(a) the Company’s “Investment” in such Subsidiary at the time of such redesignation; less 

(b) the portion (proportionate to the Company’s equity interest in such Subsidiary) of the fair market value of the net assets of
such Subsidiary at the time of such redesignation; and 
 (2) any property transferred to or from an Unrestricted Subsidiary shall be
valued at its fair market value at the time of such transfer. 

  
 20 

 The amount of any Investment outstanding at any time shall be the original cost of such
Investment, reduced by any dividend, distribution, interest payment, return of capital, repayment or other amount received in cash or Cash Equivalents by the Company or a Restricted Subsidiary in respect of such Investment. 

“JV Reinvestment” means any Investment by the Company or any Restricted Subsidiary in a joint venture to the extent funded
with the proceeds of a cash dividend or other cash distribution made by such joint venture. 
 “Lien” means, with respect
to any asset, any mortgage, lien (statutory or otherwise), pledge, hypothecation, charge, security interest or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including
any conditional sale or other title retention agreement, any lease in the nature thereof, any option or other agreement to sell or give a security interest in and any filing of or agreement to give any financing statement under the Uniform
Commercial Code (or equivalent statutes) of any jurisdiction; provided that in no event shall an operating lease be deemed to constitute a Lien. 

“Maturity Date,” when used with respect to any Note or installment of principal thereof, means the date on which the
principal of such Note or such installment of principal becomes due and payable as therein or herein provided, whether at the Stated Maturity Date or by declaration of acceleration, call for redemption, notice of option to elect repayment or
otherwise. 
 “Moody’s” means Moody’s Investors Service, Inc. and any successor to its rating agency business.

 “Net Income” means, with respect to any Person, the net income (loss) of such Person, determined in accordance with GAAP
and before any reduction in respect of Preferred Stock dividends. 
 “Net Proceeds” means the aggregate cash proceeds and
Cash Equivalents received by the Company or any of its Restricted Subsidiaries in respect of any Asset Sale, including any cash and Cash Equivalents received upon the sale or other disposition of any Designated Non-cash Consideration received in any
Asset Sale, net of the direct costs relating to such Asset Sale and the sale or disposition of such Designated Non-cash Consideration, including legal, accounting and investment banking fees, and brokerage and sales commissions, any relocation
expenses incurred as a result thereof, taxes paid or payable as a result thereof (after taking into account any available tax credits or deductions and any tax sharing arrangements), amounts required to be applied to the repayment of Indebtedness
secured by a Lien on such assets (other than required by clause (1) of Section 4.10(b)) and any deduction of appropriate amounts to be provided by the Company or any of its Restricted Subsidiaries as a reserve in accordance with GAAP
against any liabilities associated with the asset disposed of in such transaction and 

  
 21 

 
retained by the Company or any of its Restricted Subsidiaries after such sale or other disposition thereof, including pension and other post-employment benefit liabilities and liabilities related
to environmental matters or against any indemnification obligations associated with such transaction. 
 “Notes” has the
meaning assigned to it in the preamble to this Indenture. 
 “Obligations” means any principal, interest (including any
interest accruing subsequent to the filing of a petition in bankruptcy, reorganization or similar proceeding at the rate provided for in the documentation with respect thereto, whether or not such interest is an allowed claim under applicable state,
federal or foreign law), premium, penalties, fees, indemnifications, reimbursements (including reimbursement obligations with respect to letters of credit and banker’s acceptances), damages and other liabilities, and guarantees of payment of
such principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities, payable under the documentation governing any Indebtedness. 

“Offering Circular” means the offering circular of the Company with respect to the Notes issued on the Original Issue Date,
dated May 5, 2015. 
 “Officer” means the Chairman of the board of directors, the Chief Executive Officer, Chief
Financial Officer, Chief Operating Officer, the President, any Executive Vice President, Senior Vice President or Vice President, the Treasurer or the Secretary of the Company or a Guarantor. 

“Officer’s Certificate” means a certificate signed on behalf of the Company by an Officer of the Company or on behalf of
a Guarantor by an Officer of such Guarantor (or if such Guarantor is a general partnership, one of the partners of the Guarantor). 

“Opinion of Counsel” means a written opinion from legal counsel who is acceptable to the Trustee. The counsel may be an
employee of or counsel to the Company or a Subsidiary of the Company. 
 “Original Issue Date” means May 12, 2015.

 “Original Issue Discount Note” means any Note that provides for an amount less than the stated principal amount thereof
to be due and payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.02. 

“Outstanding” means, as of the date of determination, all Notes (or Series of Notes, as applicable) theretofore authenticated
and delivered under this Indenture, except: 
 (1) Notes theretofore cancelled by the Trustee or delivered to the Trustee for cancellation;

  
 22 

 (2) Notes for whose payment or redemption money in the necessary amount has been theretofore
deposited with the Trustee or any Paying Agent (other than the Company) in trust or set aside and segregated in trust by the Company (if the Company shall act as its own Paying Agent); provided that if such Notes are to be redeemed, notice of
such redemption has been duly given pursuant to this Indenture; 
 (3) Notes that have been defeased pursuant to the procedures specified in
Article VIII; and 
 (4) Notes that have been paid in lieu of reissuance relating to lost, stolen, destroyed or mutilated certificates, or
in exchange for or in lieu of which other Notes have been authenticated and delivered pursuant to this Indenture; 
 provided, however, that
in determining whether the Holders of the requisite principal amount of the Outstanding Notes have given any request, demand, authorization, direction, notice, consent or waiver under this Indenture, Notes owned by the Company or any other obligor
upon the Notes or any Affiliate of the Company or of such other obligor shall be disregarded and deemed not to be Outstanding, except that, in determining whether the Trustee shall be protected in relying upon any such request, demand,
authorization, direction, notice, consent or waiver, only Notes that a Responsible Officer of the Trustee knows to be so owned shall be so disregarded. Notes so owned that have been pledged in good faith may be regarded as Outstanding if the pledgee
establishes to the satisfaction of the Trustee the pledgee’s right so to act with respect to such Notes and that the pledgee is not the Company or any other obligor upon the Notes or any Affiliate of the Company or of such other obligor. 

“Participant” means, with respect to the Depositary, Euroclear or Clearstream, a Person who has an account with the
Depositary, Euroclear or Clearstream, respectively (and, with respect to DTC, shall include other indirect participants in The Depository Trust Company serving a similar function). 

“Permitted Asset Swap” means the substantially concurrent purchase and sale or exchange of Related Business Assets or a
combination of Related Business Assets and cash or Cash Equivalents between the Company or any of its Restricted Subsidiaries and another Person; provided, that any cash or Cash Equivalents received must be applied in accordance with
Section 4.10. 
 “Permitted Investment” means: 

(1) any Investment in the Company or any of its Restricted Subsidiaries or any Person that will become a Restricted Subsidiary as a
result of such Investment; 
 (2) any Investment in cash or Cash Equivalents or Investment Grade Securities; 

(3) any Investment acquired after the Original Issue Date as a result of the acquisition by the Company or any Restricted Subsidiary of
the Company of another Person, including by way of a merger, amalgamation or consolidation with or into the 

  
 23 

 
Company or any of its Restricted Subsidiaries in a transaction that is not prohibited by Section 5.01, to the extent that such Investments were not made in anticipation or contemplation of
such acquisition, merger, amalgamation or consolidation and were in existence on the date of such acquisition, merger, amalgamation or consolidation; 

(4) any Investment in securities or other assets, including earn-outs, not constituting Cash Equivalents or Investment Grade Securities
and received in connection with an Asset Sale made pursuant to Section 4.10(a) or any other disposition of assets not constituting an Asset Sale; 

(5) any Investment existing on the Original Issue Date or made pursuant to binding commitments in effect on the Original Issue Date or an
Investment consisting of any extension, modification or renewal of any such Investment or binding commitment existing on the Original Issue Date; provided, that the amount of any such Investment may be increased pursuant to such extension,
modification or renewal only (a) as required by the terms of such Investment or binding commitment as in existence on the Original Issue Date (including as a result of the accrual or accretion of interest or original issue discount or the
issuance of pay-in-kind securities) or (b) as otherwise permitted under this Indenture; 
 (6) any Investment acquired by the
Company or any of its Restricted Subsidiaries: 
 (a) consisting of extensions of credit in the nature of accounts receivable or notes
receivable arising from the grant of trade credit in the ordinary course of business; 
 (b) in exchange for any other Investment or
accounts receivable, endorsements for collection or deposit held by the Company or any such Restricted Subsidiary in connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment
or accounts receivable (including any trade counterparty or customer); or 
 (c) in satisfaction of judgments against other Persons; or

 (d) as a result of a foreclosure by the Company or any of its Restricted Subsidiaries with respect to any secured Investment or
other transfer of title with respect to any secured Investment in default; 
 (7) Hedging Obligations permitted under
Section 4.09(b)(10); 
 (8) Investments the payment for which consists of Equity Interests (other than Disqualified Stock) of the
Company; provided, however, that such Equity Interests will not increase the amount available for Restricted Payments under clause (3) of Section 4.07(a); 

(9) guarantees of Indebtedness of the Company and any Restricted Subsidiary permitted under Section 4.09; 

  
 24 

 (10) any transaction to the extent it constitutes an Investment that is permitted and made
in accordance with the provisions of Section 4.11(b) (except transactions described in clause (2), (4) or (6) of such Section); 

(11) Investments consisting of purchases and acquisitions of inventory, supplies, material or equipment; 

(12) additional Investments having an aggregate fair market value, taken together with all other Investments made pursuant to this clause
(12) that are at that time outstanding, not to exceed the greater of $400.0 million and 6.50% of Total Assets (with the fair market value of each Investment being measured at the time made and without giving effect to subsequent changes in
value); 
 (13) guarantees of Indebtedness of joint ventures of the Company or any Restricted Subsidiary permitted by
Section 4.09(b)(26); 
 (14) Investments (including debt obligations and Equity Interests) received in connection with the
bankruptcy or reorganization of suppliers and customers or in settlement of delinquent obligations of, or other disputes with, customers and suppliers arising in the ordinary course of business or upon the foreclosure with respect to any secured
Investment or other transfer of title with respect to any secured Investment; 
 (15) Investments in Unrestricted Subsidiaries or joint
ventures of the Company or any of its Restricted Subsidiaries having an aggregate fair market value, taken together with all other Investments made pursuant to this clause (15) that are at that time outstanding, not to exceed the greater
of $350.0 million and 5.50% of Total Assets (with the fair market value of each Investment being measured at the time made and without giving effect to subsequent changes in value); 

(16) JV Reinvestments; 

(17) any Investment in a Similar Business having an aggregate fair market value, taken together with all other Investments made pursuant
to this clause (17) that are at that time outstanding, not to exceed the greater of $250.0 million and 4.00% of Total Assets (with the fair market value of each Investment being measured at the time made and without giving effect to subsequent
changes in value); 
 (18) loans and advances to, or guarantees of Indebtedness of, officers, directors and employees not in excess of
$15.0 million outstanding at any one time, in the aggregate; 
 (19) advances, loans or extensions of trade credit in the ordinary
course of business by the Company or any of its Restricted Subsidiaries; 
 (20) any Investment in any Subsidiary or any joint venture
in connection with intercompany cash management arrangements or related activities arising in the ordinary course of business; 

  
 25 

 (21) Investments consisting of purchases and acquisitions of assets or services in the
ordinary course of business; 
 (22) Investments made in the ordinary course of business in connection with obtaining, maintaining or
renewing client contacts; 
 (23) Investments in prepaid expenses, negotiable instruments held for collection and lease, utility and
workers compensation, performance and similar deposits entered into as a result of the operations of the business in the ordinary course of business; 

(24) repurchases of Notes; 

(25) Investments in the ordinary course of business consisting of Uniform Commercial Code Article 3 endorsements for collection of
deposit and Article 4 customary trade arrangements with customers; 
 (26) Investments in the ordinary course of business in connection with
joint marketing arrangements with another Person (including the licensing or contribution of intellectual property in connection therewith); 

(27) Investments by the Company or any Restricted Subsidiary in a Securitization Special Purpose Entity or any Investment by a Securitization
Special Purpose Entity in any other Person, in each case, in connection with a Qualified Securitization Transaction, including Investments of funds held in accounts permitted or required by the arrangements governing such Qualified Securitization
Transaction or any related Indebtedness; and 
 (28) Investments made as part of the Transactions in a manner consistent in all material
respects with the disclosures set forth in the Form 10 and the Offering Circular. 
 “Permitted Liens” means, with respect
to any Person: 
 (1) pledges or deposits by such Person under workmen’s compensation laws, unemployment insurance laws or similar
legislation, or good faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases to which such Person is a party, or deposits to secure public or statutory obligations of such Person or deposits
of cash or U.S. government bonds to secure surety or appeal bonds to which such Person is a party, or deposits as security for contested taxes or import duties or for the payment of rent, in each case incurred in the ordinary course of business;

 (2) Liens imposed by law, such as carriers’, warehousemen’s and mechanics’ Liens, in each case for sums not yet
overdue for a period of more than 30 days or being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards against such Person with respect to which such Person shall then be proceeding with an appeal or
other proceedings for review if adequate reserves with respect thereto are maintained on the books of such Person in accordance with GAAP; 

  
 26 

 (3) Liens for taxes, assessments or other governmental charges not yet overdue for a period
of more than 30 days or not yet payable or subject to penalties for nonpayment or which are being contested in good faith by appropriate proceedings diligently conducted, if adequate reserves with respect thereto are maintained on the books of such
Person to the extent required by GAAP; 
 (4) Liens to secure the performance of statutory obligations or in favor of issuers of
performance, surety, bid or appeal bonds or with respect to other regulatory requirements or letters of credit issued pursuant to the request of and for the account of such Person in the ordinary course of its business; 

(5) survey exceptions, title defects, encumbrances, easements or reservations of, or rights of others for, licenses, rights-of-way,
sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions as to the use of real properties or Liens incidental to the conduct of the business of such Person or to the ownership of its
properties that, in all cases, were not incurred in connection with Indebtedness and that do not in the aggregate materially adversely affect the value of said properties or materially impair their use in the operation of the business of such
Person; 
 (6) Liens securing Indebtedness permitted to be incurred pursuant to clause (4), (10), (18) or (23) of
Section 4.09(b); 
 (7) Liens existing on the Original Issue Date; 

(8) Liens on property or shares of stock of a Person at the time such Person becomes a Subsidiary; provided, however, such
Liens are not created or incurred in connection with, or in anticipation or contemplation of, such other Person becoming such a Subsidiary; provided further, however, that such Liens may not extend to any other property owned by the
Company or any of its Restricted Subsidiaries; 
 (9) Liens on property at the time the Company or a Restricted Subsidiary acquired the
property, including any acquisition by means of a merger or consolidation with or into the Company or any of its Restricted Subsidiaries; provided, however, that such Liens are not created or incurred in connection with, or in
anticipation or contemplation of, such acquisition; provided further, however, that the Liens may not extend to any other property owned by the Company or any of its Restricted Subsidiaries; 

(10) Liens securing Indebtedness or other obligations of a Restricted Subsidiary owing to the Company or another Restricted Subsidiary
permitted to be incurred in accordance with Section 4.09; 
 (11) Liens on specific items of inventory of other goods and proceeds
of any Person securing such Person’s obligations in respect of bankers’ acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods; 

  
 27 

 (12) leases, subleases, licenses or sublicenses granted to others in the ordinary course of
business that do not materially interfere with the ordinary conduct of the business of the Company or any of its Restricted Subsidiaries and that do not secure any Indebtedness; 

(13) Liens arising from Uniform Commercial Code financing statement filings (or similar filings under applicable law) regarding operating
leases, consignment of goods or similar arrangements entered into by the Company and its Restricted Subsidiaries in the ordinary course of business and Liens of a collecting bank arising in the ordinary course of business under Section 4-208
(or the applicable corresponding section) of the Uniform Commercial Code in effect in the relevant jurisdiction covering only the items being collected upon; 

(14) Liens in favor of the Company or any Subsidiary Guarantor; 

(15) Liens on equipment of the Company or any of its Restricted Subsidiaries granted in the ordinary course of business to the
Company’s clients; 
 (16) Liens to secure any refinancing, refunding, extension, renewal or replacement (or successive
refinancing, refunding, extension, renewal or replacement) as a whole, or in part, of any Indebtedness secured by any Lien referred to in the foregoing clause (6), (7), (8) or (9) to the extent that the Indebtedness secured by such new
Lien is an amount equal to the sum of (i) the outstanding principal amount or, if greater, committed amount of the Indebtedness described under clause (6), (7), (8) or (9) at the time the original Lien became a Permitted Lien under
this Indenture, and (ii) an amount necessary to pay any fees and expenses, including premiums, related to such refinancing, refunding, extension, renewal or replacement; provided, however, that in each case such new Lien shall be
limited to all or part of the same property that secured the original Lien (plus improvements on such property); 
 (17) deposits made
in the ordinary course of business to secure liability to insurance carriers; 
 (18) other Liens securing obligations not to exceed
the greater of $400.0 million and 6.25% of Total Assets at any one time outstanding (as adjusted to give pro forma effect to any assets purchased with the proceeds of the Indebtedness that is subject to such Lien, provided that
such assets are acquired substantially concurrently with the incurrence of such Indebtedness); 
 (19) Liens securing Indebtedness of
any non-Guarantor Restricted Subsidiary permitted to be incurred under this Indenture, to the extent such Liens relate only to the assets and properties of a non-Guarantor Restricted Subsidiary (and for the avoidance of doubt, any Liens permitted by
this clause (19) at the time of incurrence thereof shall continue to be permitted by this clause (19) if such non-Guarantor Restricted Subsidiary later provides a Guarantee of the Notes); 

  
 28 

 (20) Liens securing judgments for the payment of money not constituting an Event of Default
under Section 6.01(5) so long as such Liens are adequately bonded and any appropriate legal proceedings that may have been duly initiated for the review of such judgment have not been finally terminated or the period within which such
proceedings may be initiated has not expired; 
 (21) Liens in favor of customs and revenue authorities arising as a matter of law to
secure payment of customs duties in connection with the importation of goods in the ordinary course of business; 
 (22) Liens
(i) of a collection bank arising under Section 4-210 of the Uniform Commercial Code or any comparable or successor provision on items in the course of collection, (ii) attaching to commodity trading accounts or other commodity
brokerage accounts incurred in the ordinary course of business, and (iii) in favor of banking institutions arising as a matter of law encumbering deposits (including the right of setoff) and which are within the general parameters customary in
the banking industry; 
 (23) Liens deemed to exist in connection with Investments in repurchase agreements permitted under
Section 4.09; provided that such Liens do not extend to any assets other than those that are the subject of such repurchase agreement; 

(24) Liens securing Indebtedness incurred in accordance with Section 4.09(b)(25); 

(25) Liens that are contractual rights of setoff (i) relating to the establishment of depository relations with banks not given in
connection with the issuance of Indebtedness, (ii) relating to pooled deposit or sweep accounts or other cash management arrangements of the Company or any of its Restricted Subsidiaries to permit satisfaction of overdraft or similar
obligations incurred in the ordinary course of business of the Company and its Restricted Subsidiaries or (iii) relating to purchase orders and other agreements entered into with customers of the Company or any of its Restricted Subsidiaries in
the ordinary course of business; 
 (26) Liens securing Indebtedness and other obligations to the extent permitted to be incurred under
Credit Facilities, including any letter of credit facility relating thereto, incurred pursuant to Section 4.09(b)(1); 
 (27) any
encumbrance or restriction (including put and call arrangements) with respect to capital stock of any joint venture or similar arrangement pursuant to any joint venture or similar agreement; 

(28) Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale or purchase of goods
entered into by the Company or any of its Restricted Subsidiaries in the ordinary course of business; 

  
 29 

 (29) Liens solely on any cash earnest money deposits made by the Company or any of its
Restricted Subsidiaries in connection with any letter of intent or purchase agreement permitted hereunder; 
 (30) Liens securing the
Notes (other than any Additional Note) or the Guarantees thereof; 
 (31) ground leases in respect of real property on which facilities
owned or leased by the Company or any of its Subsidiaries are located; 
 (32) Liens on insurance policies and the proceeds thereof
securing the financing of the premiums with respect thereto; 
 (33) Liens on Capital Stock of an Unrestricted Subsidiary that secure
Indebtedness or other obligations of such Unrestricted Subsidiary; 
 (34) Liens on cash advances in favor of the seller of any
property to be acquired in an Investment permitted under this Indenture to be applied against the purchase price for such Investment; 

(35) any interest or title of a lessor, sub-lessor, licensor or sub-licensor or secured by a lessor’s, sub-lessor’s,
licensor’s or sub-licensor’s interest under leases or licenses entered into by the Company or any of the Restricted Subsidiaries in the ordinary course of business; 

(36) deposits of cash with the owner or lessor of premises leased and operated by the Company or any of its Subsidiaries in the ordinary
course of business of the Company and such Subsidiary to secure the performance of the Company’s or such Subsidiary’s obligations under the terms of the lease for such premises; 

(37) prior to the date on which a Permitted Investment is consummated, Liens arising from any escrow arrangement pursuant to which the
proceeds of any equity issuance or other funds used to finance all or a portion of such Permitted Investment are required to be held in escrow pending release to consummate such Permitted Investment; 

(38) Liens in connection with contracts for the sale of assets, including customary provisions with respect to a Restricted Subsidiary of the
Company pursuant to an agreement that has been entered into for the sale or disposition of any Capital Stock or assets of such Subsidiary; 

(39) Liens on trusts, cash or Cash Equivalents or other funds in connection with the defeasance (whether by covenant or legal defeasance),
discharge or redemption of Indebtedness pending consummation of a strategic transaction, or similar obligations; provided that such defeasance, discharge or redemption is otherwise permitted by this Indenture; and 

(40) any Liens arising from the Transactions in a manner consistent in all material respects with the disclosures set forth in the Form 10 and
the Offering Circular. 

  
 30 

 In the event that a Permitted Lien meets the criteria of more than one of the types of Permitted
Liens (at the time of incurrence or at a later date), the Company in its sole discretion may divide, classify or from time to time reclassify all or any portion of such Permitted Lien in any manner that complies with this definition and such
Permitted Lien shall be treated as having been made pursuant only to the clause or clauses of the definition of Permitted Lien to which such Permitted Lien has been classified or reclassified. 

“Person” means any individual, corporation, limited liability company, partnership, joint venture, association, joint stock
company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. 

“Preferred Stock” means any Equity Interest with preferential rights of payment of dividends or upon liquidation,
dissolution, or winding up. 
 “Qualified Proceeds” means assets that are used or useful in, or Capital Stock of any Person
engaged in, a Similar Business. 
 “Qualified Securitization Transaction” means any transaction or series of transactions
entered into by the Company or any Restricted Subsidiary pursuant to which the Company or such Restricted Subsidiary sells, conveys, grants a security interest in or otherwise transfers to a Securitization Special Purpose Entity, and such
Securitization Special Purpose Entity sells, conveys, grants a security interest in or otherwise transfers to one or more other Persons, any Securitization Assets (whether now existing or arising in the future). 

“Rating Agencies” means Moody’s and S&P or if Moody’s or S&P or both shall not make a rating on the Notes
publicly available, a nationally recognized statistical rating agency or agencies, as the case may be, selected by the Company which shall be substituted for Moody’s or S&P or both, as the case may be. 

“Receivables Facility” means any receivables financing facilities or factoring (or reverse factoring) agreements or
facilities, as amended, supplemented, modified, extended, renewed, restated or refunded from time to time, the obligations in respect of which are non-recourse (except for customary representations, warranties, covenants and indemnities made in
connection with such facilities) to the Company or any of its Restricted Subsidiaries pursuant to which the Company or any of its Restricted Subsidiaries sells its accounts receivable to a Person that is not a Restricted Subsidiary. 

“Related Business Assets” means assets (other than cash or Cash Equivalents) used or useful in a Similar Business;
provided that any assets received by the Company or a Restricted Subsidiary in exchange for assets transferred by the Company or a Restricted Subsidiary shall not be deemed to be Related Business Assets if they consist of securities of a
Person, unless upon receipt of the securities of such Person, such Person would become a Restricted Subsidiary. 

  
 31 

 “Responsible Officer” with respect to the Trustee, means any vice president,
assistant vice president, trust officer, assistant trust officer or any other officer of the Trustee within the corporate trust department of the Trustee who customarily performs functions similar to those performed by the above designated officers
or to whom any corporate trust matter is referred because of such Person’s knowledge of and familiarity with the particular subject, and who shall have direct responsibility for the administration of this Indenture. 

“Restricted Investment” means an Investment other than a Permitted Investment. 

“Restricted Subsidiary” means, at any time, any direct or indirect Subsidiary of the Company (including any Foreign
Subsidiary and Foreign Subsidiary Holding Company) that is not then an Unrestricted Subsidiary. Upon an Unrestricted Subsidiary ceasing to be an Unrestricted Subsidiary, such Subsidiary shall be a Restricted Subsidiary. 

“S&P” means Standard & Poor’s, a division of The McGraw-Hill Companies, Inc., and any successor to its
rating agency business. 
 “Sale and Lease-Back Transaction” means any arrangement providing for the leasing by the Company
or any of its Restricted Subsidiaries of any real or tangible personal property, which property has been or is to be sold or transferred by the Company or such Restricted Subsidiary to a third Person in contemplation of such leasing. 

“SEC” means the U.S. Securities and Exchange Commission. 

“Secured Indebtedness” means any Indebtedness of the Company or any of its Restricted Subsidiaries secured by a Lien. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated
thereunder. 
 “Securitization Assets” means (i) all receivables, inventory or royalty or other revenue streams
transferred in connection with asset securitization transactions by the Company or any Restricted Subsidiary pursuant to documents relating to any Qualified Securitization Transaction, (ii) all rights arising under the documentation governing
or related to receivables (including rights in respect of Liens securing such receivables and other credit support in respect of such receivables), any proceeds of such receivables and any lockboxes or accounts in which such proceeds are deposited,
spread accounts and other similar accounts (and any amounts on deposit therein) established in connection with a Qualified Securitization Transaction, any warranty, indemnity, dilution and other intercompany claim, arising out of the documents
relating to such Qualified Securitization Transaction and other assets that are transferred or in respect of which security interests are granted in connection with asset securitizations involving accounts receivable, and (iii) all collections
(including recoveries) and other proceeds of the assets described in the foregoing clauses (i) and (ii). 

  
 32 

 “Securitization Fees” means distributions or payments made directly or by means
of discounts with respect to any participation interest issued or sold in connection with, and other fees paid to a Person that is not a Restricted Subsidiary in connection with, any Qualified Securitization Transaction. 

“Securitization Special Purpose Entity” means a Person (including, without limitation, a Restricted Subsidiary) created in
connection with the transactions contemplated by a Qualified Securitization Transaction, which Person engages in no activities and holds no assets other than those incidental to such Qualified Securitization Transaction. 

“Senior Indebtedness” means any Indebtedness of the Company or any Subsidiary Guarantor that ranks pari passu in right
of payment with the Notes or the Guarantee of such Subsidiary Guarantor, as the case may be. For the avoidance of doubt, any Indebtedness of the Company or any Subsidiary Guarantor that is permitted to be incurred under the terms of this Indenture
shall constitute Senior Indebtedness for the purposes of this Indenture unless the instrument under which such Indebtedness is incurred expressly provides that it is subordinate in right of payment to the Notes or any related Guarantee. 

“Senior Secured Credit Facilities” means the Senior Credit Agreement dated as of May 12, 2015, by and among the Company,
JPMorgan Chase Bank, N.A., as Administrative Agent, and the other agents and lenders party thereto, including any guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements,
modifications, extensions, renewals, restatements or refundings thereof. 
 “separation and distribution” means
(1) the series of internal transactions among DuPont and its Subsidiaries (including the Company and its Subsidiaries) pursuant to which the business of the Company and its Subsidiaries is separated from DuPont and its other Subsidiaries, as
described in the Form 10 and the Offering Circular, and (2) DuPont’s distribution of the shares of the Company’s common stock to DuPont’s stockholders. 

“Separation and Distribution Documents” means each of the following agreements between DuPont and the Company in connection
with the separation and distribution to be dated as of or prior to the Distribution Date: the Separation Agreement, the Transition Services Agreement, the Tax Matters Agreement, the Employee Matters Agreement, the Intellectual Property Cross-License
Agreement (each as referred to in the Form 10 and the Offering Circular) and any other instruments, assignments, documents and agreements executed in connection with the implementation of the Transactions. 

“Series” or “Series of Notes” means each series of Notes or other debt instruments of the Company created
pursuant to Sections 2.01 and 2.02 hereof. 
 “Significant Subsidiary” means any Restricted Subsidiary that would be a
“significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the Original Issue Date. 

  
 33 

 “Similar Business” means any business conducted or proposed to be conducted by
the Company and its Subsidiaries on the Original Issue Date or any business that is similar, reasonably related, incidental or ancillary thereto or a reasonable extension, development or expansion of such business. 

“Standard Securitization Undertakings” means all representations, warranties, covenants, indemnities, performance guarantees
and servicing obligations entered into by the Company or any Subsidiary (other than a Securitization Special Purpose Entity) that are customary in connection with any Qualified Securitization Transaction. 

“Stated Maturity Date,” when used with respect to any Note, means the date specified in such Note as the fixed date on which
an amount equal to the principal amount of such Note is due and payable. 
 “Subordinated Indebtedness” means, with respect
to the Notes, 
 (1) any Indebtedness of the Company that is by its terms subordinated in right of payment to the Notes, and 

(2) any Indebtedness of any Subsidiary Guarantor that is by its terms subordinated in right of payment to the Guarantee of such entity of
the Notes. 
 “Subsidiary” means, with respect to any Person: 

(1) any corporation, association, or other business entity (other than a partnership, joint venture, limited liability company or similar
entity) of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time of determination
owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof; and 

(2) any partnership, joint venture, limited liability company or similar entity of which 

(a) more than 50% of the capital accounts, distribution rights, total equity and voting interests or general or limited partnership
interests, as applicable, are owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof whether in the form of membership, general, special or limited partnership or
otherwise, and 
 (b) such Person or any Restricted Subsidiary of such Person is a general partner or otherwise controls such entity.

  
 34 

 “Subsidiary Guarantor” has the meaning assigned to it in the preamble to this
Indenture. 
 “TIA” means the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) and the rules and
regulations thereunder as in effect on the date on which this Indenture is qualified under the TIA; provided, however, that in the event the Trust Indenture Act of 1939 is amended after such date, “TIA” means, to the extent
required by any such amendment, the Trust Indenture Act as so amended. 
 “Total Assets” means the total assets of the
Company and the Restricted Subsidiaries on a consolidated basis, as shown on the most recent consolidated balance sheet of the Company or such other Person as may be expressly stated, as the case may be (giving pro forma effect to any
acquisitions or dispositions of assets or properties that have been made by the Company or any of its Restricted Subsidiaries subsequent to the date of such balance sheet, including through mergers or consolidations). 

“Transactions” means (1) (A) the separation and distribution, (B) any other transactions contemplated by, or
pursuant to, the Separation and Distribution Documents or otherwise in connection with the separation and distribution (including, but not limited to, any cancellation or termination of Indebtedness, agreements, arrangements, dividends, true-ups,
adjustments, commitments or understandings, including intercompany accounts payables, receivables or Indebtedness, between the Company or any of its Restricted Subsidiaries, on the one hand, and DuPont or any of its other Subsidiaries, on the other
hand, and making certain intercompany contributions and dividend payments, including, without limitation, the dividend to be paid to DuPont that is financed from the net proceeds of the senior secured term loan and the Notes issued on the Original
Issue Date as described in the Form 10) and (C) any other transactions pursuant to agreements or arrangements in effect as of the Distribution Date, in each case on substantially the terms described in, or otherwise consistent in all material
respects with, the Offering Circular, or, in the case of clauses (B) and (C), any amendment, modification, addition or supplement to any such agreement or arrangement or replacement thereof, as long as the terms of such agreement or
arrangement, as so amended, modified, added, supplemented or replaced are not materially more disadvantageous to the Holders of Notes when taken as a whole compared to the applicable agreements or arrangements as described in the Offering Circular
(as determined in good faith by the Company), (2) the payment of a cash dividend to DuPont in connection with the separation and distribution as described in the Offering Circular, (3) the issuance of the Notes on the Original Issue Date,
(4) entering into the Senior Secured Credit Facilities and the borrowing of the term loans thereunder and (5) the payment of fees and expenses in connection with the foregoing. 

“Trustee” means the party named as such in the preamble to this Indenture until a successor replaces it in accordance with
the applicable provisions of this Indenture and thereafter means the successor serving hereunder, and if at any time there is more than one such person, “Trustee” as used with respect to the Notes of any Series shall mean the Trustee with
respect to Notes of that Series. 

  
 35 

 “Unrestricted Cash” means, at any time, all cash and Cash Equivalents held by
the Company and its Restricted Subsidiaries at such time; provided that such cash and Cash Equivalents (a) do not appear (and would not be required to appear) as “restricted” on a consolidated balance sheet of the Company
prepared in conformity with GAAP (unless such classification results solely from any Lien referred to in clause (b) below) and (b) are not controlled by or subject to any Lien or other preferential arrangement in favor of any creditor,
other than Liens created under a Credit Facility. 
 “Unrestricted Subsidiary” means: 

(1) any Subsidiary of the Company that at the time of determination is an Unrestricted Subsidiary (as designated by the Company, as
provided below); and 
 (2) any Subsidiary of an Unrestricted Subsidiary. 

The Company may designate any Subsidiary of the Company (including any existing Subsidiary and any newly acquired or newly formed Subsidiary)
to be an Unrestricted Subsidiary unless such Subsidiary or any of its Subsidiaries owns any Equity Interests or Indebtedness of, or owns or holds any Lien on, any property of, the Company or any Subsidiary of the Company (other than solely any
Subsidiary of the Subsidiary to be so designated); provided that 
 (1) such designation complies with Section 4.07; and

 (2) each of the Subsidiary to be so designated and its Subsidiaries has not at the time of designation, and does not thereafter,
create, incur, issue, assume, guarantee or otherwise become directly or indirectly liable with respect to any Indebtedness pursuant to which the lender has recourse to any of the assets of the Company or any Restricted Subsidiary. 

The Company may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided that, immediately after giving effect to
such designation, no Default shall have occurred and be continuing and either: 
 (1) the Company could incur at least $1.00 of
additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in Section 4.09(a); or 
 (2) the Fixed Charge
Coverage Ratio of the Company and its Restricted Subsidiaries would be greater than such ratio of the Company and its Restricted Subsidiaries immediately prior to such designation, in each case on a pro forma basis taking into account such
designation. 
 Any such designation by the Company shall be notified by the Company to the Trustee by promptly filing with the Trustee a
copy of the resolution of the board of directors of the Company or any committee thereof giving effect to such designation and an Officer’s Certificate certifying that such designation complied with the foregoing provisions. 

  
 36 

 Actions taken by an Unrestricted Subsidiary will not be deemed to have been taken, directly or
indirectly, by the Company or any Restricted Subsidiary. 
 “Voting Stock” of any Person as of any date means the Capital
Stock of such Person that is at the time entitled to vote in the election of the board of directors of such Person. 
 “Weighted
Average Life to Maturity” means, when applied to any Indebtedness or Disqualified Stock, as the case may be, at any date, the number of years obtained by dividing: 

(1) the sum of the products of the number of years from the date of determination to the date of each successive scheduled principal
payment of such Indebtedness or redemption or similar payment with respect to such Disqualified Stock multiplied by the amount of such payment; by 

(2) the sum of all such payments. 

SECTION 1.02 Other Definitions. 
  

			
	Term	  	Defined in Section
	 “Acceptable Commitment”
	  	4.10
	 “Additional Amounts”
	  	4.09
	 “Additional Notes”
	  	2.02
	 “Affiliate Transaction”
	  	4.11
	 “Asset Sale Offer”
	  	4.10
	 “Change of Control Offer”
	  	4.13
	 “Change of Control Payment”
	  	4.13
	 “Change of Control Payment Date”
	  	4.13
	 “Covenant Defeasance”
	  	8.03
	 “Covenant Suspension Event”
	  	4.14
	 “Event of Default”
	  	6.01
	 “Excess Proceeds Threshold”
	  	4.10
	 “Guaranteed Obligations”
	  	10.01
	 “incur”
	  	4.09
	 “Legal Defeasance”
	  	8.02
	 “Legal Holiday”
	  	11.07
	 “OID”
	  	4.06
	 “Paying Agent”
	  	2.05
	 “Refinancing Indebtedness”
	  	4.09
	 “Refunding Capital Stock”
	  	4.07
	 “Registrar”
	  	2.05
	 “Regular Record Date”
	  	2.03
	 “Reversion Date”
	  	4.14
	 “Successor Company”
	  	5.01
	 “Successor Person”
	  	5.01

  
 37 

			
	Term	  	Defined in Section
	 “Suspended Covenants”
	  	4.14
	 “Suspension Period”
	  	4.14
	 “Transfer Agent”
	  	2.05
	 “Treasury Capital Stock”
	  	4.07
	 “Trustee Notice Requirement”
	  	4.02

 SECTION 1.03 Incorporation by Reference of Trust Indenture Act. When qualified under the TIA, this
Indenture shall be subject to the mandatory provisions of the TIA, which are incorporated by reference in and made a part of this Indenture. Whether or not this Indenture is so qualified, the following TIA terms used in this Indenture have the
following meanings: 
 “indenture securities” means the Notes; 

“indenture security Holder” means a Holder of a Note; 

“indenture to be qualified” means this Indenture; 

“indenture trustee” or “institutional trustee” means the Trustee; and 

“obligor” on the Notes means the Company and each Guarantor, until a successor replaces the Company or a Guarantor and thereafter
means, as to such replaced Company or Guarantor, its successor. 
 When qualified under the TIA, all other terms used in this Indenture that
are defined by the TIA, defined by the TIA’s reference to another statute or defined by SEC rule under the TIA shall have the meanings so assigned to them. 

SECTION 1.04 Rules of Construction. Unless the context otherwise requires: 

(1) a term has the meaning assigned to it; 

(2) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(3) “or” is not exclusive; 

(4) words in the singular include the plural, and in the plural include the singular; 

(5) provisions apply to successive events and transactions; 

(6) references to sections of or rules under the Securities Act shall be deemed to include substitute, replacement or successor sections or
rules adopted by the SEC from time to time; 

  
 38 

 (7) the term “consolidated” with respect to any Person refers to such Person
consolidated with its Restricted Subsidiaries, and excludes from such consolidation any Unrestricted Subsidiary as if such Unrestricted Subsidiary were not an Affiliate of such Person; and 

(8) all covenant basket sizes set forth herein, including any definitions relating thereto, are as specified in Dollars, including with
respect to any Euro Notes. 
 ARTICLE II 

THE NOTES 

SECTION 2.01 Issuable in Series. The aggregate principal amount of Notes that may be authenticated and delivered under this
Indenture is unlimited. The Notes may be issued in one or more Series. All Notes of a Series shall be identical except as may be set forth in a Board Resolution, a supplemental indenture or an Officer’s Certificate detailing the adoption of the
terms thereof pursuant to the authority granted under a Board Resolution. In the case of Notes of a Series to be issued from time to time, the Board Resolution, supplemental indenture or Officer’s Certificate may provide for the method by which
specified terms (such as interest rate, Maturity Date, Regular Record Date or date from which interest shall accrue) are to be determined. Notes may differ between Series in respect of any matters. 

SECTION 2.02 Establishment of Terms of Series of Notes. At or prior to the issuance of any Notes within a Series, the Company may
establish (as to the Series generally, in the case of subsection 2.02(a) and either as to such Notes within the Series or as to the Series generally in the case of subsections 2.02(b) through 2.02(x)) by a Board Resolution, a supplemental indenture
or an Officer’s Certificate pursuant to authority granted under a Board Resolution the following terms applicable to such Notes: 
 (a)
the title of the Notes of the Series (which shall distinguish the Notes of that particular Series from the Notes of any other Series); 

(b) any limit upon the aggregate principal amount of the Notes of the Series which may be authenticated and delivered under this Indenture
(except for Notes authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Notes of the Series); 

(c) the date or dates on which the principal and premium, if any, of the Notes of the Series are payable; 

(d) the rate or rates (which may be fixed or variable per annum) at which the Notes of the Series shall bear interest, if any, or the method
of determining such rate or rates, the date or dates from which such interest, if any, shall accrue, the 

  
 39 

 
Interest Payment Dates on which such interest, if any, shall be payable or the method by which such dates will be determined, the Regular Record Dates (in the case of Notes in registered form),
and the basis upon which such interest will be calculated if other than that of a 360-day year of twelve 30-day months; 
 (e) the currency
or currencies, including composite currencies, in which Notes of the Series shall be denominated, the place or places, if any, in addition to or instead of the office of the Trustee where the principal, premium and interest with respect to Notes of
such Series shall be payable or the method of such payment, if by wire transfer, mail or other means; 
 (f) the price or prices at which,
the period or periods within which, and the terms and conditions upon which, Notes of the Series may be redeemed, in whole or in part at the option of the Company or otherwise, including the applicability of, and any addition to or change in, the
provisions (and the related definitions) set forth in Article III which applies to Notes of the Series; 
 (g) the obligation, if any, of
the Company to redeem, purchase or repay the Notes of the Series pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof and the price or prices at which, the period or periods within which, and the terms and
conditions upon which, Notes of the Series shall be redeemed, purchased or repaid, in whole or in part, pursuant to such obligations; 
 (h)
the terms, if any, upon which the Notes of the Series may be convertible into or exchanged for any of the Company’s ordinary shares, preferred shares, other debt securities or warrants for ordinary shares, preferred shares or other securities
of any kind and the terms and conditions upon which such conversion or exchange shall be effected, including the initial conversion or exchange price or rate, the conversion or exchange period and any other additional provisions; 

(i) if other than denominations of (1) $2,000 and any integral multiple of $1,000 in excess thereof, in the case of Dollar Notes, or
(2) €100,000 and any integral multiple of €1,000 in excess thereof, in the case of Euro Notes, the denominations in which the Notes of the Series shall be issuable; 

(j) if the amount of principal, premium or interest with respect to the Notes of the Series may be determined with reference to an index or
pursuant to a formula, the manner in which such amounts will be determined; 
 (k) if the principal amount payable at the Stated Maturity
Date of Notes of the Series will not be determinable as of any one or more dates prior to such Stated Maturity Date, the amount that will be deemed to be such principal amount as of any such date for any purpose, including the principal amount
thereof which will be due and payable upon any Maturity Date other than the Stated Maturity Date and which will be deemed to be Outstanding as of any such date (or, in any such case, the manner in which such deemed principal amount is to be
determined), and if necessary, the manner of determining the equivalent thereof in Dollars or Euros, as the case may be; 

  
 40 

 (l) any changes or additions to Article VIII; 

(m) if other than the entire principal amount thereof, the portion of the principal amount of the Notes of the Series that shall be payable
upon declaration of acceleration of the maturity thereof pursuant to Section 6.02; 
 (n) the terms, if any, of the transfer, mortgage,
pledge or assignment as security for the Notes of the Series of any properties, assets, moneys, proceeds, securities or other collateral, including whether any provisions of the TIA are applicable and any corresponding changes to provisions of this
Indenture as then in effect; 
 (o) any addition to or change in the Events of Default which applies to any Notes of the Series and any
change in the right of the Trustee or the requisite Holders of such Series of Notes to declare the principal amount of, premium, if any, and interest on such Series of Notes due and payable pursuant to Section 6.02; 

(p) if the Notes of the Series shall be issued in whole or in part in the form of a Global Note, the terms and conditions, if any, upon which
such Global Note may be exchanged in whole or in part for other individual Definitive Notes of such Series, the Depositary for such Global Note and the form of any legend or legends to be borne by any such Global Note in addition to or in lieu of
the Global Note Legend; 
 (q) any Trustee, authenticating agent, Paying Agent, transfer agent or Registrar; 

(r) the applicability of, and any addition to or change in, the covenants (and the related definitions) set forth in Article IV or Article V
which applies to Notes of the Series; 
 (s) with regard to Notes of the Series that do not bear interest, the dates for certain required
reports to the Trustee; 
 (t) the intended United States federal income tax consequences of the Notes; 

(u) the terms applicable to Original Issue Discount Notes, including the rate or rates at which original issue discount will accrue; and 

(v) any other terms of Notes of the Series (which terms shall not be prohibited by the provisions of this Indenture). 

All Notes of any one Series need not be issued at the same time and may be issued from time to time, consistent with the terms of this
Indenture, if so provided by or pursuant to the Board Resolution, supplemental indenture or Officer’s Certificate referred to above, and the authorized principal amount of any Series may not be increased to provide for issuances of additional
Notes of such Series, unless otherwise provided in such Board Resolution, supplemental indenture or Officer’s Certificate. Any Notes issued after the Original Issue Date are herein referred to as “Additional Notes”. 

  
 41 

 SECTION 2.03 Denominations; Provisions for Payment. The Notes shall be issuable and
may be transferred only, except as otherwise provided with respect to any Series of Notes pursuant to Section 2.02, as registered Notes in the denominations of (1) $2,000 and any integral multiple of $1,000 in excess thereof, in the case
of Dollar Notes, or (2) €100,000 and any integral multiple of €1,000 in excess thereof, in the case of Euro Notes, subject to Section 2.02(k). The Notes of any Series shall bear interest payable on the dates and at the rate
specified with respect to that Series. Unless otherwise provided as contemplated by Section 2.02 with respect to Notes of any Series, the principal of and the interest on the Notes of any Series, as well as any premium thereon in case of
redemption thereof prior to maturity, shall be payable in Dollars, in the case of Dollar Notes, or Euros, in the case of Euro Notes. Such payment shall be made (x) in the case of the Dollar Notes, at the office or agency of the Company
maintained for such purpose, and (y) in the case of the Euro Notes, at the office or agency of the paying agent or registrar of the Euro Notes maintained for such purpose or, at the option of the Company, payment of interest may be made by
check mailed to the Holders of the Notes at their respective addresses set forth in the register of Holders; provided that all payments of principal, premium, if any, and interest with respect to (i) Dollar Notes represented by one or
more global notes registered in the name of or held by DTC or its nominee will be made by wire transfer of immediately available funds to the accounts specified by the Holder or Holders thereof, and (ii) Euro Notes represented by one or more
global notes registered in the name of a nominee of and held by the common depository for Euroclear and Clearstream will be made by the wire transfer of immediately available funds to the accounts specified by the Holder or Holders thereof. The
rights of holders of beneficial interests in the Euro Notes to receive payment on such Euro Notes are subject to applicable procedures of Euroclear and Clearstream. The Company hereby designates the office of the Trustee as one such office or agency
with respect to Dollar Notes and the Company hereby designates the office of the Euro Agent as one such office or agency with respect to Euro Notes. Each Note shall be dated the date of its authentication. Unless otherwise provided as contemplated
by Section 2.02, interest on the Notes shall be computed on the basis of a 360-day year composed of twelve 30-day months. 
 The
interest installment on any Note that is payable, and is punctually paid or duly provided for, on any Interest Payment Date for Notes of that Series shall be paid to the Person in whose name said Note (or one or more predecessor Notes) is registered
at the close of business on the Regular Record Date for such interest installment. In the event that any Note of any Series or portion thereof is called for redemption and the redemption date is subsequent to a Regular Record Date with respect to
any Interest Payment Date and prior to such Interest Payment Date, interest on such Note will be paid upon presentation and surrender of such Note as provided in Section 3.05 and Section 3.06. 

Unless otherwise set forth in a Board Resolution, a supplemental indenture or an Officer’s Certificate establishing the terms of any
Series of Notes pursuant to Section 2.02 hereof, the term “Regular Record Date” as used in this Indenture with respect to Notes of any Series with respect to any Interest Payment Date for such Series

  
 42 

 
shall mean (i) either the fifteenth day of the month immediately preceding the month in which an Interest Payment Date established for such Series pursuant to Section 2.02 hereof shall
occur, if such Interest Payment Date is the first day of a month, whether or not such date is a Business Day, or (ii) the last day of the month immediately preceding the month in which an Interest Payment Date established for such Series
pursuant to Section 2.02 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or not such date is a Business Day. 

Subject to the foregoing provisions of this Section, each Note of a Series delivered under this Indenture upon transfer of or in exchange for
or in lieu of any other Note of such Series shall carry the rights to interest accrued and unpaid, and to accrue, that were carried by such other Note. 

SECTION 2.04 Execution and Authentication. One or more Officers shall sign the Notes for the Company by manual or facsimile
signature. If an Officer whose signature is on a Note no longer holds that office at the time the Note is authenticated, the Note shall nevertheless be valid. A Note shall not be valid until authenticated by the manual signature of the Trustee or an
authenticating agent. The manual signature of the Trustee shall be conclusive evidence that the Note has been authenticated under this Indenture. The Notes may contain such notations, legends or endorsements required by law, stock exchange rule or
usage, but which shall not affect the rights, duties or immunities of the Trustee. 
 The Trustee shall at any time, and from time to time,
authenticate Notes for original issue in the principal amount provided in a Company Order. Such Company Order shall specify the amount of Notes to be authenticated, the date on which the issue of Notes is to be authenticated, the number of separate
Notes to be authenticated, the registered Holder of each Note and delivery instructions. Each Note shall be dated the date of its authentication unless otherwise provided by a Board Resolution, a supplemental indenture hereto or an Officer’s
Certificate. 
 The aggregate principal amount of Notes of any Series Outstanding at any time may not exceed any limit upon the maximum
principal amount for such Series set forth in the Board Resolution, supplemental indenture hereto or Officer’s Certificate delivered pursuant to Section 2.02, except as provided in Section 2.09. 

Prior to the first issuance of Notes of any Series, the Trustee shall have received and (subject to Section 7.02) shall be fully
protected in relying on: (a) the Board Resolution, supplemental indenture hereto or Officer’s Certificate establishing the form of the Notes of that Series or of Notes within that Series and the terms of the Notes of that Series or of
Notes within that Series, (b) an Officer’s Certificate with respect to both the issuance and authentication of such Notes, and (c) other than with respect to Notes issued on the Original Issue Date, an Opinion of Counsel with respect
to both the issuance and authentication of such Notes which shall also state: (i) that such Notes, when authenticated and delivered by the Trustee and issued by the Company in the manner and subject to any conditions specified in such Opinion
of Counsel, will 

  
 43 

 
constitute valid and legally binding obligations of the Company, enforceable in accordance with their terms, subject to bankruptcy, insolvency, reorganization and other laws of general
applicability relating to or affecting the enforcement of creditors’ rights and to general equity principles; (ii) that the Guarantees relating to such Notes constitute valid and legally binding obligations of the Guarantors, enforceable
in accordance with their terms, subject to bankruptcy, insolvency, reorganization and other laws of general applicability relating to or affecting the enforcement of creditors’ rights and to general equity principles; (iii) that this
Indenture and any such supplemental indenture constitute valid and legally binding obligations of the Company and the Guarantors, enforceable in accordance with their terms, subject to bankruptcy, insolvency, reorganization and other laws of general
applicability relating to or affecting the enforcement of creditors’ rights and to general equity principles; and (iv) all conditions precedent, if any, in connection with the execution of such supplemental indenture have been satisfied.

 The Trustee shall have the right to decline to authenticate and deliver any Notes of such Series: (a) if the Trustee, being advised
by counsel, determines that such action may not lawfully be taken; (b) if the Trustee shall determine that such action would expose the Trustee to personal liability to Holders of any then Outstanding Series of Notes or otherwise exposes the
Trustee to liability hereunder or under any Series of Notes; or (c) if the issue of such Notes will adversely affect the Trustee’s own rights, duties or immunities under the Notes and this Indenture or otherwise in a manner that is not
reasonably acceptable to the Trustee. 
 The Trustee may appoint an authenticating agent acceptable to the Company to authenticate Notes. An
authenticating agent may authenticate Notes whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent. An authenticating agent has the same rights as an Agent to deal with
the Company or an Affiliate of the Company. 
 SECTION 2.05 Registrar, Paying Agent and Transfer Agent. The Company shall
maintain one or more offices or agencies where Notes may be presented for registration of transfer or for exchange (each, a “Registrar”) and one or more offices or agencies where Notes may be presented for payment (each, a
“Paying Agent”). The Registrar shall keep a register of the Notes and of their transfer and exchange. The Company may appoint one or more co-Registrars and one or more additional Paying Agents. The term “Registrar”
includes any co-Registrar and the term “Paying Agent” includes any additional Paying Agent. The Company shall also maintain a transfer agent with respect to any Euro Notes (a “Transfer Agent”). The Transfer Agent shall be
responsible for, among other things, facilitating any transfers or exchanges of beneficial interests in Euro Notes represented by global notes between Holders. 

The Company shall give prompt written notice to the Trustee of any such co-Registrar or additional Paying Agents and of any change in the name
or address of any such Registrar, Transfer Agent or Paying Agent. The Company may change any Paying Agent or Registrar without notice to any Holder. If the Company fails to appoint or maintain another entity as Registrar or Paying Agent, the Trustee
shall act as such, or 

  
 44 

 
appoint any necessary Registrar or Paying Agent. The Company may change the Paying Agents, the Registrars or the Transfer Agent without prior notice to the Holders. The Company or any of its
Subsidiaries may act as a Paying Agent or Registrar with respect to any Dollar Notes. If and for so long as any Euro Notes are listed on the Global Exchange Market and the rules of the Irish Stock Exchange so permit, the Company shall publish a
notice of any change of Paying Agent, Registrar or Transfer Agent on the official website of the Irish Stock Exchange (http://www.ise.ie). 

The Company undertakes that, so long as any Euro Notes remain outstanding, it will ensure that it maintains a Paying Agent with respect to
such Euro Notes in a member state of the European Union that will not be obligated to withhold or deduct tax pursuant to the Council of the European Union Directive 2003/48/EC (as amended from time to time) or any other law or directive implementing
the conclusions of the Economic and Financial Affairs Council meeting of 26 and 27 November 2000 on the taxation of savings income, or any law implementing, or complying with or introduced in order to conform to, such directive. The applicable
Paying Agent will make payments on the Notes on behalf of the Company. 
 The Company hereby appoints the Trustee to be the initial
Registrar and initial Paying Agent for any Dollar Notes. The Company hereby appoints Elavon Financial Services Limited, UK Branch, to be the initial Paying Agent for any Euro Notes. The Company hereby appoints Elavon Financial Services Limited to be
the initial Registrar and initial Transfer Agent for any Euro Notes. 
 SECTION 2.06 Paying Agent To Hold Money in Trust. Each
Paying Agent, other than the Trustee, agrees that it will hold in trust, for the benefit of Holders of any Series of Notes or the Trustee, all money held by the Paying Agent for the payment of principal of or interest on the Series of Notes, and
will notify the Trustee of any default by the Company in making any such payment. While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee. Notwithstanding anything in this Section 2.06
to the contrary, (i) the agreement to hold sums in trust as provided in this Section 2.06 is subject to the provisions of Section 8.06, and (ii) the Company may at any time, for the purpose of obtaining the satisfaction and
discharge of this Indenture or for any other purpose, pay, or direct any Paying Agent to pay, to the Trustee all sums held in trust by the Company or such Paying Agent, such sums to be held by the Trustee upon the same terms and conditions as those
upon which such sums were held by the Company or such Paying Agent; and, upon such payment by any Paying Agent to the Trustee, such Paying Agent (if other than the Company) shall be released from all further liability with respect to the money. If
the Company acts as Paying Agent, it shall segregate and hold in a separate trust fund for the benefit of Holders of any Series of Notes all money held by it as Paying Agent. The Euro Agent hereby agrees to the terms of this Section 2.06. 

SECTION 2.07 Holder Lists. (a) The Registrar shall preserve in as current a form as is reasonably practicable the most recent
list available to it of the names and addresses of Holders of each Series of 

  
 45 

 
Notes and the Company undertakes to provide, or cause the Depositary to provide, such a list at the Registrar’s or Trustee’s reasonable request but in any case no more often than at
stated intervals of six months, unless the Company and the Trustee or Registrar shall otherwise agree. If the Trustee is not the Registrar, the Company shall furnish to the Trustee at least ten days before each Interest Payment Date and at such
other times as the Trustee may request in writing a list, in such form and as of such date as the Trustee may reasonably require, of the names and addresses of Holders of each Series of Notes. 

(b) The Trustee may destroy any list furnished to it as provided in Section 2.07(a) upon receipt of a new list so furnished. 

SECTION 2.08 Transfer and Exchange. When Notes of a Series are presented to the Registrar with a request to register a transfer or
to exchange them for an equal principal amount of Notes of the same Series, the Registrar shall register the transfer or make the exchange if its requirements for such transactions are met. To permit registrations of transfers and exchanges, the
Company shall execute, and the Trustee, upon a Company Order, shall authenticate, Notes. No service charge shall be made for any registration of transfer or exchange (except as otherwise expressly permitted herein), but the Company may require
payment from the transferring or exchanging Holder, as the case may be, of a sum sufficient to cover any transfer tax or similar governmental charge payable in connection therewith (other than any such transfer tax or similar governmental charge
payable upon exchanges pursuant to Section 2.11, 3.06 or 9.04). 
 Neither the Company nor the Trustee shall be required (a) to
issue, register the transfer of, or exchange Notes of any Series for the period beginning at the opening of business 30 days immediately preceding the mailing of a notice of redemption of Notes of that Series selected for redemption and ending at
the close of business on the day of such mailing, or (b) to register the transfer or exchange of Notes of any Series selected, called or being called for redemption as a whole or the portion being redeemed of any such Notes selected, called or
being called for redemption in part. 
 All Notes presented or surrendered for exchange or registration of transfer, as provided in this
Section 2.08, shall be accompanied by a written instrument or instruments of transfer satisfactory to the Company and the Trustee, duly executed by the registered Holder or by such Holder’s duly authorized attorney in writing and, if
necessary, by the transferee or such transferee’s duly authorized attorney in writing. 
 The provisions of this Section 2.08 are,
with respect to any Global Note, subject to Section 2.14 hereof. 
 SECTION 2.09 Mutilated, Destroyed, Lost and Stolen
Notes. If any mutilated Note is surrendered to the Trustee (in the case of Dollar Notes) or the applicable Registrar (in the case of Euro Notes), the Company shall execute and the Trustee, upon a Company Order, shall authenticate and deliver in
exchange therefor a new Note of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding. 

  
 46 

 If there shall be delivered to the Company and the Trustee or such Registrar (i) evidence to
their satisfaction of the destruction, loss or theft of any Note and (ii) such security or indemnity as may be required by them to save each of them and any agent of either of them harmless, then, in the absence of notice to the Company or the
Trustee or such Registrar that such Note has been acquired by a bona fide purchaser, the Company shall execute and the Trustee or such Registrar, upon a Company Order, shall authenticate and make available for delivery, in lieu of any such
destroyed, lost or stolen Note, a new Note of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding. 

In case any such mutilated, destroyed, lost or stolen Note has become or is about to become due and payable, the Company in its discretion
may, instead of issuing a new Note, pay such Note (without surrender thereof except in the case of a mutilated Note) if the applicant for such payment shall furnish to the Company and the Trustee or such Registrar such security or indemnity as may
be required by them to save each of them and any agent of either of them harmless, and, in case of destruction, loss or theft, evidence to their satisfaction of the destruction, loss or theft of such Note and of the ownership thereof. 

Upon the issuance of any new Note under this Section 2.09, the Company may require the payment of a sum sufficient to cover any tax or
other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee or such Registrar) connected therewith. 

Every new Note of any Series issued pursuant to this Section 2.09 in lieu of any destroyed, lost or stolen Note shall constitute an
original additional contractual obligation of the Company, whether or not the mutilated, destroyed, lost or stolen Note shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and
proportionately with any and all other Notes of that Series duly issued hereunder. 
 The provisions of this Section 2.09 are exclusive
and shall preclude (to the extent lawful) any and all other rights and remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary, with respect to the replacement or payment of mutilated, destroyed, lost or stolen
Notes, negotiable instruments or other securities. 
 SECTION 2.10 Treasury Notes. In determining whether the Holders of the
required principal amount of Notes of a Series have concurred in any request, demand, authorization, direction, notice, consent or waiver, Notes of a Series owned by the Company or any Guarantor, or any of their respective subsidiaries, shall be
disregarded, except that for the purposes of determining whether the Trustee shall be protected in relying on any such request, demand, authorization, direction, notice, consent or waiver only Notes of a Series that a Responsible Officer of the
Trustee actually knows are so owned shall be so disregarded. Subject to the foregoing, only Notes Outstanding at the time shall be considered in any such determination. 

  
 47 

 SECTION 2.11 Temporary Notes. Until Definitive Notes are ready for delivery, the
Company may prepare and the Trustee shall authenticate temporary Notes upon a Company Order. Temporary Notes shall be substantially in the form of Definitive Notes but may have variations that the Company considers appropriate for temporary Notes,
which shall not affect the rights, duties or immunities of the Trustee. Without unreasonable delay, the Company shall prepare and the Trustee, upon a Company Order, shall authenticate Definitive Notes of the same Series and Maturity Date in exchange
for temporary Notes. Until so exchanged, temporary Notes shall have the same rights under this Indenture as the Definitive Notes. 

SECTION 2.12 Cancellation. The Company at any time may deliver Notes to the Trustee for cancellation. The Registrar and the Paying
Agent shall forward to the Trustee any Notes surrendered to them for registration of transfer, exchange or payment. The Trustee shall cancel all Notes surrendered for transfer, exchange, payment, replacement or cancellation and shall destroy such
canceled Notes (subject to the record retention requirement of the Exchange Act and its customary practices) and, upon request, provide evidence of the cancellation of all cancelled Notes to the Company. The Company may not issue new Notes to
replace Notes that they have paid or delivered to the Trustee for cancellation. The Company shall deliver, or cause to be delivered, notice of such cancellation to the Company Announcements Office of the Irish Stock Exchange (as long as any Euro
Notes are admitted to the Official List and to trading on the Global Exchange Market of the Irish Stock Exchange and the rules of the Irish Stock Exchange so require). 

SECTION 2.13 Defaulted Interest. If the Company defaults in a payment of interest on a Series of Notes, it shall pay the defaulted
interest in any lawful manner, plus, to the extent permitted by law and if the terms of such Series so provide, any interest payable on the defaulted interest, to the persons who are Holders of the Series on a subsequent special record date. The
Company shall fix the record date and payment date. At least 10 days before the record date, the Company shall mail or deliver to the Trustee and to each Holder of the Series a notice that states the record date, the payment date and the amount of
interest to be paid, including any defaulted interest and interest thereon. 
 SECTION 2.14 Global Notes. (a) Terms of
Notes. A Board Resolution, a supplemental indenture hereto or an Officer’s Certificate shall establish whether the Notes of a Series shall be issued in whole or in part in the form of one or more Global Notes and the Depositary for such
Global Note or Notes. 
 (b) Transfer and Exchange. Notwithstanding any provisions to the contrary contained in Section 2.08 of
this Indenture and in addition thereto, any Global Note shall be exchangeable pursuant to Section 2.08 of this Indenture for Notes registered 

  
 48 

 
in the names of Holders (and held in definitive form) other than the Depositary for such Note or its nominee only if (i) such Depositary notifies the Company that it is unwilling or unable
to continue as Depositary for such Global Note or if at any time such Depositary ceases to be a clearing agency registered under the Exchange Act, and, in either case, the Company fails to appoint a successor Depositary within 90 days of such event,
and (ii) the Company executes and delivers to the Trustee an Officer’s Certificate (and any other deliverables required hereunder) stating that such Global Note shall be so exchangeable. Any Global Note that is exchangeable pursuant to the
preceding sentence shall be exchangeable for Notes registered in such names as the Depositary shall direct in writing in an aggregate principal amount equal to the principal amount of the Global Note with like tenor and terms. 

Except as provided in this Section 2.14(b), a Global Note may only be transferred in whole but not in part (i) by the Depositary
with respect to such Global Note to a nominee of such Depositary, (ii) by a nominee of such Depositary to such Depositary or another nominee of such Depositary or (iii) by the Depositary or any such nominee to a successor Depositary or a
nominee of such a successor Depositary. 
 (c) Legend. Any Global Note issued hereunder shall bear a legend in substantially
the following form; provided that any global note legend required by a supplemental indenture or Officer’s Certificate with respect to one or more series of Notes shall be appended in addition to or in replacement of the following
form: 
 “This Note is held by the Depositary (as defined in the Indenture governing this Note) or its nominee in custody
for the benefit of the beneficial owners hereof, and is not transferable to any person under any circumstances except that (a) the Trustee or the Registrar may make such notations hereon as may be required pursuant to Section 2.04 of the
Indenture, (b) this Note may be exchanged in whole but not in part pursuant to Section 2.14(b) of the Indenture, (c) this Global Note may be delivered to the Trustee for cancellation pursuant to Section 2.12 of the Indenture and
(d) except as otherwise provided in Section 2.14(b) of the Indenture, this Note may be transferred, in whole but not in part, only (x) by the Depositary to a nominee of the Depositary, (y) by a nominee of the Depositary to the
Depositary or another nominee of the Depositary or (z) by the Depositary or any nominee to a successor Depositary or to a nominee of such successor Depositary.” 

(d) Acts of Holders. (i) Any request, demand, authorization, direction, notice, consent, waiver or other action provided by this
Indenture to be given or taken by Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in person or by an agent duly appointed in writing; and, except as herein otherwise expressly
provided, such action shall become effective when such instrument or instruments are delivered to the Trustee and, where it is hereby expressly required, to the Company. Such instrument or instruments (and the action embodied therein and evidenced
thereby) are herein sometimes referred to as the “Act” of Holders signing such instrument or instruments. Proof of execution of any such instrument or of a writing appointing any such agent shall be sufficient for any purpose of this
Indenture and conclusive in favor of the Trustee and the Company, if made in the manner provided in this Section. 
 (ii)
The fact and date of the execution by any Person of any such instrument or writing may be proved by any reasonable manner which the Trustee deems sufficient. 

  
 49 

 (iii) The ownership of registered securities shall be proved by the register
maintained by the Registrar. 
 (iv) Any request, demand, authorization, direction, notice, consent, waiver or other Act of
the Holder of any Note shall bind every future Holder of the same Note and the Holder of every Note issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof in respect of anything done, omitted or suffered to be
done by the Trustee or the Company in reliance thereon, whether or not notation of such action is made upon such Note. 

(v) If the Company shall solicit from the Holders any request, demand, authorization, direction, notice, consent,
waiver or other act, the Company may, at its option, by or pursuant to a Board Resolution, fix in advance a record date for the determination of Holders entitled to give such request, demand, authorization, direction, notice, consent, waiver or
other act, but the Company shall have no obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or other act may be given before or after such record date, but only the Holders of
record at the close of business on such record date shall be deemed to be Holders for the purposes of determining whether Holders of the requisite proportion of Outstanding Notes have authorized or agreed or consented to such request, demand,
authorization, direction, notice, consent, waiver or other act, and for that purpose the Outstanding Notes shall be computed as of such record date; provided, that such authorization, agreement or consent by the Holders on such record date
shall not be deemed effective unless it shall become effective pursuant to the provisions of this Indenture within six months after the record date. 

The Depositary, as a Holder, may establish procedures for beneficial owners of Notes who hold interests in the Notes through Participants to
provide any request, demand, authorization, direction, notice, consent, waiver or other action that a Holder is entitled to give or take under this Indenture and it may take actions as Holder consistent with such instructions in accordance with such
procedures. Neither the Trustee nor any Agent shall have any duty, obligation, responsibility or liability with respect to any Depositary’s procedures, action or inaction. 

(e) Payments. Notwithstanding the other provisions of this Indenture, unless otherwise specified as contemplated by Section 2.02,
payment of the principal of and interest, if any, on any Global Note shall be made to the Holder thereof. 
 (f) Depositaries. The
Company hereby appoints DTC to act as initial Dollar Depositary with respect to any Dollar Notes. The Company hereby appoints Elavon Financial Services Limited to act as initial Common Depositary with respect to any Euro Notes. 

  
 50 

 SECTION 2.15 CUSIP Numbers, ISINs and Common Code Numbers. The Company in issuing the
Notes may use “CUSIP” numbers, “ISINs” and “Common Code” numbers (if then generally in use), and, if so, the Company shall use “CUSIP” numbers, “ISINs” or “Common Code” numbers in notices
of redemption as provided in Section 3.03; provided that (i) neither the Company nor the Trustee shall have any responsibility or liability for any defect in the “CUSIP” number, “ISIN” or “Common Code”
number that appears on any Note, check, advice of payment or redemption notice, (ii) any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of
a redemption, (iii) reliance may be placed only on the other elements of identification printed on the Notes and (iv) any such redemption shall not be affected by any defect in or omission of such numbers. The Company shall notify the
Trustee of changes in the “CUSIP” number, “ISIN” or “Common Code” number for the Notes of which it becomes aware. 

SECTION 2.16 Benefits of Indenture. Nothing in this Indenture or in the Notes, express or implied, shall give or be construed to
give to any Person, other than the parties hereto and the Holders of the Notes, any legal or equitable right, remedy or claim under or in respect of this Indenture, or under any covenant, condition or provision herein contained; all such covenants,
conditions and provisions being for the sole benefit of the parties hereto and of the Holders of the Notes. 
 SECTION 2.17
Performance of the Transactions. Notwithstanding any provision of this Indenture or the Notes, nothing herein or therein shall be deemed to prevent, restrict or otherwise impose limitations on the ability of DuPont, the Company and their
respective Subsidiaries to enter into and perform the Transactions (including the Separation and Distribution Documents) and to consummate the separation and distribution and no such action, in and of itself, shall be deemed to constitute or result
in a Default or an Event of Default. 
 ARTICLE III 

REDEMPTION AND PREPAYMENT 

SECTION 3.01 Notices to Trustee. The Company may, with respect to any Series of Notes, reserve the right to redeem and pay the
Series of Notes or may covenant to redeem and pay the Series of Notes or any part thereof prior to the Stated Maturity Date thereof at such time and on such terms as provided for in such Series of Notes. If a Series of Notes is

  
 51 

 
redeemable and the Company wants or is obligated to redeem prior to the Stated Maturity Date thereof all or part of the Series of Notes pursuant to the terms of such Notes, the Company shall
notify the Trustee in writing of the redemption date and the principal amount of Notes of the Series to be redeemed and the redemption price. Except as otherwise provided in Section 3.03, the Company shall give such written notice to the
Trustee in the form of an Officer’s Certificate at least 10 days before notice of redemption is required to be mailed or caused to be mailed to Holders pursuant to Section 3.03 hereof unless the Trustee consents to a shorter period. 

If and for so long as any Euro Notes are listed on the Official List of the Irish Stock Exchange and admitted to trading on the Global
Exchange Market and the rules of the Irish Stock Exchange so require, any such notice to the holder of the relevant Euro Notes shall also be released by the Company through the Companies Announcement Office of the Irish Stock Exchange and, in
connection with any redemption, the Company will notify the Irish Stock Exchange of any change in the principal amount of Euro Notes outstanding. 

SECTION 3.02 Selection of Notes To Be Redeemed. Unless otherwise indicated for a particular Series by a Board Resolution, a
supplemental indenture or an Officer’s Certificate, if less than all of the Notes of a Series are to be redeemed or purchased in an offer to purchase at any time, the Trustee shall select the Notes to be redeemed or purchased as follows: 

(1) if the Company notifies the Trustee in writing that the Notes are listed on an exchange, in compliance with the
requirements of such exchange; or 
 (2) on a pro rata basis to the extent practicable, or, if a pro rata basis is not
practicable or permitted for any reason, by lot or by such other method as may be prescribed by, in respect of Dollar Notes, DTC’s applicable procedures, or, in respect of Euro Notes, Euroclear’s and Clearstream’s applicable
procedures. 
 No Dollar Notes of $2,000 of principal amount or less (or, in the case of any Series of Dollar Notes
established in denominations less than $2,000, the principal amount or less of such denomination) will be redeemed in part. No Euro Notes of €100,000 of principal amount or less (or, in the case of any Series of Euro Notes established in
denominations less than €100,000, the principal amount or less of such denomination) will be redeemed in part. Except as provided in the two preceding sentences, provisions of this Indenture that apply to Notes called for redemption also apply
to portions of Notes called for redemption. The Trustee shall make the selection from Outstanding Notes of a Series not previously called for redemption. 

If any Note is to be redeemed in part only, the notice of redemption that relates to such Note of the same Series and Stated
Maturity Date shall state the portion of the principal amount of that Note to be redeemed. A new Note in principal amount equal to the unredeemed portion of the original Note presented for redemption will be issued in the name of the Holder thereof
upon cancellation of the original Note. On and after the redemption date, interest ceases to accrue or accrete on Notes or portions of them called for redemption. 

  
 52 

 SECTION 3.03 Notice of Redemption. Unless otherwise provided for a particular Series
of Notes by a Board Resolution, a supplemental indenture or an Officer’s Certificate, at least 30 days but not more than 60 days before a redemption date, the Company shall deliver electronically or mail or cause to be mailed, by first-class
mail, postage prepaid (or otherwise delivered in accordance with the procedures of DTC with respect to Dollar Notes or the procedures of Euroclear and Clearstream with respect to Euro Notes), a notice of redemption to each Holder whose Notes are to
be redeemed at its registered address. 
 The notice shall identify the Notes to be redeemed and shall state: 

(1) the redemption date; 

(2) the redemption price, which will include interest accrued and unpaid to the date fixed for redemption; 

(3) if any Note is being redeemed in part, the portion of the principal amount of such Note to be redeemed and that, after the
redemption date upon surrender of such Note, a new Note or Notes in principal amount equal to the unredeemed portion shall be issued upon cancellation of the original Note; 

(4) the name and address of the Paying Agent; 

(5) that Notes called for redemption must be surrendered to the Paying Agent to collect the redemption price; 

(6) that, unless the Company defaults in making such redemption payment or the Paying Agent is prohibited from making such
payment pursuant to the terms of this Indenture, interest on Notes (or portion thereof) called for redemption ceases to accrue on and after the redemption date; 

(7) the paragraph of the Notes and/or provision of this Indenture or any supplemental indenture pursuant to which the Notes
called for redemption are being redeemed; 
 (8) the CUSIP number, ISIN and Common Code number, if any, printed on the Notes
being redeemed; 
 (9) any applicable conditions precedent and the procedures for notice to the Trustee and Holders of any
failure or delay to satisfy such conditions; 
 (10) whether payment of the redemption price and the performance of the
Company’s obligations with respect to such redemption will be performed by another Person; and 
 (11) that no
representation is made as to the correctness or accuracy of the CUSIP number, ISIN or Common Code number, if any, listed in such notice or printed on the Notes. 

  
 53 

 At the Company’s request, the Trustee shall give the notice of redemption in the
Company’s name and at its expense; provided, however, that the Company shall deliver to the Trustee, at least 10 days prior to the intended delivery or mailing of any such notice (or such shorter period as may be acceptable to the
Trustee), an Officer’s Certificate requesting that the Trustee give such notice and setting forth the information to be stated in such notice as required by this Section. 

SECTION 3.04 Effect of Notice of Redemption. Once notice of redemption is delivered or mailed in accordance with Section 3.03
hereof and any conditions set forth therein have been satisfied, Notes called for redemption become due and payable on the redemption date at the redemption price, subject to the following paragraph. Failure to give notice or any defect in the
notice to any Holder shall not affect the validity of the notice to any other Holder. 
 Notice of any redemption may be given prior to the
completion of any offering or other corporate transaction, and any redemption or notice may, at the Company’s discretion, be subject to one or more conditions precedent, including, but not limited to, the completion of the related offering or
corporate transaction. 
 SECTION 3.05 Deposit of Redemption Price. No later than 10:00 a.m. local time on the redemption date
in the place of payment of such redemption, the Company shall deposit with the Trustee or with the applicable Paying Agent money in Dollars (in the case of Dollar Notes) and Euros (in the case of Euro Notes) sufficient to pay the redemption price of
and accrued interest on all Notes (or portions of Notes) to be redeemed on that date. Neither the Trustee nor the applicable Paying Agent shall be obligated to make payments to Holders or the Depositary without receipt of such sufficient funds. Each
Euro amount payable hereunder shall be paid unconditionally by credit transfer in Euros and freely transferable, cleared funds on the date specified above, except as otherwise agreed between the Paying Agent for the applicable Euro Notes and the
Company, to such account with such bank as the Paying Agent for such Euro Notes shall, by four Business Days prior notice to the Company, specify for such purpose. The Company shall procure that, before 10:00 a.m. (Luxembourg Time) on the third
Business Day before each redemption date, the bank effecting payment to the Paying Agent for such Euro Notes confirms by authenticated SWIFT message to the Paying Agent for such Euro Notes the irrevocable payment instructions relating to such
payment. The Trustee or the Paying Agent shall as promptly as practicable return to the Company any money deposited with the Trustee or the Paying Agent by the Company in excess of the amounts necessary to pay the redemption price of, and accrued
interest on, all Notes to be redeemed. If such money is then held by the Company in trust and is not required for such purpose it shall be discharged from such trust. 

  
 54 

 If the Company complies with the provisions of the immediately preceding paragraph, on and after
the redemption date, interest shall cease to accrue on the Notes or the portions of Notes called for redemption. If a Note is redeemed on or after a Regular Record Date but on or prior to the related Interest Payment Date, then any accrued and
unpaid interest shall be paid on the redemption date to the Person in whose name such Note was registered at the close of business on such Regular Record Date. If any Note called for redemption shall not be so paid upon surrender for redemption
because of the failure of the Company to comply with the preceding paragraph, interest shall be paid on the unpaid principal, from the redemption date until such principal is paid, and, to the extent permitted by law and if the terms of such Series
so provide, on any interest not paid on such unpaid principal, in each case at the rate provided in the Notes. 
 SECTION 3.06 Notes
Redeemed in Part. Upon surrender of a Note that is redeemed in part, the Company shall execute and the Trustee, upon a Company Order and receipt of the deliverables required hereunder, shall authenticate for the Holder (at the Company’s
expense) a new Note of the same Series and Stated Maturity Date equal in principal amount to the unredeemed portion of the Note surrendered. 

SECTION 3.07 Optional Redemption. The Company may redeem all or part of the Notes within a Series pursuant to the terms of any
Board Resolution, supplemental indenture or Officer’s Certificate pursuant to which such Series was established. 
 ARTICLE IV 

COVENANTS 

SECTION 4.01 Payment of Notes. The Company covenants and agrees, for the benefit of the Holders of each Series of Notes, that it
will duly and punctually make all payments in respect of each Series of Notes on the dates and in the manner provided in such Series of Notes and this Indenture. Principal, premium, if any, and interest will be considered paid on the date due if the
Paying Agent, if other than the Company or a Subsidiary thereof, holds as of 10:00 a.m. local time in the place of payment on the due date money deposited by the Company in immediately available funds and designated for and sufficient to pay all
principal, premium, if any, and interest, if any, then due. Such payments shall be considered made on the date due if on such date the Trustee or the Paying Agent holds, in accordance with this Indenture, money sufficient to make all payments with
respect to such Notes then due and the Trustee or the Paying Agent, as the case may be, is not prohibited from paying such money to the Holders on that date pursuant to the terms of this Indenture. Neither the Trustee nor the applicable Paying Agent
shall be obligated to make payments to Holders or the Depositary without receipt of such sufficient funds. 

  
 55 

 SECTION 4.02 Reports and Other Information. 

(a) For so long as the Company is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company will file
with the SEC (subject to the next sentence), and provide to the Trustee and holders of the Notes, within the time periods specified in such Sections: 

(i) all quarterly and annual reports that would be required to be filed with the SEC on Forms 10-Q and 10-K if the Company
were required to file such reports; and 
 (ii) all current reports that would be required to be filed with the SEC on Form
8-K if the Company were required to file such reports. 
 All such reports will be prepared in all material respects in accordance with the
rules and regulations applicable to such reports. While the Company remains subject to the periodic reporting requirements of the Exchange Act, the Company agrees that it will not take any action for the purpose of causing the SEC not to accept such
filings. 
 (b) If, at any time, the Company is not subject to the reporting requirements of Section 13 or 15(d) of the Exchange
Act for any reason, the Company will nevertheless post the substance of the reports specified in Section 4.01(a) (other than separate financial statements or condensed consolidating financial information required by Rule 3-10 or 3-16 of
Regulation S-X) on its website and will provide those to the Trustee (but will not be required to file such reports with the SEC), in each case within the time periods that would apply if the Company were required to file those reports with the SEC;
provided that, (1) with respect to the quarter ended March 31, 2015, the Company may provide the information required by this Section 4.02(b) with respect to such quarter at any time on or prior to June 30, 2015, including
by means of an amendment to the Form 10, (2) with respect to the quarter ended June 30, 2015, if the separation and distribution have not occurred on or prior to August 14, 2015, the Company may provide the information required by
this Section 4.02(b) with respect to such quarter at any time on or prior to September 30, 2015, including by means of an amendment to the Form 10 and (3) with respect to the quarter ended September 30, 2015, if the separation
and distribution have not occurred on or prior to November 16, 2015, the Company may provide the information required by this Section 4.02(b) with respect to such quarter at any time on or prior to November 30, 2015, including by
means of an amendment to the Form 10. 
 (c) For purposes of this Section 4.02, the Company will be deemed to have provided a
required report to the Trustee and holders of the Notes if it has timely filed such report with the SEC via the EDGAR filing system (or any successor system). 

(d) At any time when the Company is not subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company
will furnish to the holders of the Notes and to prospective investors, upon the requests of such holders, any information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act so long as the Notes are not freely transferable
under the Securities Act. 

  
 56 

 (e) Notwithstanding the foregoing, in the event that any direct or indirect parent company of the
Company becomes a Guarantor, the Company may satisfy its obligations pursuant to this Section 4.02 with respect to financial information relating to the Company by furnishing or filing the required financial information relating to such direct
or indirect parent company. 
 (f) In addition, (i) the Trustee shall be entitled (but not obligated) and (ii) holders of not less
than 25% of the aggregate principal amount of the then outstanding Notes of a series shall be entitled, each at any time, to request in writing that the Company provide to the Trustee, within 20 Business Days following such request, an
Officer’s Certificate confirming whether or not the Company, as at the end of the most recently ended quarterly period, had designated any of its Subsidiaries to be Unrestricted Subsidiaries that, alone or taken together, represented either
(a) 10% or more of the total assets of the Company as at the end of the relevant period, (b) 10% or more of the consolidated net income of the Company for the relevant most recent consecutive four-quarter period, or (c) 10% or more of
the consolidated earnings before interest, tax, depreciation and amortization of the Company for the relevant most recent consecutive four- quarter period (the “Trustee Notice Requirement”). A copy of any such request delivered by
the relevant holders pursuant to clause (ii) above shall be provided to the Trustee. If the Trustee Notice Requirement is satisfied, the Officer’s Certificate to be delivered pursuant to the foregoing requirement shall specify (a) the
Total Assets, the Consolidated Net Income and the EBITDA of the Company and its Restricted Subsidiaries and (b) the total assets, the consolidated net income and the earnings before interest, tax, depreciation and amortization of the
Unrestricted Subsidiaries. The Trustee shall deliver such Officer’s Certificate to the Holders of the Notes within five Business Days of the date of receipt by the Trustee of the Officer’s Certificate, and the Trustee shall not have any
responsibility or liability for any information set forth in such Officer’s Certificate or for any analysis thereof. 
 (g) Delivery of
reports, information and documents to the Trustee under this Section 4.02 is for informational purposes only, and the Trustee’s receipt of the foregoing shall not constitute constructive notice of any information contained therein or
determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely on Officer’s Certificates). The Trustee shall have no responsibility or
liability for the content, filing or timeliness of any report to be issued or filed by the Company or Guarantors, as applicable. 

SECTION 4.03 Compliance Certificate. The Company shall deliver to the Trustee within 120 days after the end of each fiscal year of
the Company an Officer’s Certificate stating that a review of the activities of the Company and its Restricted Subsidiaries during the preceding fiscal year has been made under the supervision of the signing Officer with a view to determining
whether the Company and each of its Restricted Subsidiaries has kept, observed, performed and fulfilled its obligations under this Indenture, and further stating, as to such Officer signing such certificate, that, to such Officer’s knowledge,
the Company and each of its Restricted 

  
 57 

 
Subsidiaries has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not in default in the performance or observance of any of the terms, provisions
and conditions hereof (or, if a Default or Event of Default shall have occurred and is continuing, describing all such Defaults or Events of Default of which such Officer has knowledge and what action the Company and its Restricted Subsidiaries are
taking or propose to take, if any, with respect thereto). 
 SECTION 4.04 Further Instruments and Acts. The Company and the
Guarantors shall execute and deliver to the Trustee such further instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purpose of this Indenture. 

SECTION 4.05 Corporate Existence. Subject to Article V hereof, the Company shall do or cause to be done all things necessary to
preserve and keep in full force and effect: 
 (1) its existence in accordance with its organizational documents (as the same
may be amended from time to time); and 
 (2) the rights (charter and statutory), licenses and franchises of the
Company and each of its Restricted Subsidiaries; provided, however, that the Company shall not be required to preserve any such right, license or franchise if the Board of Directors of the Company shall determine that the preservation
thereof is no longer desirable in the conduct of the business of the Company and its Subsidiaries, taken as a whole, and that the loss thereof is not adverse in any material respect to the Holders of the Notes. 

SECTION 4.06 Calculation of Original Issue Discount. If the Notes are issued with original issue discount (other than de
minimis original issue discount) (“OID”), as defined under the Internal Revenue Code, the Company shall file with the Trustee promptly at the end of each calendar year (i) a written notice specifying the amount of OID
(including daily rates and accrual periods) accrued on Outstanding Notes as of the end of such year and (ii) such other specific information relating to such OID as may then be relevant under the Internal Revenue Code. 

SECTION 4.07 Restricted Payments. 

(a) The Company will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly: 

(i) declare or pay any dividend or make any payment or distribution on account of the Company’s, or any of its Restricted
Subsidiaries’ Equity Interests, including any dividend or distribution payable in connection with any merger or consolidation involving the Company or any Restricted Subsidiary, other than: 

(A) dividends or distributions by the Company payable solely in Equity Interests (other than Disqualified Stock) of the
Company; or 
 (B) dividends or distributions by a Restricted Subsidiary so long as, in the case of any dividend or
distribution payable on or in respect of any class or series of securities issued by a Restricted Subsidiary, the Company or a Restricted Subsidiary receives at least its pro rata share of such dividend or distribution in accordance with its Equity
Interests in such class or series of securities; 

  
 58 

 (ii) purchase, redeem, defease or otherwise acquire or retire for value any
Equity Interests of the Company, or any direct or indirect parent of the Company, including any such purchase, redemption, defeasance, acquisition or retirement in connection with any merger or consolidation; 

(iii) make any principal payment on, or redeem, repurchase, defease or otherwise acquire or retire for value, in each case,
prior to any scheduled repayment, sinking fund payment or maturity, any Subordinated Indebtedness, other than (a) Indebtedness permitted under Section 4.09(b)(7) or (8) or (b) the payment, redemption, repurchase, defeasance or
other acquisition of Subordinated Indebtedness in anticipation of satisfying a rescheduled payment, sinking fund obligation, principal installment or maturity, in each case due within one year of the date of payment, redemption, repurchase,
defeasance or acquisition; or 
 (iv) make any Restricted Investment 

(all such payments and other actions set forth in clauses (I) through (IV) above (other than any exceptions thereto) being collectively referred to as
“Restricted Payments”), unless, at the time of such Restricted Payment: 
 (1) no Default shall have
occurred and be continuing or would occur as a consequence thereof; 
 (2) immediately after giving effect to such
transaction on a pro forma basis, the Company could incur $1.00 of additional Indebtedness under Section 4.09(a); and 

  
 59 

 (3) such Restricted Payment, together with the aggregate amount of all other
Restricted Payments made by the Company and its Restricted Subsidiaries after the Original Issue Date (including Restricted Payments permitted by Section 4.07(b)(1), but excluding all other Restricted Payments permitted by
Section 4.07(b)), is less than the sum of (without duplication): 
 (a) 50% of the Consolidated Net Income of the
Company for the period (taken as one accounting period) beginning on April 1, 2015 to the end of the Company’s most recently ended fiscal quarter for which internal financial statements are available at the time of such Restricted Payment,
or, in the case such Consolidated Net Income for such period is a deficit, minus 100% of such deficit; plus 
 (b) 100% of
the aggregate net cash proceeds and the fair market value of marketable securities or other property received by the Company since immediately after the Original Issue Date (other than net cash proceeds to the extent such net cash proceeds have been
used to incur Indebtedness, or issue Disqualified Stock or Preferred Stock, pursuant to Section 4.09(b)(12)(a)) from the issue or sale of: 

(i) Equity Interests of the Company, including Treasury Capital Stock, but excluding cash proceeds and the fair market value
of marketable securities or other property received from the sale of: 
 (x) Equity Interests to any present, former or future employees,
directors, officers, managers or consultants of the Company or any of the Company’s Subsidiaries after the Original Issue Date to the extent such amounts have been applied to the amount of available Restricted Payments in accordance with
Section 4.07(b)(5); and 
 (y) Designated Preferred Stock; and 

(ii) debt securities of the Company or any Restricted Subsidiary that have been converted into or exchanged for such Equity
Interests of the Company; 
 provided, however, that this clause (b) shall not include the proceeds from (W) Refunding Capital Stock
(as defined below), (X) Equity Interests or convertible debt securities of the Company sold to a Restricted Subsidiary, (Y) Disqualified Stock or debt securities that have been converted into Disqualified Stock or (Z) Excluded
Contributions; plus 
 (c) 100% of the aggregate net cash proceeds and the fair market value of marketable securities
or other property received by the Company or any Restricted Subsidiary by means of: 
 (i) the sale or other disposition
(other than to the Company or a Restricted Subsidiary) of Restricted Investments made by the Company or its Restricted Subsidiaries and repurchases and redemptions of such Restricted Investments from the Company or its Restricted Subsidiaries and
repayments of loans or advances that constitute Restricted Investments by the Company or its Restricted Subsidiaries, in each case after the Original Issue Date; or 

(ii) the sale (other than to the Company or a Restricted Subsidiary) of the stock of an Unrestricted Subsidiary (other than to
the extent the Investment in such Unrestricted Subsidiary was made by the Company or a Restricted Subsidiary pursuant to Section 4.07(b)(11) or (17) or to the extent such Investment constituted a Permitted Investment) or a distribution or
dividend from an Unrestricted Subsidiary, in each case, after the Original Issue Date; plus 

  
 60 

 (d) in the case of the redesignation of an Unrestricted Subsidiary as a
Restricted Subsidiary, the fair market value (as determined in good faith by the Company, provided that if such fair market value may exceed $50.0 million, such determination shall be made by the board of directors of the Company and
evidenced by a board resolution) of the Investment in such Unrestricted Subsidiary at the time of the redesignation of such Unrestricted Subsidiary as a Restricted Subsidiary other than to the extent the Investment in such Unrestricted Subsidiary
was made by the Company or a Restricted Subsidiary pursuant to Section 4.07(b)(11) or (17) or to the extent such Investment constituted a Permitted Investment. 

(b) The provisions of Section 4.07(a) will not prohibit: 

(1) the payment of any dividend or distribution or the consummation of any irrevocable redemption within 60 days after the date of declaration
thereof or the giving of the irrevocable redemption notice, as applicable, if at the date of declaration or notice such payment would have complied with the provisions of this Indenture; 

(2) (a) the redemption, repurchase, defeasance, retirement or other acquisition of any Equity Interests (“Treasury Capital
Stock”) or Subordinated Indebtedness of the Company in exchange for, or out of the proceeds of the substantially concurrent sale (other than to a Restricted Subsidiary) of, Equity Interests of the Company to the extent contributed to the
Company (in each case, other than any Disqualified Stock or Designated Preferred Stock) (“Refunding Capital Stock”) and (b) if immediately prior to the retirement of Treasury Capital Stock, the declaration and payment of
dividends thereon was permitted under Section 4.07(b)(7), the declaration and payment of dividends on the Refunding Capital Stock in an aggregate per annum amount no greater than the aggregate amount of dividends per annum that were declarable
and payable on such Treasury Capital Stock immediately prior to such retirement; 
 (3) any other Restricted Payment made in exchange for,
or out of the proceeds of the substantially concurrent sale (other than to a Restricted Subsidiary) of, Equity Interests of the Company (other than any Disqualified Stock or Designated Preferred Stock); 

(4) the redemption, repurchase, defeasance or other acquisition or retirement of Subordinated Indebtedness or Disqualified Stock of the
Company or a Subsidiary Guarantor made in exchange for, or out of the proceeds of the substantially 

  
 61 

 
concurrent sale of, new Indebtedness or Disqualified Stock of the Company or a Subsidiary Guarantor, as the case may be, that in each case is incurred in compliance with Section 4.09 but
only: 
 (a) to the extent that the principal amount (or accreted value, if applicable) of such new Indebtedness does not exceed the
principal amount (or accreted value, if applicable) of, plus any accrued and unpaid interest on, the Subordinated Indebtedness being so redeemed, repurchased, acquired or retired for value, plus the amount of any premium to be paid, defeasance costs
and any fees and expenses incurred in connection with the issuance of such new Indebtedness, and any excess amount is otherwise permitted under this Indenture; 

(b) if such new Indebtedness is subordinated to the Notes or the applicable Guarantee at least to the same extent, if at all, as such
Subordinated Indebtedness so purchased, exchanged, redeemed, repurchased, defeased, acquired or retired for value; 
 (c) if such new
Indebtedness or Disqualified Stock has a final scheduled maturity date equal to or later than the final scheduled maturity date of the Subordinated Indebtedness or Disqualified Stock being so redeemed, repurchased, defeased, acquired or retired; and

 (d) if such new Indebtedness or Disqualified Stock has a Weighted Average Life to Maturity equal to or greater than the remaining Weighted
Average Life to Maturity of the Subordinated Indebtedness or Disqualified Stock being so redeemed, repurchased, defeased, acquired or retired; 

(5) a Restricted Payment to pay for the repurchase, redemption or other acquisition or retirement for value of Equity Interests (other
than Disqualified Stock) of the Company held by any future, present or former employee, director, officer, manager or consultant of the Company or any of its Subsidiaries pursuant to any management equity plan or stock option plan or any other
management, director or employee benefit plan or agreement (x) upon the death or disability of such employee, director, officer, manager or consultant or (y) upon the resignation or other termination of employment of such employee,
director, officer, manager or consultant; provided, however, that the aggregate Restricted Payments made under this clause (5) do not exceed in any calendar year $40.0 million (with unused amounts in any calendar year being
carried over to succeeding calendar years); provided further that such amount in any calendar year may be increased by an amount not to exceed: 

(a) the cash proceeds from the sale of Equity Interests (other than Disqualified Stock) of the Company to employees, directors, officers,
managers or consultants of the Company or any of its Restricted Subsidiaries that occurs after the Original Issue Date, to the extent the cash proceeds from the sale of such Equity Interests have not otherwise been applied to the payment of
Restricted Payments by virtue of Section 4.07(a)(4); plus 

  
 62 

 (b) the cash proceeds of key man life insurance policies received by the Company or its
Restricted Subsidiaries after the Original Issue Date; less 
 (c) the amount of any Restricted Payments previously made with the cash
proceeds described in clause (a) or (b) of this clause (5); 
 and provided further that (i) cancellation of
Indebtedness owing to the Company or any of its Restricted Subsidiaries from any future, present or former employees, directors, officers, managers or consultants of the Company or any of its Restricted Subsidiaries in connection with a repurchase
of Equity Interests of the Company and (ii) the repurchase of Equity Interests deemed to occur upon the exercise of options, warrants or similar instruments if such Equity Interests represents all or a portion of the exercise price thereof or
payments, in lieu of the issuance of fractional Equity Interests or withholding to pay other taxes payable in connection therewith, in the case of each of clauses (i) and (ii), will not be deemed to constitute a Restricted Payment for purposes
of this covenant or any other provision of this Indenture; 
 (6) the declaration and payment of dividends to holders of any class or
series of Disqualified Stock of the Company or any of its Restricted Subsidiaries, or of Preferred Stock of any Restricted Subsidiary, in each case issued in accordance with Section 4.09; 

(7) (a) the declaration and payment of dividends to holders of any class or series of Designated Preferred Stock (other than Disqualified
Stock) issued by the Company after the Original Issue Date; (b) the declaration and payment of dividends on Refunding Capital Stock that is Preferred Stock in excess of the dividends declarable and payable thereon pursuant to
Section 4.07(b)(2); 
 provided, however, in the case of each of subclauses (a) and (b) of this clause (7), that
for the most recently ended four full fiscal quarters for which internal financial statements are available immediately preceding the date of issuance of such Designated Preferred Stock or Refunding Capital Stock that is Preferred Stock, after
giving effect to such issuance or declaration on a pro forma basis, the Company and its Restricted Subsidiaries on a consolidated basis would have had a Fixed Charge Coverage Ratio of at least 2.00 to 1.00; 

(8) repurchases of Equity Interests deemed to occur (i) upon the exercise of stock options, warrants or other equity-based awards if such
Equity Interests represent a portion of the exercise price of such options, warrants or awards or (ii) for the purposes of satisfying any required tax withholding obligation upon the exercise or vesting of a grant or award of any stock options,
warrants or other equity-based awards; 

  
 63 

 (9) the declaration and payment of ordinary dividends or distributions in respect of, or
repurchases of, the Company’s common stock in an aggregate amount not to exceed (a) for dividends declared and paid or distributions made in respect of, or repurchases during, the period commencing on the Original Issue Date and ending on
December 31, 2015, an aggregate of $200.0 million in respect of, or repurchases during, such period and (b) for dividends declared and paid or distributions made in respect of any subsequent fiscal year, an aggregate of $400.0 million in
respect of such period; 
 (10) Restricted Payments in an amount equal to the amount of Excluded Contributions previously received; 

(11) other Restricted Payments in an aggregate amount taken together with all other Restricted Payments made pursuant to this clause
(11) not to exceed the greater of $350.0 million and 5.50% of Total Assets; 
 (12) Restricted Payments comprising the payment or
distribution of any Securitization Fees; 
 (13) the repurchase, redemption or other acquisition or retirement for value of any
Subordinated Indebtedness in accordance with the provisions similar to those set forth in Sections 4.10 and 4.13; provided that all Notes tendered in connection with a Change of Control Offer or Asset Sale Offer, as applicable, have
first been repurchased, redeemed or acquired for value; 
 (14) the distribution, by dividend or otherwise, of shares of Capital
Stock of, or Indebtedness owed to the Company or a Restricted Subsidiary by, Unrestricted Subsidiaries (other than Unrestricted Subsidiaries the primary assets of which are cash and/or Cash Equivalents); 

(15) any Restricted Payment made as part of the Transactions in a manner consistent in all material respects with the disclosures set
forth in the Form 10 and the Offering Circular; provided that immediately after giving effect to the separation and distribution, the Company and its Restricted Subsidiaries shall, subject to the adjustment procedures for Cash Equivalents (as
such term is defined in the Separation Agreement) set forth in the Separation Agreement in relation to such requirement, have not less than $200.0 million in Cash Equivalents (as such term is defined in the Separation Agreement); 

(16) payments made or expected to be made by the Company or any Restricted Subsidiary in respect of withholding or similar taxes payable by
any present, former or future employees, director, officers, managers or consultants of the Company or any Restricted Subsidiary; and 

(17) the making of other Restricted Payments if, at the time of the making of such Restricted Payment, and after giving pro
forma effect thereto (including, without limitation, the incurrence of any Indebtedness to finance such Restricted Payment and the application of the net proceeds thereof), the Consolidated Net Leverage Ratio of the Company would not exceed 3.00
to 1.00; 

  
 64 

 provided, however, that at the time of, and after giving effect to, any Restricted Payment
permitted under clauses (3), (9), (11), (14) and (17), no Default shall have occurred and be continuing or would occur as a consequence thereof. 

(c) For purposes of determining compliance with this Section 4.07, in the event that a proposed Restricted Payment (or a portion thereof)
meets the criteria of clauses (1) through (17) of Section 4.07(b) or is entitled to be made pursuant to Section 4.07(a), the Company will be entitled to classify or later reclassify (based on circumstances existing on the date of
such reclassification) such Restricted Payment (or a portion thereof) between such clauses (1) through (17) and Section 4.07(a) in any manner that otherwise complies with this Section 4.07. 

(d) The Company will not permit any Unrestricted Subsidiary to become a Restricted Subsidiary except pursuant to the provisions of the
definition of “Unrestricted Subsidiary.” For purposes of designating any Restricted Subsidiary as an Unrestricted Subsidiary, all outstanding Investments by the Company and its Restricted Subsidiaries (except to the extent repaid) in the
Subsidiary so designated will be deemed to be Restricted Payments in an amount determined as set forth in the last sentence of the definition of “Investments.” Such designation will be permitted only if a Restricted Payment in such amount
would be permitted at such time, whether pursuant to Section 4.07(a) or under clause (3), (10), (11) or (17) of Section 4.07(b), or if it is a Permitted Investment, and if such Subsidiary otherwise meets the definition of an
Unrestricted Subsidiary. Unrestricted Subsidiaries will not be subject to any of the restrictive covenants set forth in this Indenture. 

SECTION 4.08 Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries. 

(a) The Company will not, and will not permit any of its Restricted Subsidiaries that are not Guarantors to, directly or indirectly, create or
otherwise cause or suffer to exist or become effective any consensual encumbrance or consensual restriction on the ability of any Restricted Subsidiary that is not a Guarantor to: 

(1) (A) pay dividends or make any other distributions to the Company or any Subsidiary Guarantor on its Capital Stock, or

 (B) pay any Indebtedness owed to the Company or any Subsidiary Guarantor; 

(2) make loans or advances to the Company or any Subsidiary Guarantor; or 

(3) sell, lease or transfer any of its properties or assets to the Company or any Subsidiary Guarantor. 

  
 65 

 (b) The restrictions in Section 4.08(a) shall not apply to encumbrances or restrictions
existing under or by reason of: 
 (1) contractual encumbrances or restrictions in effect on the Original Issue Date,
including pursuant to the Senior Secured Credit Facilities and the related documentation and Hedging Obligations in effect on the Original Issue Date and any related documentation; 

(2) this Indenture, the Notes and the Guarantees thereof; 

(3) purchase money obligations for property acquired in the ordinary course of business that impose restrictions of the nature
discussed in Section 4.08(a)(3) above on the property so acquired; 
 (4) applicable law or any applicable rule,
regulation, order, approval, license, permit or other similar restriction, including under contracts with domestic or foreign governments or agencies thereof entered into in the ordinary course of business; 

(5) any agreement or other instrument (including an instrument governing Capital Stock or Indebtedness) of a Person acquired by
the Company or any Restricted Subsidiaries in existence at the time of such acquisition or at the time it merges with or into the Company or any of its Restricted Subsidiaries or assumed in connection with the acquisition of assets from such Person
(but, in any such case, not created in anticipation or contemplation thereof), which encumbrance or restriction is not applicable to any Person, or the properties or assets of any Person, other than the Person and its Subsidiaries, or the property
or assets of the Person and its Subsidiaries, so acquired or the property or assets so assumed; 
 (6) contracts for the sale
of assets, including customary restrictions with respect to a Subsidiary of the Company pursuant to an agreement that has been entered into for the sale or disposition of any Capital Stock or assets of such Subsidiary; 

(7) Secured Indebtedness otherwise permitted to be incurred pursuant to Sections 4.09 and 4.12 to the extent limiting the
right of the Company or any of its Restricted Subsidiaries to dispose of assets subject to such Lien; 
 (8) restrictions on
cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary course of business; 

(9) other Indebtedness, Disqualified Stock or Preferred Stock of Foreign Subsidiaries permitted to be incurred
subsequent to the Original Issue Date pursuant to Section 4.09; provided that such encumbrances and restrictions apply only to such Restricted Subsidiary and its assets; and provided, further, that the Company has
determined in good faith, at the time of creation of each such encumbrance or restriction, that such encumbrances and restrictions would not individually or in the aggregate have a material adverse effect on the Company’s ability to make
required payments in respect of the Notes; 

  
 66 

 (10) customary provisions in joint venture agreements and other similar
agreements or arrangements relating solely to such joint venture; 
 (11) customary provisions contained in leases, licenses
or similar agreements, including with respect to intellectual property and other agreements, in each case, entered into in the ordinary course of business; 

(12) non-assignment provisions of any contract or any lease of any Restricted Subsidiary entered into in the ordinary course of
business; 
 (13) restrictions on the transfer of assets subject to any Lien permitted under this Indenture imposed by the
holder of such Lien; 
 (14) any agreement or instrument governing Capital Stock of any Person that is acquired; 

(15) restrictions or conditions contained in any trading, netting, operating, construction, service, supply, purchase,
sale or other agreement to which the Company or any of its Restricted Subsidiaries is a party entered into in the ordinary course of business; provided that such agreement prohibits the encumbrance solely of the property or assets of the
Company or such Restricted Subsidiary that are subject to such agreement, the payment rights arising thereunder or the proceeds thereof and does not extend to any other asset or property of the Company or such Restricted Subsidiary or the assets or
property of another Restricted Subsidiary; 
 (16) contractual requirements of a Securitization Special Purpose
Entity in connection with a Qualified Securitization Transaction; provided that such restrictions apply only to such Securitization Special Purpose Entity;  

(17) any encumbrances, restrictions, contractual requirements or other provisions of the Separation and Distribution Documents
or in connection with any of the Transactions in a manner consistent in all material respects with the disclosures set forth in the Form 10 and the Offering Circular; 

(18) any encumbrances or restrictions of the type referred to in Sections 4.08(a)(1) and (2) above to the extent that
such encumbrances or restrictions do not materially adversely affect the consolidated cash position of the Company and the Subsidiary Guarantors; 

(19) any encumbrances or restrictions of the type referred to in Sections 4.08(a)(1), (2) and (3) above imposed
by any amendments, modifications, restatements, renewals, increases, supplements, refundings, replacements or refinancings of the contracts, instruments or obligations referred to in clauses (1) through (17) of this Section 4.08(b);
provided that such 

  
 67 

 
amendments, modifications, restatements, renewals, increases, supplements, refundings, replacements or refinancings are, in the good faith judgment of the Company, either (i) not materially
more restrictive with respect to such encumbrance and other restrictions taken as a whole than those prior to such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing, or (ii) ordinary and
customary with respect to such instruments and obligations at the time of such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing; or 

(20) restrictions created in connection with any Receivables Facility that are customarily entered into in relation to
transactions of that nature. 
 SECTION 4.09 Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and
Preferred Stock. 
 (a) The Company will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly, create,
incur, issue, assume, guarantee or otherwise become directly or indirectly liable, contingently or otherwise (collectively, “incur” and each instance thereof, an “incurrence”), with respect to any Indebtedness
(including Acquired Indebtedness), and the Company will not issue any shares of Disqualified Stock and will not permit any Restricted Subsidiary to issue any shares of Disqualified Stock or Preferred Stock; provided, however, that the
Company may incur Indebtedness (including Acquired Indebtedness) or issue shares of Disqualified Stock, and any of its Restricted Subsidiaries may incur indebtedness (including Acquired Indebtedness), issue shares of Disqualified Stock and issue
shares of Preferred Stock, if the Fixed Charge Coverage Ratio on a consolidated basis for the Company and its Restricted Subsidiaries’ most recently ended four fiscal quarters for which internal financial statements are available immediately
preceding the date on which such additional Indebtedness is incurred or such Disqualified Stock or Preferred Stock is issued would have been at least 2.00 to 1.00, determined on a pro forma basis (including a pro forma application of
the net proceeds therefrom), as if the additional Indebtedness had been incurred, or the Disqualified Stock or Preferred Stock had been issued, as the case may be, and the application of proceeds therefrom had occurred at the beginning of such
four-quarter period. 
 (b) The provisions of Section 4.09(a) shall not prohibit the incurrence of any of the following items of
Indebtedness: 
 (1) the incurrence of Indebtedness pursuant to Credit Facilities by the Company or any of its Restricted
Subsidiaries and the issuance and creation of letters of credit and bankers’ acceptances thereunder (with letters of credit and bankers’ acceptances being deemed to have a principal amount equal to the face amount thereof), up to an
aggregate principal amount at any one time outstanding not to exceed the greater of (a) $3,200 million and (b) 375.0% of the EBITDA of the Company and its Restricted Subsidiaries on a consolidated basis for the most

  
 68 

 
recently ended four fiscal quarters ending immediately prior to the date of such incurrence for which internal financial statements are available determined on a pro forma basis in a
manner consistent with the definition of Fixed Charge Coverage Ratio; 
 (2) the incurrence by the Company and any Subsidiary
Guarantor of Indebtedness under the Notes issued on the Original Issue Date (including Guarantees thereof) and any Notes (including Guarantees thereof) issued in exchange for such Notes pursuant to a registration rights agreement; 

(3) Indebtedness and Disqualified Stock of the Company and its Restricted Subsidiaries in existence on the Original Issue Date;

 (4) Indebtedness (including Capitalized Lease Obligations) and Disqualified Stock incurred or issued by the Company
or any of its Restricted Subsidiaries, and the issuance of Preferred Stock by any Restricted Subsidiary of the Company, to finance the purchase, lease or improvement of property (real or personal) or equipment that is used or useful in a Similar
Business, whether through the direct purchase of assets or the purchase of Capital Stock of any Person owning such assets, in an aggregate principal amount at the date of such incurrence (including all Refinancing Indebtedness incurred to refinance
any other Indebtedness incurred pursuant to this clause (4)) not to exceed the greater of $300.0 million and 4.75% of Total Assets (as adjusted to give pro forma effect to any assets purchased with the proceeds of the Indebtedness to be
incurred, provided that such assets are acquired substantially concurrently with the incurrence of such Indebtedness); provided, however, that such Indebtedness exists at the date of such purchase or transaction or is created
within 365 days thereafter (for the avoidance of doubt, the purchase date for any asset shall be the later of the date of completion of installation and the beginning of the full productive use of such asset); 

(5) Indebtedness incurred by the Company or any of its Restricted Subsidiaries constituting reimbursement obligations
with respect to letters of credit issued in the ordinary course of business, including letters of credit in respect of workers’ compensation claims, death, disability or other employee benefits or property, casualty or liability insurance, or
other Indebtedness with respect to reimbursement-type obligations regarding workers’ compensation claims; provided, however, that upon the drawing of such letters of credit or the incurrence of such Indebtedness, such obligations
(a) are reimbursed within 30 days following such drawing or incurrence or (b) are permitted to be incurred (and thereupon shall deemed to be incurred) pursuant to clause (4) above following the expiry of such 30 day period;

 (6) Indebtedness arising from agreements of the Company or its Restricted Subsidiaries providing for indemnification,
adjustment of purchase price or similar obligations, including earnouts, in each case, incurred or assumed in connection with the disposition of any business, assets or a Subsidiary, other than 

  
 69 

 
guarantees of Indebtedness incurred by any Person acquiring all or any portion of such business, assets or a Subsidiary for the purpose of financing such acquisition; provided,
however, that such Indebtedness is not reflected on the balance sheet of the Company or any of its Restricted Subsidiaries (contingent obligations referred to in a footnote to financial statements and not otherwise reflected on the balance
sheet will not be deemed to be reflected on such balance sheet for purposes of this clause (6)); 
 (7) Indebtedness
of the Company to a Restricted Subsidiary; provided that any such Indebtedness owing to a Restricted Subsidiary that is not a Subsidiary Guarantor shall be subordinated in right of payment to the Notes; provided further that any
subsequent issuance or transfer of any Capital Stock or any other event which results in the Restricted Subsidiary holding such Indebtedness ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such Indebtedness (except to
the Company or another Restricted Subsidiary) shall be deemed, in each case, to be an incurrence of such Indebtedness not permitted by this clause (7); 

(8) Indebtedness of a Restricted Subsidiary to the Company or another Restricted Subsidiary; provided that if a
Subsidiary Guarantor incurs such Indebtedness to a Restricted Subsidiary that is not a Subsidiary Guarantor, such Indebtedness shall be subordinated in right of payment to the Guarantee of the Notes of such Subsidiary Guarantor; provided
further that any subsequent issuance or transfer of any Capital Stock or any other event which results in any such Indebtedness being held by a person other than the Company or a Restricted Subsidiary or any subsequent transfer of any such
Indebtedness (except to the Company or another Restricted Subsidiary) shall be deemed, in each case, to be an incurrence of such Indebtedness not permitted by this clause (8); 

(9) shares of Preferred Stock of a Restricted Subsidiary issued to the Company or another Restricted Subsidiary;
provided that any subsequent issuance or transfer of any Capital Stock or any other event which results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such shares of Preferred
Stock (except to the Company or another Restricted Subsidiary) shall be deemed in each case to be an issuance of such shares of Preferred Stock not permitted by this clause (9); 

(10) Hedging Obligations (excluding Hedging Obligations entered into for speculative purposes) for the purpose of limiting
interest rate risk with respect to any Indebtedness of the Company or any Restricted Subsidiary permitted to be incurred pursuant to Section 4.09, exchange rate risk or commodity pricing risk; 

(11) obligations in respect of self-insurance and obligations in respect of performance, bid, appeal, stay, surety, customs and
replevin bonds and performance and completion guarantees provided by the Company or any of its Restricted Subsidiaries in the ordinary course of business; 

  
 70 

 (12) (a) Indebtedness or Disqualified Stock of the Company and
Indebtedness, Disqualified Stock or Preferred Stock of any Restricted Subsidiary equal to 100.0% of the net cash proceeds received by the Company since immediately after the Original Issue Date from the issue or sale of Equity Interests of the
Company or cash contributed to the capital of the Company (in each case, other than proceeds of Disqualified Stock, Designated Preferred Stock or sales of Equity Interests to the Company or any of its Subsidiaries) as determined in accordance with
Section 4.07(a)(3)(c) to the extent such net cash proceeds or cash have not been applied pursuant to such clauses to make Restricted Payments or to make other Investments, payments or exchanges pursuant to Section 4.07(b) or to make a
Permitted Investment and (b) Indebtedness or Disqualified Stock of the Company and Indebtedness, Disqualified Stock or Preferred Stock of any Restricted Subsidiary not otherwise permitted hereunder in an aggregate principal amount or
liquidation preference that, when aggregated with the principal amount and liquidation preference of all other Indebtedness, Disqualified Stock and Preferred Stock then outstanding and incurred pursuant to this clause (12)(b), does not exceed the
greater of $350.0 million and 5.50% of Total Assets (as adjusted to give pro forma effect to any assets purchased with the proceeds of the Indebtedness to be incurred, provided that such assets are acquired substantially
concurrently with the incurrence of such Indebtedness); 
 (13) the incurrence or issuance by the Company or any
Restricted Subsidiary of Indebtedness or Disqualified Stock, and the issuance by any Restricted Subsidiary of Preferred Stock, in each case that serves to refund, refinance, replace, renew, extend or defease any Indebtedness or Disqualified Stock of
the Company or any Restricted Subsidiary or Preferred Stock of any Restricted Subsidiary incurred or issued as permitted under Section 4.09(a) or clause (2), (3), (4) or (12)(a) of this Section 4.09(b), this clause (13) or
clause (14) of this Section 4.09(b) or any Indebtedness, Disqualified Stock or Preferred Stock previously incurred or issued to so refund, refinance, replace, renew, extend or defease such Indebtedness or Disqualified Stock or Preferred
Stock, including additional Indebtedness, Disqualified Stock or Preferred Stock incurred or issued to pay premiums (including tender premiums), defeasance costs, accrued interest, fees and expenses in connection therewith (the “Refinancing
Indebtedness”) prior to its respective maturity; provided, however, that such Refinancing Indebtedness: 

(a) has a Weighted Average Life to Maturity at the time such Refinancing Indebtedness is incurred that is not less than the
remaining Weighted Average Life to Maturity of the Indebtedness or Disqualified Stock or Preferred Stock being refunded, refinanced, replaced, renewed, extended or defeased (or requires no or nominal payments in cash prior to the date that is 91
days after the maturity date of the Notes); 
 (b) to the extent such Refinancing Indebtedness refunds, refinances,
replaces, renews, extends or defeases (i) Subordinated Indebtedness, such Refinancing Indebtedness is subordinated in right of 

  
 71 

 
payment to the Notes or the Guarantee thereof at least to the same extent as the Indebtedness being refunded, refinanced, replaced, renewed, extended or defeased or (ii) Disqualified Stock
or Preferred Stock, such Refinancing Indebtedness must be Disqualified Stock or Preferred Stock, respectively; and 
 (c)
shall not include: 
 (i) Indebtedness, Disqualified Stock or Preferred Stock of a Subsidiary of the Company that is not a
Guarantor that refinances Indebtedness, Disqualified Stock or Preferred Stock of the Company; 
 (ii) Indebtedness,
Disqualified Stock or Preferred Stock of a Subsidiary of the Company that is not a Guarantor that refinances Indebtedness, Disqualified Stock or Preferred Stock of a Subsidiary Guarantor; or 

(iii) Indebtedness or Disqualified Stock of the Company or Indebtedness, Disqualified Stock or Preferred Stock of a Restricted
Subsidiary that refinances Indebtedness, Disqualified Stock or Preferred Stock of an Unrestricted Subsidiary; 
 and,
provided, further, that subclause (a) of this clause (13) will not apply to any refunding, refinancing, replacement, renewal, extension or defeasance of any Secured Indebtedness; 

(14) (x) Indebtedness or Disqualified Stock of the Company and Indebtedness, Disqualified Stock or Preferred Stock
of a Restricted Subsidiary incurred or issued to finance an acquisition (or other purchase of assets) or (y) Indebtedness, Disqualified Stock or Preferred Stock of Persons that are acquired by the Company or any Restricted Subsidiary or merged
into or consolidated with the Company or a Restricted Subsidiary in accordance with the terms of this Indenture; provided that in the case of (x) and (y) after giving effect to such acquisition, merger or consolidation, either
(a) the Company would be permitted to incur at least $1.00 of additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in the first sentence of this covenant or (b) the Fixed Charge Coverage Ratio of the Company
and the Restricted Subsidiaries is greater than immediately prior to such acquisition; 
 (15) Indebtedness arising
from the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business; 

(16) Indebtedness of the Company or any of its Restricted Subsidiaries supported by a letter of credit issued pursuant to
Credit Facilities, in a principal amount not in excess of the stated amount of such letter of credit; 

  
 72 

 (17) (a) any guarantee by the Company or a Restricted Subsidiary of
Indebtedness or other obligations of any Restricted Subsidiary so long as the incurrence of such Indebtedness incurred by such Restricted Subsidiary is permitted under the terms of this Indenture, and 

(b) any guarantee by a Restricted Subsidiary of Indebtedness of the Company; 

(18) Indebtedness of the Company or any of its Restricted Subsidiaries consisting of (i) the financing of insurance
premiums or (ii) take-or-pay obligations contained in supply arrangements, in each case incurred in the ordinary course of business; 

(19) Indebtedness consisting of Indebtedness issued by the Company or any of its Restricted Subsidiaries to current or former
officers, directors and employees thereof, their respective estates, spouses or former spouses, in each case to finance the purchase or redemption of Equity Interests of the Company or any direct or indirect parent company of the Company to the
extent described in Section 4.07(b)(4); 
 (20) Indebtedness consisting of cash management services incurred in the
ordinary course of business, including in respect of credit card obligations, overdrafts and related liabilities arising from treasury, depositary and cash management services or in connection with any automated clearinghouse transfers of funds;

 (21) customer deposits and advance payments received in the ordinary course of business from customers for goods purchased
in the ordinary course of business; 
 (22) Indebtedness owed on a short-term basis of no longer than 30 days to banks and
other financial institutions incurred in the ordinary course of business of the Company and its Restricted Subsidiaries with such banks or financial institutions and arising in connection with ordinary banking arrangements to manage cash balances of
the Company and its Restricted Subsidiaries; 
 (23) Indebtedness incurred by the Company or a Restricted Subsidiary in
connection with bankers’ acceptances or discounted bills of exchange, in each case incurred or undertaken consistent with past practice or in the ordinary course of business; 

(24) Indebtedness of Foreign Subsidiaries of the Company in an amount not to exceed, at any one time outstanding and together
with any other Indebtedness incurred under this clause (24), the greater of $250.0 million and 4.00% of Total Assets; 
 (25)
Indebtedness incurred by a Securitization Special Purpose Entity pursuant to a Qualified Securitization Transaction that is without recourse to the Company or to any Restricted Subsidiary (other than Standard Securitization Undertakings); 

  
 73 

 (26) to the extent constituting Indebtedness, any obligations incurred as part of
the Transactions in a manner consistent in all material respects with the disclosures set forth in the Form 10 and the Offering Circular; and 

(27) Indebtedness representing guarantees of Indebtedness of joint ventures of the Company or any Restricted Subsidiary not to
exceed the greater of $100.0 million and 1.50% of Total Assets. 
 (c) For purposes of determining compliance with this
Section 4.09, (1) in the event that an item of Indebtedness, Disqualified Stock or Preferred Stock (or any portion thereof) meets the criteria of more than one of the categories of permitted Indebtedness, Disqualified Stock or Preferred
Stock described in clauses (1) through (27) of Section 4.09(b) or is entitled to be incurred pursuant to Section 4.09(a), the Company, in its sole discretion, will classify or reclassify such item of Indebtedness, Disqualified
Stock or Preferred Stock (or any portion thereof) and will only be required to include the amount and type of such Indebtedness, Disqualified Stock or Preferred Stock in one of the above clauses or under the first paragraph of this covenant; and
(2) at the time of incurrence, the Company will be entitled to divide and classify an item of Indebtedness in more than one of the types of Indebtedness described in Sections 4.09(a) and (b) above; provided that all Indebtedness
outstanding under the Senior Secured Credit Facilities on the Original Issue Date will be treated as incurred under clause (1) of Section 4.09(b).  

(d) Notwithstanding anything else in this Section 4.09, Restricted Subsidiaries that are not Subsidiary Guarantors may not incur
Indebtedness or issue Disqualified Stock or Preferred Stock pursuant to Section 4.09(a) or clause (12), (13), (14) or (24) of Section 4.09(b) if, after giving pro forma effect to such incurrence or issuance (including a
pro forma application of the net proceeds therefrom), the aggregate amount of Indebtedness, Disqualified Stock and Preferred Stock of Restricted Subsidiaries that are not Subsidiary Guarantors incurred or issued pursuant to
Section 4.09(a) and clause (12), (13), (14) and (24) of Section 4.09(b) at any one time outstanding would exceed the greater of $500.0 million and 8.00% of Total Assets (as adjusted to give pro forma effect to any assets
purchased with the proceeds of the Indebtedness to be incurred, provided that such assets are acquired substantially concurrently with the incurrence of such Indebtedness). 

(e) Accrual of interest or dividends, the accretion of accreted value, the accretion or amortization of original issue discount, the payment
of interest in the form of additional Indebtedness and the payment of dividends in the form of additional Disqualified Stock or Preferred Stock, as applicable, will in each case not be deemed to be an incurrence of Indebtedness or Disqualified Stock
or Preferred Stock for purposes of this Section 4.09. 
 (f) For purposes of determining compliance with any
U.S. Dollar-denominated restriction on the incurrence of Indebtedness, the U.S. Dollar-equivalent 

  
 74 

 
principal amount of Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was incurred, in the
case of term debt, or first committed, in the case of revolving credit debt; provided that if such Indebtedness is incurred to refinance other Indebtedness denominated in a foreign currency, and such refinancing would cause the applicable
U.S. Dollar denominated restriction to be exceeded if calculated at the relevant currency exchange rate in effect on the date of such refinancing, such U.S. Dollar-denominated restriction shall be deemed not to have been exceeded so long
as the principal amount of such refinancing Indebtedness does not exceed (a) the principal amount of such Indebtedness being refinanced, plus (b) the aggregate amount of fees, underwriting discounts, premiums (including tender premiums)
and other costs and expenses (including original issue discount, upfront fees or similar fees) incurred in connection with such refinancing. 

(g) The principal amount of any Indebtedness incurred to refinance other Indebtedness, if incurred in a different currency from the
Indebtedness being refinanced, shall be calculated based on the currency exchange rate applicable to the currencies in which such respective Indebtedness is denominated that is in effect on the date of such refinancing. 

(h) The Company shall not, and shall not permit any Subsidiary Guarantor to, directly or indirectly, incur any Indebtedness (including
Acquired Indebtedness) that is expressly subordinated or junior in right of payment to any Indebtedness of the Company or such Subsidiary Guarantor, as the case may be, unless such Indebtedness is expressly subordinated in right of payment to the
Notes or such Subsidiary Guarantor’s Guarantee to the extent and on substantially identical terms as such Indebtedness is subordinated to other Indebtedness of the Company or such Subsidiary Guarantor, as the case may be. 

(i) For purposes of this Section 4.09, (1) unsecured Indebtedness shall not be deemed to be subordinated or junior to Secured
Indebtedness merely because it is unsecured and (2) Senior Indebtedness shall not be deemed to be subordinated or junior to any other Senior Indebtedness merely because it has a junior priority with respect to the same collateral or because
such other Senior Indebtedness is guaranteed by other obligors. 
 SECTION 4.10 Asset Sales. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, consummate an Asset Sale, unless: 

(1) the Company or such Restricted Subsidiary, as the case may be, receives consideration at the time of such Asset Sale at
least equal to the fair market value (as determined in good faith by the Company at the time of contractually agreeing to such Asset Sale) of the assets sold or otherwise disposed of or the Equity Interests issued; and 

  
 75 

 (2) except in the case of a Permitted Asset Swap, at least 75% of the
consideration therefor received by the Company or such Restricted Subsidiary, as the case may be, is in the form of cash or Cash Equivalents; provided that the following shall be deemed to be cash for purposes of this provision and for no
other purpose: 
 (A) any liabilities (as reflected in the Company’s or such Restricted Subsidiary’s most
recent balance sheet or in the footnotes thereto or, if incurred, increased or accrued subsequent to the date of such balance sheet, such liabilities that would have been shown on the Company’s or such Restricted Subsidiary’s balance sheet
or in the footnotes thereto if such incurrence, increase or accrual had taken place on the date of such balance sheet, as determined in good faith by the Company) of the Company or such Restricted Subsidiary (other than Contingent Obligations and
liabilities that are by their terms subordinated to the Notes or the applicable Guarantee) that are assumed by the transferee of any such assets pursuant to a written agreement that releases or indemnifies the Company or such Restricted Subsidiary
from such liabilities or that are otherwise extinguished by the transferee in connection with such transaction; 
 (B) any
securities, notes or other similar obligations received by the Company or such Restricted Subsidiary from such transferee that are converted by the Company or such Restricted Subsidiary into cash or Cash Equivalents (to the extent of the cash or
Cash Equivalents received) within 180 days of the receipt thereof; 
 (C) any Designated Non-cash Consideration received by
the Company or such Restricted Subsidiary in such Asset Sale having an aggregate fair market value, taken together with all other Designated Non-cash Consideration received pursuant to this clause (C) that is at that time outstanding, not to
exceed the greater of $200.0 million and 3.25% of Total Assets at the time of the receipt of such Designated Non-cash Consideration, with the fair market value of each item of Designated Non-cash Consideration being measured at the time received and
without giving effect to subsequent changes in value; and 
 (D) Capital Stock of a Person that is a Restricted Subsidiary
or of a Person engaged in a Similar Business that shall become a Restricted Subsidiary immediately upon the acquisition thereof by the Company or any Restricted Subsidiary. 

(b) Within 365 days after the receipt of any Net Proceeds of any Asset Sale, the Company or such Restricted Subsidiary, at its option, may
apply an amount equal to the Net Proceeds from such Asset Sale, 
 (1) to permanently reduce Indebtedness as follows: 

(A) to permanently reduce Secured Indebtedness, including Indebtedness under the Senior Secured Credit Facilities, in each
case, that is secured by a Lien that is permitted by this Indenture and (if applicable) to permanently reduce commitments with respect thereto; 

  
 76 

 (B) to permanently reduce Obligations under other Senior Indebtedness of
the Company or a Subsidiary Guarantor (and (if applicable) to permanently reduce commitments with respect thereto), provided that the Company shall equally and ratably reduce (or offer to reduce, as applicable) Obligations under the Notes;
provided further that all reductions of Obligations under the Notes shall be made as provided under any applicable optional redemption provisions or through open-market purchases (to the extent such purchases are at or above 100% of the
principal amount thereof plus accrued and unpaid interest) or by making an offer (in accordance with the procedures set forth below for an Asset Sale Offer) to all Holders of Notes to purchase their Notes at 100% of the principal amount thereof,
plus the amount of accrued but unpaid interest, if any, on the amount of Notes of the applicable Series that would otherwise be prepaid; or 

(C) if the assets that are the subject of such Asset Sale are the property or assets of a Restricted Subsidiary that is not a
Subsidiary Guarantor, to permanently reduce Indebtedness of a Restricted Subsidiary that is not a Subsidiary Guarantor, other than Indebtedness owed to the Company or any Restricted Subsidiary; 

(2) to make (A) an Investment in any one or more businesses; provided that such Investment in any business
is in the form of the acquisition of Capital Stock and results in the Company or any of its Restricted Subsidiaries, as the case may be, owning an amount of the Capital Stock of such business such that it constitutes a Restricted Subsidiary,
(B) capital expenditures or (C) acquisitions of other businesses, properties, assets or intellectual property rights that, in the case of each of (A), (B) and (C), are used or useful in a Similar Business; and/or 

(3) to make an Investment in (A) any one or more businesses; provided that such Investment in any business is in
the form of the acquisition of Capital Stock and results in the Company or any of its Restricted Subsidiaries, as the case may be, owning an amount of the Capital Stock of such business such that it constitutes a Restricted Subsidiary,
(B) properties or (C) acquisitions of other businesses, properties, assets or intellectual property rights that, in the case of each of (A), (B) and (C), replace the businesses, properties, assets or intellectual property rights that
are the subject of such Asset Sale; 
 provided that, in the case of clauses (2) and (3) of this Section 4.10(b), a binding commitment
entered into not later than the end of such 365-day period shall be treated as a permitted application of the Net Proceeds from the date of such commitment so long as 

  
 77 

 
the Company or such Restricted Subsidiary enters into such commitment with the good faith expectation that an amount equal to the Net Proceeds will be applied to satisfy such commitment within
180 days of the end of such 365-day period (an “Acceptable Commitment”) and, in the event any Acceptable Commitment is later cancelled or terminated for any reason before an amount equal to the Net Proceeds is so applied, then the
Company or such Restricted Subsidiary shall be permitted to apply an amount equal to the Net Proceeds in any manner set forth above before the expiration of such 180-day period and, in the event the Company or such Restricted Subsidiary fails to do
so, then such Net Proceeds shall constitute Excess Proceeds. 
 (c) Any Net Proceeds from the Asset Sale that are not invested or applied as
provided and within the time period set forth in Section 4.10(b) will be deemed to constitute “Excess Proceeds.” When the aggregate amount of Excess Proceeds exceeds $100.0 million (the “Excess Proceeds Threshold”),
the Company shall make an offer to all Holders of the Notes and, if required by the terms of any Senior Indebtedness, to the holders of such Senior Indebtedness (an “Asset Sale Offer”), to purchase the maximum aggregate principal
amount of the Notes and such Senior Indebtedness that, in the case of Dollar Notes, is an integral multiple of $1,000 (but in minimum amounts of $2,000 of principal amount) and, in the case of Euro Notes, is an integral multiple of €1,000 (but
in minimum amounts of €100,000 of principal amount) that may be purchased with such Excess Proceeds at an offer price, in the case of the Notes, in cash in an amount equal to 100% of the principal amount thereof, plus accrued and unpaid
interest to the date fixed for the closing of such offer, and in the case of any Senior Indebtedness at the offer price required by the terms thereof but not to exceed 100% of the principal amount thereof, plus accrued and unpaid interest, if any,
in each case in accordance with the procedures set forth in this Indenture. The Company will commence an Asset Sale Offer with respect to Excess Proceeds within 10 Business Days after the date that Excess Proceeds exceed the Excess Proceeds
Threshold by delivering the notice required pursuant to the terms of this Indenture, with a copy to the Trustee for delivery to Holders. The Company may satisfy the foregoing obligations with respect to any Net Proceeds from an Asset Sale by making
an Asset Sale Offer with respect to such Net Proceeds prior to the expiration of the relevant 365-day period. Upon the completion of each Asset Sale Offer (including a voluntary Asset Sale Offer with respect to all Excess Proceeds even though less
than the Excess Proceeds Threshold), the amount of Excess Proceeds shall be reset to zero. 
 (d) To the extent that the aggregate principal
amount of Notes and such Senior Indebtedness, as the case may be, tendered pursuant to an Asset Sale Offer is less than the Excess Proceeds, the Company may use any remaining Excess Proceeds for any purposes not otherwise prohibited under this
Indenture. If the aggregate principal amount of Notes or Senior Indebtedness, as the case may be, surrendered by such holders thereof exceeds the amount of Excess Proceeds, such Notes or Senior Indebtedness, as the case may be, will be purchased on
a pro rata basis based on the accreted value or principal amount of such Notes or Senior Indebtedness, as the case may be, tendered (and the Trustee or applicable Registrar will select the tendered Notes of tendering holders on a pro rata basis, or
such other basis in accordance with DTC procedures with respect to the Dollar Notes or the procedures of Euroclear and Clearstream with respect to the Euro Notes, based on the amount of Notes tendered). 

  
 78 

 (e) Pending the final application of any Net Proceeds, the holder of such Net Proceeds may apply
such Net Proceeds temporarily to reduce Indebtedness outstanding under a revolving credit facility or otherwise invest such Net Proceeds in any manner not prohibited by this Indenture. 

(f) The Company shall comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations
thereunder to the extent such laws or regulations are applicable in connection with the repurchase of the Notes pursuant to an Asset Sale Offer. To the extent that the provisions of any securities laws or regulations conflict with the provisions of
this Indenture, the Company will comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations set forth in this Indenture by virtue thereof. 

(g) The provisions under this Indenture relative to the Company’s obligation to make an offer to repurchase the Notes as a result of an
Asset Sale may be waived or modified, with respect to a Series of Notes, with the written consent of the Holders of a majority in principal amount of the Notes of the applicable series then outstanding. 

SECTION 4.11 Transactions with Affiliates. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, make any payment to, or sell, lease, transfer or
otherwise dispose of any of its properties or assets to, or purchase any property or assets from, or enter into, or make or amend, any transaction, contract, agreement, understanding, loan, advance or guarantee with, or for the benefit of, any
Affiliate of the Company (each of the foregoing, an “Affiliate Transaction”) involving aggregate payments or consideration in excess of $25.0 million, unless: 

(1) such Affiliate Transaction is on terms that are not materially less favorable, taken as a whole, as determined in good
faith by the Company, to the Company or the relevant Restricted Subsidiary than those that would have been obtained in a comparable transaction by the Company or such Restricted Subsidiary with an unrelated Person on an arm’s-length basis; and

 (2) the Company delivers to the Trustee, with respect to any Affiliate Transaction or series of related Affiliate
Transactions involving aggregate payments or consideration in excess of $50.0 million, a resolution adopted by the majority of the disinterested members of the board of directors of the Company approving such Affiliate Transaction and set forth in
an Officer’s Certificate certifying that such Affiliate Transaction complies with clause (1) above. 
 (b) Section 4.11(a)
shall not apply to the following: 
 (1) transactions between or among the Company or any of its Restricted Subsidiaries;

  
 79 

 (2) Restricted Payments permitted by Section 4.07 and the definition of
“Permitted Investment”; 
 (3) the payment of reasonable and customary compensation and fees paid to, and
indemnities provided for the benefit of, or employment, service or benefit plan agreements with or for the benefit of, former, current or future officers, directors, employees or consultants of the Company or any of its Restricted Subsidiaries; 

(4) transactions in which the Company or any of its Restricted Subsidiaries, as the case may be, delivers to the Trustee a
letter from an Independent Financial Advisor either stating that such transaction is fair to the Company or such Restricted Subsidiary from a financial point of view or stating that such terms are not materially less favorable to the Company or its
relevant Restricted Subsidiary than those that would have been obtained in a comparable transaction by the Company or such Restricted Subsidiary with an unrelated Person on an arm’s-length basis; 

(5) any agreement as in effect as of the Original Issue Date, or any amendment, supplement, modification, extension or renewal
thereto or thereof or any transaction contemplated thereby (including pursuant to any amendment, supplement, modification, extension or renewal thereto or thereof) or by any replacement agreement thereto (so long as any such amendment or replacement
agreement is not more disadvantageous to the Holders in any material respect when taken as a whole as compared to the applicable agreement as in effect on the Original Issue Date as determined in good faith by the Company); 

(6) transactions with customers, clients, suppliers, or purchasers or sellers of goods or services, in each case in the
ordinary course of business and otherwise in compliance with the terms of this Indenture that are fair to the Company and its Restricted Subsidiaries, as determined in good faith by the Company, or are on terms at least as favorable as might
reasonably have been obtained at such time from an unaffiliated party; 
 (7) the sale and/or issuance of Equity Interests of
the Company to any director, officer, employee or consultant of the Company or its Restricted Subsidiaries; 
 (8) any
issuances of securities or other payments, awards, grants in cash, securities or otherwise or loans (or cancellation of loans) to employees or consultants of the Company or any of its Restricted Subsidiaries pursuant to, or for the funding of,
employment arrangements or agreements, stock option plans, stock ownership plans and other similar arrangements with such employees or consultants which, in each case, are approved by the Company in good faith; 

  
 80 

 (9) any transaction with any Person that is an Affiliate of the Company or any
Restricted Subsidiary that would constitute an Affiliate Transaction solely because the Company or any Restricted Subsidiary owns (directly or indirectly) an equity interest in, or controls (including pursuant to any management agreement or
otherwise), such Person; 
 (10) transactions with joint ventures on terms that are not materially less favorable, taken as a
whole, to the Company or any Restricted Subsidiary (as applicable), as determined in good faith by the Company, than the other joint venture partner(s); 

(11) the Transactions and the payment of all fees and expenses related to the Transactions; 

(12) transactions effected as part of a Qualified Securitization Transaction; 

(13) transactions with Affiliates solely in their capacity as holders of Indebtedness or Capital Stock of the Company or any
Restricted Subsidiary where such Affiliate receives the same consideration or is treated in the same manner as non-Affiliates that are party to (or have the benefit of) such transaction; and 

(14) any agreement that grants SEC registration rights or customary exchange offer rights to the direct or indirect
securityholders of the Company or any Restricted Subsidiary (and the performance of any such agreement). 
 SECTION 4.12 Liens.

 (a) The Company shall not, and shall not permit any Subsidiary Guarantor to, directly or indirectly, create, incur, assume or otherwise
cause or suffer to exist any Lien (except Permitted Liens) that secures obligations under any Indebtedness or any related Guarantee of the Company or any Subsidiary Guarantor, on any asset or property of the Company or any Subsidiary Guarantor, or
any income or profits therefrom, or assign or convey any right to receive income therefrom, unless: 
 (1) in the case of any
Liens securing Subordinated Indebtedness, the Notes and related Guarantees are secured by a Lien on such property, assets or proceeds that is senior in priority to such Liens; and 

(2) in all other cases, the Notes or the Guarantees are equally and ratably secured, except that the foregoing shall not apply
to or restrict Liens securing obligations in respect of the Notes and the related Guarantees. 
 (b) Any Lien created for the benefit of the
Holders of the Notes pursuant to this Section 4.12 shall be deemed automatically and unconditionally released and discharged upon the release and discharge of each of the Lien (other than a release as a result of the enforcement of remedies in
respect of such Lien or the Obligations secured by such Lien) that gave rise to the obligation to secure the Notes or such Guarantee pursuant to Section 4.12(a). 

  
 81 

 SECTION 4.13 Offer to Repurchase Upon Change of Control. 

(a) If a Change of Control occurs after the Original Issue Date, unless the Company has previously or concurrently mailed a redemption notice
with respect to all the outstanding Notes under the applicable optional redemption provisions, the Company will make an offer to purchase all of the Notes pursuant to the offer described below (the “Change of Control Offer”) at a
price in cash (the “Change of Control Payment”) equal to 101% of the aggregate principal amount thereof plus accrued and unpaid interest, if any, to, but excluding, the date of purchase, subject to the right of Holders of the Notes
of record on the relevant record date to receive interest due on the relevant interest payment date. For the avoidance of doubt, the separation and distribution will not be deemed to be a Change of Control. Within 30 days following any Change of
Control, the Company will deliver notice of such Change of Control Offer with a copy to the Trustee, to each Holder of Notes to the address of such Holder appearing in the security register or otherwise in accordance with the procedures of DTC with
respect to the Dollar Notes or the procedures of Euroclear and Clearstream with respect to the Euro Notes, with the following information: 

(1) that a Change of Control Offer is being made pursuant to Section 4.13 under this Indenture and that all Notes properly
tendered pursuant to such Change of Control Offer will be accepted for payment by the Company; 
 (2) the purchase price and
the purchase date, which will be no earlier than 30 days nor later than 60 days from the date such notice is sent (the “Change of Control Payment Date”), except in the case of a conditional Change of Control Offer made in advance of
a Change of Control as described below; 
 (3) that any Note not properly tendered will remain outstanding and continue to
accrue interest; 
 (4) that, unless the Company defaults in the payment of the Change of Control Payment required to be
made, all Notes accepted for payment pursuant to the Change of Control Offer will cease to accrue interest on the Change of Control Payment Date; 

(5) that Holders electing to have any Notes purchased pursuant to a Change of Control Offer will be required to surrender such
Notes, with the form entitled “Option of Holder to Elect Purchase” on the reverse of such Notes completed, to the paying agent specified in the notice at the address specified in the notice prior to the close of business on the third
Business Day preceding the Change of Control Payment Date; 
 (6) that Holders will be entitled to withdraw their tendered
Notes and their election to require the Company to purchase such Notes; provided that the applicable paying agent receives, not later than the close of business on the expiration date of the Change of Control Offer, a telegram, telex,
facsimile 

  
 82 

 
transmission or letter setting forth the name of the Holder of the Notes, the principal amount of Notes tendered for purchase, and a statement that such Holder is withdrawing its tendered Notes
and its election to have such Notes purchased; 
 (7) the other instructions, as determined by the Company, consistent with
the covenant described hereunder, that a Holder must follow; and 
 (8) if such notice is sent prior to the occurrence of a
Change of Control, stating that the Change of Control Offer is conditional upon the occurrence of such Change of Control. 
 (b) The Company
shall comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent such laws or regulations are applicable in connection with the repurchase of Notes pursuant to a Change of
Control Offer. To the extent that the provisions of any securities laws or regulations conflict with the provisions of this Section 4.13, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to
have breached its obligations set forth in this Section 4.13 by virtue of such conflict. 
 (c) On the Change of Control Payment Date,
the Company will, to the extent permitted by law, 
 (1) accept for payment all Notes or portions thereof properly tendered
pursuant to the Change of Control Offer, 
 (2) deposit with the applicable paying agent an amount equal to the aggregate
Change of Control Payment in respect of all Notes or portions thereof properly tendered, and 
 (3) deliver, or cause to be
delivered, to the Trustee for cancellation the Notes so accepted together with an Officer’s Certificate to the Trustee stating that such Notes or portions thereof have been tendered to, and purchased by, the Company. 

(d) Notwithstanding anything to the contrary herein, the Company shall not be required to make a Change of Control Offer following a Change of
Control if a third party makes the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Section 4.13 applicable to a Change of Control Offer made by the Company and purchases
all Notes properly tendered and not withdrawn under such Change of Control Offer. 
 (e) Notwithstanding anything to the contrary herein, a
Change of Control Offer may be made in advance of a Change of Control, conditional upon such Change of Control, if a definitive agreement is in place for the Change of Control at the time of making the Change of Control Offer. 

(f) The provisions under this Section 4.13 relating to the Company’s obligation to make an offer to repurchase the Notes as a result
of a Change of Control 

  
 83 

 
may be waived or modified, with respect to any Series of Notes, with the written consent of the Holders of a majority in principal amount of the Notes of the applicable series then outstanding,
including after the entry into of an agreement that would result in the need to make a Change of Control Offer. 
 (g) If and for so long as
any Euro Notes are listed on the Official List of the Irish Stock Exchange and admitted to trading on the Global Exchange Market and the rules of the Irish Stock Exchange so require, notices of any amendment, supplement or waiver shall be published
through the Companies Announcement Office of the Irish Stock Exchange and/or, to the extent and in the manner permitted by the rules of the Irish Stock Exchange, on the official website of the Irish Stock Exchange. 

SECTION 4.14 Covenant Suspension. 

(a) If on any date following the Original Issue Date (i) the Notes of a series have Investment Grade Ratings from both Rating Agencies,
and (ii) no Default or Event of Default has occurred and is continuing under this Indenture, then, beginning on that day (the “Suspension Date” and, the occurrence of the events described in the foregoing clauses (i) and
(ii) being collectively referred to as a “Covenant Suspension Event”) and continuing until the occurrence of the Reversion Date, (i) the Company shall promptly provide notice of such Covenant Suspension Event to the
Trustee and (ii) the covenants specifically listed under the following sections of this Indenture will not be applicable to such Notes (collectively, the “Suspended Covenants”): 

(1) Section 4.10; 

(2) Section 4.07; 

(3) Section 4.09; 

(4) Section 5.01(a)(4); 

(5) Section 4.11; and 

(6) Section 4.08. 

(b) During any period that the foregoing Sections have been suspended, the Company may not designate any of its Subsidiaries as Unrestricted
Subsidiaries, unless such designation would have complied with Section 4.07 as if such Section were in effect during such period. 

(c) In the event that the Company and its Restricted Subsidiaries are not subject to the Suspended Covenants under this Indenture for any
period of time as a result of the foregoing, and on any subsequent date (the “Reversion Date”) one or both of the Rating Agencies withdraw their Investment Grade Rating or downgrade the rating assigned to the applicable Notes below
an Investment Grade Rating, then (i) the Company shall promptly provide notice of such Reversion Date to the Trustee and (ii) the 

  
 84 

 
Company and its Restricted Subsidiaries will thereafter again be subject to the Suspended Covenants under this Indenture with respect to future events. The period of time between the Suspension
Date and the Reversion Date is referred to in this Indenture as the “Suspension Period.” Upon the occurrence of a Covenant Suspension Event, the amount of Excess Proceeds from Asset Sales shall be reset to zero. 

(d) During any Suspension Period, the Company shall not, and shall not permit any Restricted Subsidiary to, enter into any Sale and
Lease-Back Transaction; provided, however, that the Company or any Restricted Subsidiary may enter into a Sale and Lease-Back Transaction if (i) the Company or such Restricted Subsidiary could have incurred a Lien to secure the
Indebtedness attributable to such Sale and Lease-Back Transaction pursuant to Section 4.12 without equally and ratably securing the Notes pursuant to the covenant described therein; and (ii) the consideration received by the Company or
such Restricted Subsidiary in that Sale and Lease-Back Transaction is at least equal to the fair market value of the property sold and otherwise complies with Section 4.10; provided, further, that this Section 4.14(d) shall
cease to apply on and subsequent to any Reversion Date. 
 (e) During the Suspension Period, the Company and its Restricted
Subsidiaries will be entitled to incur Liens to the extent provided for under Section 4.12 (including, without limitation, Permitted Liens) to the extent provided for in such covenant, and any Permitted Liens that refer to one or more Suspended
Covenants shall be interpreted as though such applicable Suspended Covenant(s) continued to be applicable during the Suspension Period (but solely for purposes of Section 4.12 and for no other covenant). 

(f) Notwithstanding the foregoing, in the event of any such reinstatement, no action taken or omitted to be taken by the Company or any
of its Restricted Subsidiaries during the Suspension Period shall give rise to a Default or Event of Default under any of the Suspended Covenants; provided that (1) after such reinstatement, the amount of Restricted Payments since the
Original Issue Date will be calculated as though Section 4.07 had been in effect prior to, but not during, the Suspension Period; (2) all Indebtedness incurred, or Disqualified Stock issued, during the Suspension Period will be classified
to have been incurred or issued pursuant to Section 4.09(b)(3); (3) any Affiliate Transaction entered into after such reinstatement pursuant to an agreement entered into during any Suspension Period shall be deemed to be permitted pursuant
to Section 4.11(b)(11); and (4) any encumbrance or restriction on the ability of any Restricted Subsidiary that is not a Guarantor to take any action described in clauses (1) through (3) of Section 4.08(a) that becomes
effective during any Suspension Period shall be deemed to be permitted pursuant to Section 4.08(b)(1). 

  
 85 

 ARTICLE V 

SUCCESSORS 

SECTION 5.01 Merger, Consolidation or Sale of All or Substantially All Assets. 

(a) The Company. The Company may not, directly or indirectly, consolidate or merge with or into or wind up into (whether or not
the Company is the surviving corporation) or sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of the Company’s properties or assets, in one or more related transactions, to any Person unless: 

(1) the Company is the surviving entity or the Person formed by or surviving any such consolidation or merger (if other than
the Company) or to which such sale, assignment, transfer, lease, conveyance or other disposition will have been made is a corporation, partnership (including a limited partnership), trust or limited liability company organized or existing under the
laws of the jurisdiction of organization of the Company or the laws of the United States, any state thereof, the District of Columbia or any territory thereof (such Person, as the case may be, being herein called the “Successor
Company”); provided that in the case where the Successor Company is not a corporation, a co-obligor of the Notes is a corporation; 

(2) the Successor Company, if other than the Company, expressly assumes all the obligations of the Company under the Notes,
pursuant to a supplemental indenture or other documents or instruments; 
 (3) immediately after such transaction, no Default
or Event of Default exists; 
 (4) immediately after giving pro forma effect to such transaction and any
related financing transactions, as if such transactions had occurred at the beginning of the applicable four-quarter period, 
 (a)
the Company or the Successor Company, as applicable, would be permitted to incur at least $1.00 of additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in Section 4.09(a) or 

(b) the Fixed Charge Coverage Ratio of the Company (or, if applicable, the Successor Company) and its Restricted Subsidiaries would be equal to
or greater than such ratio of the Company and its Restricted Subsidiaries immediately prior to such transaction; 
 (5) each
Subsidiary Guarantor, unless (i) it is the other party to the transactions described above, in which case Section 5.01(b)(1)(b) shall apply or (ii) the Company is the surviving entity, shall have by supplemental indenture confirmed
that its Guarantee shall apply to such Person’s obligations under this Indenture and the applicable Notes; and 
 (6)
the Company (or, if applicable, the Successor Company) shall have delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating that such consolidation, merger or transfer and such supplemental indenture, if any,
complies with this Indenture. 

  
 86 

 The Successor Company will succeed to, and be substituted for, the Company under this Indenture,
the Guarantees and the Notes, as applicable. Notwithstanding the foregoing clauses (3) and (4), 
 (1) any Restricted
Subsidiary may consolidate with or merge into or transfer all or part of its properties and assets to the Company or a Subsidiary Guarantor, and 

(2) the Company may merge with an Affiliate of the Company, as the case may be, solely for the purpose of reincorporating the
Company in the United States, any state thereof, the District of Columbia or any territory thereof or for the sole purpose of forming or collapsing a holding company structure. 

(b) Subsidiary Guarantors. No Subsidiary Guarantor shall, and the Company shall not permit any Subsidiary Guarantor to,
consolidate or merge with or into or wind up into (whether or not such Subsidiary Guarantor is the surviving corporation), or sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of its properties or assets, in one
or more related transactions, to, any Person unless: 
 (1) (a) such Guarantor is the surviving entity or the
Person formed by or surviving any such consolidation or merger (if other than such Guarantor) or to which such sale, assignment, transfer, lease, conveyance or other disposition will have been made is a corporation, partnership, trust or limited
liability company organized or existing under the laws of the jurisdiction of organization of such Guarantor, as the case may be, or the laws of the United States, any state thereof, the District of Columbia or any territory thereof (such Guarantor
or such Person, as the case may be, being herein called the “Successor Person”); 
 (b) the Successor Person, if other than
a Guarantor, expressly assumes all the obligations of such Guarantor under this Indenture and such Guarantor’s related Guarantee pursuant to a supplemental indenture or other documents or instruments; 

(c) immediately after such transaction, no Default or Event of Default exists; and 

(d) the Company shall have delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating that such
consolidation, merger or transfer and such supplemental indenture, if any, complies with this Indenture; 
 (2) the
transaction is made in compliance with Section 4.10, if applicable; or 
 (3) in the case of assets comprised of Equity
Interests of Subsidiaries that are not Guarantors, such Equity Interests are sold, assigned, transferred, leased, conveyed or otherwise disposed of to one or more Restricted Subsidiaries. 

  
 87 

 Subject to Section 5.02, the Successor Person will succeed to, and be substituted for, such
Guarantor under this Indenture and such Guarantor’s Guarantee. Notwithstanding the foregoing, any Subsidiary Guarantor may (1) merge or consolidate with or into, wind up into or transfer all or part of its properties and assets to another
Subsidiary Guarantor or the Company, (2) merge with an Affiliate of the Company solely for the purpose of reincorporating the Subsidiary Guarantor in the United States, any state thereof, the District of Columbia or any territory thereof,
(3) convert into a corporation, partnership, limited partnership, limited liability company or trust organized or existing under the laws of the jurisdiction of organization of such Subsidiary Guarantor or (4) liquidate or dissolve or
change its legal form if the Company determines in good faith that such action is in the best interests of the Company, in each case, without regard to the requirements set forth in the preceding paragraph. 

SECTION 5.02 Successor Corporation Substituted. Upon any consolidation or merger, or any sale, assignment, transfer, lease,
conveyance or other disposition of all or substantially all of the properties or assets of the Company in a transaction that is subject to, and that complies with the provisions of, Section 5.01 hereof, in which the Company is not the
continuing corporation, the successor Person formed by such consolidation or into or with which the Company is merged or to which such sale, assignment, transfer, lease, conveyance or other disposition is made shall succeed to, and be substituted
for (so that from and after the date of such consolidation, merger, sale, assignment, transfer, lease, conveyance or other disposition, the provisions of this Indenture referring to the “Company” shall refer instead to the successor Person
and not to the Company), and may exercise every right and power of the Company under this Indenture with the same effect as if such successor Person had been named as the Company herein; provided, however, that the predecessor Company
shall not be relieved from the obligation to pay the principal of, premium on, if any, and interest, if any, on, the Notes except in the case of a sale of all of the Company’s assets in a transaction that is subject to, and that complies with
the provisions of, Section 5.01 hereof. 
 ARTICLE VI 

DEFAULTS AND REMEDIES 

SECTION 6.01 Events of Default. Unless otherwise indicated for a particular Series of Notes by a Board Resolution, a supplemental
indenture hereto or an Officer’s Certificate, each of the following constitutes an “Event of Default” with respect to each Series of Notes: 

(1) default in payment when due and payable (whether at maturity, upon redemption, acceleration or otherwise) of principal of,
or premium, if any, on the Notes of such Series; 

  
 88 

 (2) default for 30 days or more in the payment when due of interest on or with
respect to the Notes of such Series; 
 (3) failure by the Company or any Subsidiary Guarantor for 60 days after receipt of
written notice given by the Trustee or the Holders of not less than 25% of the aggregate principal amount of the then outstanding Notes of a series (with a copy to the Trustee) to comply with any of its other obligations, covenants or agreements
(other than a default referred to in clauses (1) and (2) above) contained in this Indenture or the applicable Notes; 

(4) default under any mortgage, indenture or instrument under which there is issued or by which there is secured or evidenced
any Indebtedness for money borrowed by the Company or any of its Restricted Subsidiaries or the payment of which is guaranteed by the Company or any of its Restricted Subsidiaries, other than Indebtedness owed to the Company or a Restricted
Subsidiary, whether such Indebtedness or guarantee exists on the Original Issue Date or is created after the issuance of the Notes, if both: 

(a) such default either results from the failure to pay any principal of such Indebtedness at its stated final maturity (after giving effect
to any applicable grace periods) or relates to an obligation other than the obligation to pay principal of any such Indebtedness at its stated final maturity and results in the holder or holders of such Indebtedness causing such Indebtedness to
become due prior to its stated maturity; and 
 (b) the principal amount of such Indebtedness, together with the principal amount of any
other such Indebtedness in default for failure to pay principal at stated final maturity (after giving effect to any applicable grace periods), or the maturity of which has been so accelerated, aggregates $100.0 million or more; 

(5) failure by the Company or any Significant Subsidiary to pay final judgments for the payment of money aggregating in excess
of $100.0 million, which final judgments remain unpaid, undischarged and unstayed for a period of more than 60 days after such judgment becomes final and non-appealable, and in the event such judgment is covered by insurance, an enforcement
proceeding has been commenced by any creditor upon such judgment or decree which is not promptly stayed; 
 (6) the Company
or any Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: 
 (A) commences a voluntary case,
files for suspension of payments or any similar relief; 

  
 89 

 (B) consents to the entry of an order for relief against it in an involuntary
case, files for bankruptcy or commences a similar insolvency proceeding; 
 (C) consents to the appointment of a Custodian
of it or for all or substantially all of its property; or 
 (D) makes a general assignment for the benefit of its
creditors; 
 (7) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(A) is for relief against the Company or any Significant Subsidiary in an involuntary case; 

(B) appoints a Custodian of the Company or any Significant Subsidiary for all or substantially all of its property; or 

(C) orders the winding up or liquidation of the Company or any Significant Subsidiary; 

or any similar relief is granted under any foreign law or laws, and the order or decree remains unstayed and in effect for 60 days; 

(8) the Guarantee of any Significant Subsidiary shall for any reason cease to be in full force and effect or be declared null
and void, or any responsible officer of any Subsidiary Guarantor that is a Significant Subsidiary denies in writing that it has any further liability under its Guarantee or gives notice to such effect, other than by reason of the termination of this
Indenture or the release of any such Guarantee in accordance with this Indenture. 
 The term “Custodian” means, for the purposes
of this Article VI only, any receiver, trustee, assignee, liquidator, custodian or similar official under any Bankruptcy Law. 
 The Company
shall, within 30 days of any Officer becoming aware of any continuing Default, deliver to the Trustee a statement specifying such Default and steps to be taken to cure such Default. 

SECTION 6.02 Acceleration. (a) If an Event of Default with respect to any Series of Notes at the time Outstanding (other than
an Event of Default specified in Section 6.01(6) or (7)) occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the Outstanding Notes of that Series by notice to the Company (and to the Trustee, if
notice is given by the Holders), may declare the principal amount of (or, in the case of Original Issue Discount Notes of that Series, the portion thereby specified in the terms of such Note), premium, if any, and accrued and unpaid interest on all
the Notes of that Series to be due and payable. Upon such a declaration, such amounts shall be due and payable 

  
 90 

 
immediately. If an Event of Default specified in Section 6.01(6) or (7) occurs, the principal amount of (or, in the case of Original Issue Discount Notes of that Series, the portion
thereby specified in the terms of such Note), premium, if any, and accrued and unpaid interest on all the Notes of each Series of Note shall ipso facto become and be immediately due and payable without any declaration or other act on the part
of the Trustee or any Holder. 
 (b) At any time after the principal of the Notes of any Series of Notes shall have been so declared due and
payable (or have become immediately due and payable), and before any judgment or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the Holders of a majority in principal amount of the Notes of that
Series then Outstanding hereunder, by written notice to the Company and the Trustee, may rescind and annul such declaration and its consequences if: (i) the Company has paid or deposited with the Trustee a sum sufficient to pay all matured
installments of interest upon all the Notes of that Series and the principal of (and premium, if any, on) any and all Notes of that Series that shall have become due otherwise than by acceleration (with interest upon such principal and premium, if
any, and, to the extent that such payment is enforceable under applicable law, upon overdue installments of interest, at the rate per annum expressed in the Notes of that Series to the date of such payment or deposit and all reasonable expenses,
disbursements and advances of the Trustee (including reasonable compensation, disbursements and expenses of the Trustee’s counsel) and compensation for the Trustee’s services) and (ii) any and all Events of Default under this
Indenture with respect to such Series of Notes, other than the nonpayment of principal (or, in the case of Original Issue Discount Notes of that Series, the portion thereby specified in the terms of such Note) and interest, if any, on Notes of that
Series that have become due solely by such declaration of acceleration, shall have been remedied or waived as provided in Section 6.04. No such rescission shall affect any subsequent Default or impair any right consequent thereto. 

(c) In the event of any Event of Default specified in Section 6.01(4), such Event of Default and all consequences thereof (excluding any
resulting payment default, other than as a result of acceleration of the Notes) shall be annulled, waived and rescinded, automatically and without any action by the Trustee or the Holders, if within 30 days after such Event of Default arose: 

(1) the Indebtedness or guarantee that is the basis for such Event of Default has been discharged; 

(2) holders thereof have rescinded or waived the acceleration, notice or action (as the case may be) giving rise to such Event of Default; or

 (3) the default that is the basis for such Event of Default has been cured. 

SECTION 6.03 Other Remedies. If an Event of Default with respect to any Series of Notes occurs and is continuing, the Trustee may
proceed to protect and enforce its rights and the rights of the Holders by such appropriate judicial proceedings as shall be most effectual to 

  
 91 

 
protect and enforce such rights, whether for the specific enforcement of any covenant or agreement in this Indenture or in aid of the exercise of any power granted herein, or to enforce any other
proper remedy. 
 The Trustee may institute and maintain a suit or legal proceeding even if it does not possess any of the Notes of a Series
or does not produce any of them in the proceeding. A delay or omission by the Trustee or any Holder in exercising any right or remedy accruing upon an Event of Default with respect to any Series of Notes shall not impair the right or remedy or
constitute a waiver of or acquiescence in the Event of Default. No remedy is exclusive of any other remedy. All available remedies are cumulative to the extent permitted by law. 

SECTION 6.04 Waiver of Past Defaults. The Holders of a majority in principal amount of the Outstanding Notes of any Series may, on
behalf of the Holders of all the Notes of such Series by written notice to the Trustee, waive an existing Default except (i) a Default in the payment of the principal amount of (or, in the case of Original Issue Discount Notes of that Series,
the portion thereby specified in the terms of such Note), premium, if any, and accrued and unpaid interest on a Note of that Series, (ii) a Default arising from the failure to redeem or purchase any Note of that Series when required pursuant to
the terms of this Indenture or (iii) a Default in respect of a provision that under Section 9.02 cannot be amended without the consent of each Holder of that Series affected; provided, however, that the Holders of a majority in
principal amount of the Outstanding Notes of any Series may rescind an acceleration and its consequences, including any related payment default that resulted from such acceleration in accordance with Section 6.02. When a Default is waived, it
shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured, but no such waiver shall extend to any subsequent or other Default or impair any consequent right. 

SECTION 6.05 Control by Majority. The Holders of a majority in principal amount of the Outstanding Notes of any Series may direct
the time, method and place of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee with respect to that Series, provided that (i) such direction shall not conflict
with law or this Indenture or expose the Trustee to personal liability, or be unduly prejudicial to Holders not joining therein, and (ii) the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such
direction. Prior to taking any action hereunder, the Trustee shall be entitled to security or indemnity reasonably satisfactory to the Trustee against all fees, losses and expenses related to taking or not taking such action. The Trustee shall be
under no obligation to execute any of the rights or powers under this Indenture at the request or direction of any Holders unless such Holders have offered to the Trustee security or indemnity reasonably satisfactory to the Trustee. 

SECTION 6.06 Limitation on Suits. Except to enforce the right to receive payment of the principal amount of (or, in the case of
Original Issue Discount Notes, the portion thereby specified in the 

  
 92 

 
terms of such Note), premium, if any, and accrued and unpaid interest on the Notes of any Series held by such Holder when due, no Holder of a Note of that Series may pursue any remedy with
respect to this Indenture or the Notes of that Series unless: 
 (i) such Holder has previously given the Trustee written
notice that an Event of Default with respect to the applicable Series of Notes is continuing; 
 (ii) Holders of at least
25% in the aggregate principal amount of all Outstanding Notes of such Series have requested in writing that the Trustee pursue the remedy; 

(iii) Holders of the applicable Notes have offered the Trustee security or indemnity satisfactory to the Trustee against any
loss, liability or expense in connection therewith; 
 (iv) the Trustee has not complied with such request within
60 days after the receipt thereof and the offer of security or indemnity; and 
 (v) Holders of a majority in principal
amount of all Outstanding Notes of such Series have not given the Trustee a direction inconsistent with such request within such 60-day period. 

A Holder of Notes of any Series may not use this Indenture to prejudice the rights of another Holder of that Series or to obtain a preference
or priority over another Holder of that Series. 
 SECTION 6.07 Rights of Holders to Receive Payment. Notwithstanding any other
provision of this Indenture, the right of any Holder to receive payment of the principal amount of (or, in the case of Original Issue Discount Notes, the portion thereby specified in the terms of such Note), premium, if any, and accrued and unpaid
interest on the Notes held by such Holder, on or after their Maturity Dates, or to bring suit for the enforcement of any such payment on or after their Maturity Dates, is absolute and unconditional and shall not be impaired or affected without the
consent of such Holder. 
 SECTION 6.08 Collection Suit by Trustee. If an Event of Default specified in Section 6.01(1) or
(2) occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company for the whole amount then due and owing (together with interest on any unpaid interest to the extent lawful)
and any amounts provided for hereunder. 
 SECTION 6.09 Trustee May File Proofs of Claim. The Trustee may file such proofs of
claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the 

  
 93 

 
reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders allowed in any judicial proceedings relative to the Company and the
Guarantors, their creditors or their property and shall be entitled and empowered to collect and receive any moneys or other property payable or deliverable on any such claims and to distribute the same, and any custodian, receiver, assignee,
trustee or liquidator (or other similar official) in any such judicial proceeding is hereby authorized by each Holder to make payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the
Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and its counsel, and any other amounts due to the Trustee hereunder. Nothing herein contained shall
be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder thereof, or to authorize the
Trustee to vote in respect of the claim of any Holder in any such proceeding. 
 SECTION 6.10 Priorities. Any money or property
collected by the Trustee pursuant to this Article VI with respect to any Series of Notes shall be applied in the following order, at the date or dates fixed by the Trustee, and, in case of the distribution of such money on account of principal or
interest, upon presentation of the Notes and the notation thereon of the payment if only partially paid and upon surrender thereof if fully paid: 

FIRST: to the Trustee acting in any capacity hereunder and any Agent, for all amounts due hereunder; 

SECOND: to Holders, for amounts due and unpaid on the Notes of that Series for the principal amount of (or, in the case of Original Issue
Discount Notes of that Series, the portion thereby specified in the terms of such Note), premium, if any, and accrued and unpaid interest, ratably, without preference or priority of any kind, according to the amounts due and payable on the Notes of
that Series for the principal amount of (or, in the case of Original Issue Discount Notes of that Series, the portion thereby specified in the terms of such Note), premium, if any, and accrued and unpaid interest, respectively; and 

THIRD: to the Company. 

SECTION 6.11 Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit
against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing, by any party litigant in the suit, of an undertaking to pay the costs of the suit, and the court in its discretion may assess
reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section does not apply to a
suit by the Trustee, a suit by a Holder pursuant to Section 6.07 or a suit by Holders of more than 10% in principal amount of the then Outstanding Notes of any Series. 

  
 94 

 SECTION 6.12 Waiver of Stay or Extension Laws. The Company (to the extent it may
lawfully do so) agrees that it shall not at any time insist upon, plead or in any manner whatsoever claim to take the benefit or advantage of any stay or extension law, wherever enacted, now or at any time hereafter in force, which may affect the
covenants or the performance of this Indenture; and the Company (to the extent that it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and shall not hinder, delay or impede the execution of any power herein
granted to the Trustee, but shall suffer and permit the execution of every such power as though no such law had been enacted. 
 ARTICLE VII

 TRUSTEE 

SECTION 7.01 Duties of Trustee. (a) If an Event of Default has occurred and is continuing with respect to any Series of
Notes, the Trustee shall exercise such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in the exercise thereof, as a prudent man would exercise or use under the circumstances in the conduct of his
own affairs. 
 (b) Except during the continuance of an Event of Default with respect to any Series of Notes: 

(1) the Trustee undertakes to perform such duties and only such duties as are specifically set forth in this Indenture with
respect to the Notes of that Series, as modified or supplemented by a supplemental indenture hereto, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 

(2) in the absence of willful misconduct on its part, the Trustee may, with respect to Notes of that Series, conclusively rely,
as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture. However, in the case of any such certificates or
opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture (but need not
confirm or investigate the accuracy of mathematical calculations or other facts stated therein nor shall the Trustee have any responsibility or liability for any information set forth therein). 

  
 95 

 (c) No provision of this Indenture shall be construed to relieve the Trustee from liability for
its own negligent action, its own negligent failure to act or its own willful misconduct, except that: 
 (1) this paragraph
does not limit the effect of paragraph (b) of this Section; 
 (2) the Trustee shall not be liable for any error of
judgment made in good faith unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; 
 (3)
the Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05; and 

(4) no provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur any financial
liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers, if it shall have reasonable grounds to believe that repayment of such funds or adequate indemnity against such risk or liability is not
reasonably assured to it. 
 (d) Whether or not therein expressly so provided, every provision of this Indenture relating to the conduct or
affecting the liability of or affording protection to the Trustee is subject to paragraphs (a), (b) and (c) of this Section. 

(e) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company. 

(f) Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 

SECTION 7.02 Rights of Trustee. (a) The Trustee may conclusively rely on, and shall be protected in acting or refraining from
acting upon, any resolution, certificate, statement, instrument, opinion, notice, report, bond, request, direction, consent, order or other document believed by it to be genuine and to have been signed or presented by the proper Person or Persons.
The Trustee need not investigate any fact or matter stated in the document. 
 (b) Before the Trustee acts or refrains from acting, it shall
receive an Officer’s Certificate and an Opinion of Counsel. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on the Officer’s Certificate or Opinion of Counsel. 

(c) The Trustee may act through agents or attorneys and shall not be responsible for the misconduct or negligence of any agent or attorney
appointed by it with due care. No Depositary shall be deemed an agent of the Trustee, and the Trustee shall not be responsible for or have any liability for any act or omission by any Depositary. 

  
 96 

 (d) The Trustee shall not be liable for any action it takes or omits to take in good faith which
it believes to be authorized or within its rights or powers; provided, however, that the Trustee’s conduct does not constitute negligence or willful misconduct. 

(e) The Trustee may consult with counsel of its choice, and the advice or opinion of counsel shall be full and complete authorization and
protection in respect of any action taken, omitted or suffered by it hereunder in reliance thereon. 
 (f) Unless otherwise specifically
provided in this Indenture, any demand, request, direction or notice from the Company shall be sufficient if signed by an Officer of the Company, and the Trustee may rely thereon. 

(g) The Trustee shall not be deemed to have notice of any Default or Event of Default with respect to the Notes of any Series unless a
Responsible Officer of the Trustee has actual knowledge thereof or unless written notice of such a Default is received by a Responsible Officer of the Trustee at the office of the Trustee, and such notice references such Notes and this Indenture and
states that it is a notice of Default. 
 (h) The rights, privileges, protections, immunities and benefits given to the Trustee hereunder,
including, without limitation, its right to be indemnified, are extended to and shall be enforceable by the Trustee in each of its capacities and any Agent. 

(i) The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or
direction of any of the Holders pursuant to this Indenture, unless such Holders shall have offered to the Trustee security or indemnity reasonably satisfactory to the Trustee against the fees, costs, expenses and liabilities which might be incurred
by the Trustee in compliance with such request or direction. 
 (j) The Trustee shall not be bound to make any investigation into the facts
or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Trustee may make such
further inquiry or investigation into such facts or matters as it may see fit, and if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company,
personally or by agent or attorney. 
 (k) The Trustee shall not be liable for any action taken, suffered, or omitted to be taken by it in
good faith and reasonably believed by it to be authorized or within the discretion or rights or powers conferred upon it by this Indenture. 

(l) The Trustee shall not be required to give any bond or surety in respect of the performance of its duties or powers hereunder. 

  
 97 

 (m) The Trustee may request that the Company deliver a certificate of incumbency setting forth
the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture. 
 (n) In
no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work
stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or other force majeure events, and interruptions, loss or malfunctions of utilities, communications or computer (software and
hardware) services; it being understood that the Trustee shall use commercially reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. 

(o) The parties hereto acknowledge that in accordance with Section 326 of the U.S.A. Patriot Act, as amended, the Trustee, in accordance
with requirements applicable to financial institutions, may be required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. Each party to this
Indenture agrees that it will provide the Trustee with such information as the Trustee may request in order for the Trustee to comply with the requirements of the U.S.A. Patriot Act applicable to the Trustee. 

(p) The Trustee shall not be responsible or liable for special, indirect, punitive or consequential losses or damages (including, but not
limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action. 

(q) Whenever in the administration of this Indenture the Trustee shall deem it desirable that a matter be proved or established prior to
taking, suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may, in the absence of willful misconduct on its part, rely upon an Officer’s Certificate. 

SECTION 7.03 Individual Rights of Trustee. The Trustee in its individual or any other capacity may become the owner or pledgee of
Notes and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. Any Paying Agent, Transfer Agent, Registrar or co-paying agent may do the same with like rights. However, the Trustee must
comply with Sections 7.10 and 7.11. 
 SECTION 7.04 Trustee’s Disclaimer. The Trustee shall not be responsible for and
makes no representation as to the validity or adequacy of this Indenture or the Notes, it shall not be accountable for the Company’s uses of the proceeds from the Notes, and it shall not be responsible for any statement of the Company or the
Guarantors in this Indenture, in the 

  
 98 

 
Notes or in any document executed in connection with the sale of the Notes, other than those set forth in the Trustee’s certificate of authentication. The recitals contained herein and in
the Notes shall be taken as the statements of the Company and the Guarantors, and the Trustee assumes no responsibility or liability for their correctness. 

SECTION 7.05 Notice of Defaults. If a Default with respect to Notes of any Series occurs and is continuing and if it is actually
known to a Responsible Officer of the Trustee, the Trustee shall mail (or electronically deliver in accordance with the procedures of DTC, Euroclear and/or Clearstream, as applicable) to each Holder of that Series notice of the Default within 60
days after it occurs, unless such Default shall have been cured or waived. The Trustee may withhold the notice (except in the case of a Default in payment of principal, premium or interest) if and so long as the Trustee determines that withholding
the notice is in the interests of the Holders of such Series of Notes. 
 SECTION 7.06 Reports by Trustee to Holders. If this
Indenture is qualified under the TIA, unless otherwise specified in the applicable Board Resolution, supplemental indenture hereto or Officer’s Certificate, within 60 days after each May 12 beginning with May 12, 2016 for so long as
Notes remain Outstanding, the Trustee shall mail or otherwise deliver to each Holder a brief report dated as of such reporting date in accordance with and to the extent required under § 313(a) of the TIA. The Trustee shall also comply with
§ 313(b)(2) of the TIA. 
 A copy of each report at the time of its mailing to Holders shall be filed with each stock exchange (if any)
on which the Notes are listed, if required by the rules of such stock exchange. The Company agrees to notify promptly the Trustee whenever the Notes become listed on any stock exchange and of any delisting thereof. 

SECTION 7.07 Compensation and Indemnity. The Company and the Guarantors shall pay to the Trustee (acting in any capacity
hereunder) and any Agent from time to time compensation for all services rendered by the Trustee as the Company and the Trustee shall agree in writing. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of
an express trust. The Company and the Guarantors shall reimburse the Trustee (acting in any capacity hereunder) and any Agent upon request for all reasonable and duly documented out-of-pocket expenses, disbursements and advances incurred or made by
it in accordance with any provision of this Indenture, including costs of collection and the fees, expenses and disbursements of their respective agents and counsel, in addition to the reasonable compensation for their respective services. The
Company and Guarantors shall indemnify and hold harmless the Trustee (acting in any capacity hereunder) or any Agent and their respective officers, directors, employees and agents against any and all loss, liability or expense incurred on its part,
arising out of or in connection with the acceptance or administration of this Indenture or the transactions contemplated hereunder, including the costs and expenses of defending itself against any claim or liability in connection with the exercise
or performance of any of its powers or duties hereunder. The Trustee or any Agent shall 

  
 99 

 
notify the Company of any claim for which it may seek indemnity promptly upon obtaining actual knowledge thereof; provided, however, that any failure to so notify the Company shall
not relieve the Company and Guarantors of their indemnity obligations hereunder, except to the extent that the rights of the Company or the Guarantors are actually prejudiced by such failure. Neither the Company nor any Guarantor will need to
reimburse any expense or indemnify against any loss, liability or expense incurred by an indemnified party attributable to such party’s own gross negligence or willful misconduct as determined by a court of competent jurisdiction in a final
non-appealable order. The Company and the Guarantors shall not be obligated to pay any settlement effected without their prior written consent (which shall not be unreasonably withheld). 

To secure the Company’s and the Guarantors’ payment obligations in this Section 7.07, the Trustee shall have a lien prior to
the Notes on all money or property held or collected by the Trustee, other than money or property held in trust to pay the principal of and/or interest on particular Notes. 

The Company’s and the Guarantors’ payment obligations pursuant to this Section 7.07 and the rights, protections and indemnities
afforded to the Trustee and any Agent under this Article VII shall survive the satisfaction or discharge of this Indenture or the resignation or removal of the Trustee or any Agent, as the case may be. When the Trustee or any Agent incurs expenses
after the occurrence of a Default specified in Section 6.01(6) or (7) with respect to the Company, the expenses are intended to constitute expenses of administration under the Bankruptcy Law. 

Any right, protection and indemnity provided to the Trustee hereunder shall also be afforded to any Agent hereunder or under any supplemental
indenture. 
 SECTION 7.08 Replacement of Trustee. The Trustee may resign with respect to the Notes of any Series by so
notifying the Company in writing at least 30 days prior to the date of the proposed resignation. The Holders of a majority in principal amount of the Notes of any Series may remove the Trustee and may appoint a successor Trustee with respect to such
Series of Notes by so notifying the Trustee and the Company in writing not less than 30 days prior to the effective date of such removal. The Company shall remove the Trustee with respect to Notes of one or more Series if: 

(1) the Trustee fails to comply with Section 7.10; 

(2) the Trustee is adjudged bankrupt or insolvent; 

(3) a receiver or other public officer takes charge of the Trustee or its property; or 

(4) the Trustee otherwise becomes incapable of acting. 

If the Trustee resigns, is removed by the Company or by the Holders of a majority in principal amount of the Notes of any Series and such
Holders do not reasonably promptly appoint a successor Trustee or if a vacancy exists in the office of Trustee for any reason (the Trustee in such event being referred to herein as the retiring Trustee), the Company shall promptly appoint a
successor Trustee. 

  
 100 

 A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee
and to the Company. Thereupon the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee with respect to each Series of Notes for which it is
acting as Trustee under this Indenture. The successor Trustee shall mail or otherwise deliver a notice of its succession to Holders of that Series of Notes. The retiring Trustee shall promptly transfer all property held by it as Trustee to the
successor Trustee, subject to the lien provided for in Section 7.07. 
 If a successor Trustee does not take office within 60 days
after the retiring Trustee resigns or is removed, the retiring Trustee or the Holders of at least a majority in principal amount of the Notes of that Series may petition, at the expense of the Company, any court of competent jurisdiction for the
appointment of a successor Trustee. 
 If the Trustee fails to comply with Section 7.10, any Holder of that Series of Notes may
petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 
 Notwithstanding
the replacement of the Trustee pursuant to this Section 7.08, the Company’s obligations under Section 7.07 shall continue for the benefit of the retiring Trustee with respect to fees, expenses and liabilities incurred by it prior to
such replacement. The retiring or removed Trustee shall have no responsibility or liability for the action or inaction of any successor Trustee. 

SECTION 7.09 Successor Trustee by Merger. If the Trustee consolidates with, merges or converts into, or transfers all or
substantially all of its corporate trust business or assets to, another Person, the resulting, surviving or transferee Person without any further act shall be the successor Trustee. 

In case at the time such successor or successors by merger, conversion or consolidation to the Trustee shall succeed to the trusts created by
this Indenture any of the Notes shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee, and deliver such Notes so authenticated; and if at that time
any of the Notes shall not have been authenticated, any such successor to the Trustee may authenticate such Notes either in the name of any predecessor hereunder or in the name of the successor to the Trustee; and in all such cases such certificates
shall have the full force which it is anywhere in the Notes or in this Indenture provided that the certificate of the Trustee shall have. 

Any corporation into which the Trustee or any Paying Agent may be merged or converted, or any corporation with which the Trustee or Paying
Agent may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Trustee or Paying Agent shall be a party, or any corporation, including 

  
 101 

 
affiliated corporations, to which the Trustee or Paying Agent shall sell or otherwise transfer: (a) all or substantially all of its assets or (b) all or substantially all of its
corporate trust business shall, on the date when the merger, conversion, consolidation or transfer becomes effective and to the extent permitted by any applicable laws and subject to any credit rating requirements set out in this Indenture become
the successor Trustee or Paying Agent under this Indenture or any supplemental indenture without the execution or filing of any paper or any further act on the part of the parties to this Indenture, unless otherwise required by the Company, and
after the said effective date all references in this Indenture or supplemental indenture to the Trustee or any Paying Agent shall be deemed to be references to such successor corporation. Written notice of any such merger, conversion, consolidation
or transfer shall immediately be given to the Company by the Trustee or Paying Agent, as applicable. 
 SECTION 7.10 Eligibility;
Disqualification. The Trustee shall at all times satisfy the requirements of TIA § 310(a)(1), (2) and (5). The Trustee shall have a combined capital and surplus of at least $25,000,000 as set forth in its most recent published annual
report of condition. The Trustee shall comply with TIA § 310(b); provided, however, that there shall be excluded from the operation of TIA § 310(b)(1) the following: (i) each Series of Notes issued under this Indenture
and (ii) any other indenture or indentures under which other securities or certificates of interest or participation in other securities of the Company are outstanding if the requirements for such exclusion set forth in TIA § 310(b)(1) are
met. 
 SECTION 7.11 Preferential Collection of Claims Against the Company and Guarantors. The Trustee shall comply with TIA
§ 311(a), excluding any creditor relationship listed in TIA § 311(b). A Trustee who has resigned or has been removed shall be subject to TIA § 311(a) to the extent indicated. 

ARTICLE VIII 
 LEGAL
DEFEASANCE, COVENANT DEFEASANCE 
 AND SATISFACTION AND DISCHARGE 

SECTION 8.01 Option To Effect Legal Defeasance or Covenant Defeasance. The Company may, at any time, elect to have either
Section 8.02 or 8.03 hereof be applied to all Outstanding Notes of any Series upon compliance with the conditions set forth below in this Article VIII. 

SECTION 8.02 Legal Defeasance and Discharge. Upon the Company’s exercise under Section 8.01 hereof of the option
applicable to this Section 8.02 with respect to any Series of Notes, the Company shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be deemed to have been discharged from its obligations with respect to
all Outstanding Notes of that Series on the date the 

  
 102 

 
conditions set forth below are satisfied (hereinafter, “Legal Defeasance”). For this purpose, Legal Defeasance means that the Company shall be deemed to have paid and discharged
the entire indebtedness represented by the Outstanding Notes, which shall thereafter be deemed to be “Outstanding” only for the purposes of Section 8.05 hereof and the other Sections of this Indenture referred to in clauses
(a) and (b) below, and to have satisfied all its other obligations under such Notes and this Indenture (and the Trustee, on demand of and at the expense of the Company, shall execute proper instruments acknowledging the same), except for
the following provisions which shall survive until otherwise terminated or discharged hereunder: 
 (a) the Company’s obligations with
respect to such Notes of that Series under Sections 2.05, 2.06, 2.08 and 2.09 hereof; 
 (b) the rights, indemnities and immunities of the
Trustee (and any Agent) hereunder and the Company’s and Guarantors’ obligations in connection therewith (including, but not limited to, the rights of the Trustee (and any Agent) and the duties of the Company and Guarantors under
Section 7.07, which shall survive despite the satisfaction in full of all obligations hereunder); and 
 (c) Sections 8.02, 8.04, 8.05,
8.06, 8.07 and 8.08 hereof. 
 Subject to compliance with this Article VIII, the Company may exercise its option under this
Section 8.02 notwithstanding the prior exercise of its option under Section 8.03 hereof. In the event that the Company terminates all of its obligations under the Notes and this Indenture (with respect to such Series of Notes) by
exercising the Legal Defeasance option or the Covenant Defeasance option, the obligations of each Guarantor under its Guarantee of such Notes shall be terminated simultaneously with the termination of such obligations. 

SECTION 8.03 Covenant Defeasance. Upon the Company’s exercise under Section 8.01 hereof of the option applicable to this
Section 8.03 with respect to any Series of Notes, the Company shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be released from its obligations under the covenants contained in Sections 4.05, 4.07,
4.08, 4.09, 4.10, 4.11 and 4.12 of this Indenture (if applicable to such Series) and any covenants made applicable to the Series of Notes that are subject to defeasance under the terms of a Board Resolution, a supplemental indenture hereto or an
Officer’s Certificate with respect to the Outstanding Notes of that Series on and after the date the conditions set forth in Section 8.04 are satisfied (hereinafter, “Covenant Defeasance”), and the Notes of that Series
shall thereafter be deemed not “Outstanding” for the purposes of any direction, waiver, consent or declaration or act of Holders (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed
“Outstanding” for all other purposes hereunder (it being understood that such Notes shall not be deemed Outstanding for accounting purposes). For this purpose, Covenant Defeasance means that, with respect to the Outstanding Notes of that
Series, the Company and its Restricted Subsidiaries may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, 

  
 103 

 
whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other
document and such omission to comply shall not constitute a Default or an Event of Default under Section 6.01 hereof, but, except as specified above, the remainder of this Indenture and such Notes shall be unaffected thereby. In addition, upon
the Company’s exercise under Section 8.01 hereof of the option applicable to this Section 8.03 with respect to any Series of Notes, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, Sections 6.01(3)
(only with respect to defeased covenants hereunder), 6.01(4) and 6.01(5) hereof shall not constitute Events of Default with respect to such Notes. In the event that the Company terminates all of its obligations under the Notes and this Indenture
(with respect to such Series of Notes) by exercising the Legal Defeasance option or the Covenant Defeasance option, the obligations of each Guarantor under its Guarantee of such Notes shall be terminated simultaneously with the termination of such
obligations. 
 SECTION 8.04 Conditions to Legal or Covenant Defeasance. The following shall be the conditions to the
application of either Section 8.02 or 8.03 hereof to the Outstanding Notes: 
 In order to exercise either Legal Defeasance or Covenant
Defeasance with respect to any Series of Notes: 
 (1) the Company must irrevocably deposit or cause to be irrevocably
deposited with the Trustee, in trust, for the benefit of the Holders of that Series of Notes, (a) with respect to Dollar Notes, cash in Dollars, Government Securities or a combination thereof and (b) with respect to Euro Notes, cash in
Euros, European Government Obligations or a combination of both, in such amounts as will be sufficient, in the opinion of a nationally recognized firm of independent public accountants, to pay the principal of, premium, if any, and interest on the
Outstanding Notes of that Series on the stated date for payment thereof or on the applicable redemption date, as the case may be; 

(2) in the case of an election under Section 8.02 hereof, the Company shall have delivered, or cause to be delivered, to
the Trustee an Opinion of Counsel confirming that (a) the Company has received from, or there has been published by, the U.S. Internal Revenue Service a ruling, or (b) since the date of this Indenture, there has been a change in the
applicable U.S. federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of the Outstanding Notes will not recognize income, gain or loss for U.S. federal income tax
purposes as a result of such Legal Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred; 

(3) in the case of an election under Section 8.03 hereof, the Company shall have delivered, or cause to be delivered, to
the Trustee an Opinion of Counsel confirming that the Holders of the Outstanding Notes of that Series will not 

  
 104 

 
recognize income, gain or loss for U.S. federal income tax purposes as a result of such Covenant Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner
and at the same times as would have been the case if such Covenant Defeasance had not occurred; 
 (4) no Default or Event of
Default shall have occurred and be continuing on the date the Company makes such deposits (other than a Default or Event of Default resulting from the borrowing of funds to be applied to such deposit or the granting of Liens in connection
therewith); 
 (5) such Legal Defeasance or Covenant Defeasance shall not result in a breach or violation of, or constitute a
default under, the Senior Secured Credit Facilities or any other material agreement or instrument (other than this Indenture) to which the Company or any Guarantor is a party or by which the Company or any Guarantor is bound (other than that
resulting with respect to any Indebtedness being defeased from any borrowing of funds to be applied to make the deposit required to effect such Legal Defeasance or Covenant Defeasance and any similar and simultaneous deposit relating to such
Indebtedness, and the granting of Liens in connection therewith); 
 (6) the Company shall have delivered, or shall have
caused to be delivered, to the Trustee an Officer’s Certificate stating that the deposit was not made by the Company with the intent of defeating, hindering, delaying or defrauding any creditors of the Company or any Guarantor or others; and

 (7) the Company shall have delivered, or shall have caused to be delivered, to the Trustee an Officer’s Certificate
and an Opinion of Counsel (which Opinion of Counsel may be subject to customary assumptions and exclusions) each stating that all conditions precedent provided for or relating to the Legal Defeasance or the Covenant Defeasance, as the case may be,
have been complied with. 
 SECTION 8.05 Deposited Money and Government Obligations to be Held in Trust; Other Miscellaneous
Provisions. Subject to Section 8.06 hereof, all money, Government Securities and European Government Obligations (including any proceeds thereof) deposited with the Trustee pursuant to Section 8.04 hereof in respect of the Outstanding
Notes of the Series shall be held in trust and applied by the Trustee, in accordance with the provisions of such Notes and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as Paying Agent) as
the Trustee may determine, to the Holders of such Notes of all sums due and to become due thereon in respect of principal, premium, if any, and interest, but such money need not be segregated from other funds except to the extent required by law.

 The Company and Guarantors shall pay and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the
cash, Government Securities or European Government Obligations deposited pursuant to Section 8.04 

  
 105 

 
hereof or the principal and interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of the Outstanding Notes of that
Series. 
 Anything in this Article VIII to the contrary notwithstanding, the Trustee shall deliver or pay to the Company from time to time
upon the request of the Company any money, Government Securities or European Government Obligations held by it as provided in Section 8.04 hereof that, in the opinion of a nationally recognized firm of independent public accountants expressed
in a written certification thereof delivered to the Trustee (which may be the opinion delivered under Section 8.04(1) hereof), are in excess of the amount thereof that would then be required to be deposited to effect an equivalent Legal
Defeasance or Covenant Defeasance. 
 SECTION 8.06 Repayment to the Company. Any money deposited with the Trustee or any Paying
Agent, or then held by the Company, in trust for the payment of the principal of, premium, if any, or interest on any Note and remaining unclaimed for two years after such principal, and premium, if any, or interest has become due and payable shall
be paid to the Company on its request or, if then held by the Company, shall be discharged from such trust; and the Holder of such Note shall thereafter look only to the Company for payment thereof as general creditors, unless an applicable
abandoned property law designates another person, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon cease; provided, however,
that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Company cause to be published once, in the New York Times or The Wall Street Journal (national edition), notice that such money
remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such notification or publication, any unclaimed balance of such money then remaining will be repaid to the Company. 

SECTION 8.07 Satisfaction and Discharge of Indenture. If at any time: 

(a) either: 

(i) all Notes of a Series theretofore authenticated and delivered, except lost, stolen or destroyed Notes that have been
replaced or paid and Notes for whose payment money has theretofore been deposited in trust, have been delivered to the Trustee for cancellation; or 

(ii) all Notes of such Series not theretofore delivered to the Trustee for cancellation have become due and payable by reason
of the making of a notice of redemption or otherwise, will become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption by the Trustee
in the name, 

  
 106 

 
and at the expense, of the Company, and the Company or any Guarantor has irrevocably deposited or caused to be deposited with the Trustee as trust funds in trust (x) solely for the benefit
of the Holders of any Dollar Notes of such Series, cash in Dollars, Government Securities, or a combination thereof, and (y) solely for the benefit of the Holders of any Euro Notes of such Series, cash in Euros, Government Securities, European
Government Obligations or a combination thereof, in each case, in such amounts as will be sufficient without consideration of any reinvestment of interest to pay and discharge the entire indebtedness on the Notes of such Series not theretofore
delivered to the Trustee for cancellation for principal, premium, if any, and accrued interest to the date of maturity or redemption; 
 (b)
the Company has paid or caused to be paid all sums payable by it under this Indenture; and 
 (c) the Company has delivered irrevocable
instructions to the Trustee to apply the deposited money toward the payment of the Notes of such Series at maturity or the redemption date, as the case may be; and 

(d) the Company shall have delivered to the Trustee an Opinion of Counsel and an Officer’s Certificate, each stating that all conditions
precedent relating to the satisfaction and discharge of this Indenture with respect to such Series have been complied with, 
 then this Indenture shall
thereupon cease to be of further effect with respect to such Series except for the rights, indemnities and immunities of the Trustee hereunder and the Company’s and the Guarantors’ obligations in connection therewith (including, but not
limited to, the rights of the Trustee and the duties of the Company and the Guarantors under Section 7.07, which shall survive despite the satisfaction in full of all obligations hereunder) and, if money shall have been deposited with the
Trustee pursuant to this Section 8.07: 
 (i) the Company’s obligations with respect to such Notes of that Series
under Sections 2.05, 2.06, 2.08 and 2.09 hereof; 
 (ii) the agreements of the Company and the Subsidiary Guarantors set
forth in Article V; and 
 (iii) Sections 8.02, 8.04, 8.05, 8.06, 8.07, 8.08 and 11.11 hereof, 

shall each survive until the Notes have been paid in full. 

Upon the Company’s exercise of this Section 8.07, the Trustee, on demand of the Company and at the cost and expense of the Company,
shall execute proper instruments acknowledging satisfaction of and discharging this Indenture with respect to such Series. 

  
 107 

 SECTION 8.08 Reinstatement. If the Trustee or any Paying Agent is unable to apply any
Dollars, Euros, Government Securities or European Government Obligations in accordance with this Article VIII, as the case may be, by reason of any order or judgment of any court or Governmental Authority enjoining, restraining or otherwise
prohibiting such application, then the Company’s and the Guarantors’ obligations under this Indenture, the Notes and the Guarantees shall be revived and reinstated as though no deposit had occurred pursuant to this Article VIII until such
time as the Trustee or Paying Agent is permitted to apply all such money in accordance this Article VIII; provided, however, that, if the Company makes any payment of principal of, premium, if any, or interest on any Note following the
reinstatement of their obligations, the Company shall be subrogated to the rights of the Holders of such Notes to receive such payment from the money held by the Trustee or Paying Agent. 

ARTICLE IX 
 AMENDMENTS

 SECTION 9.01 Without Consent of Holders. The Company, the Guarantors and the Trustee may amend or supplement this
Indenture, the Guarantees or the Notes without the consent of any Holder: 
 (1) to cure any ambiguity, omission, mistake,
defect or inconsistency; 
 (2) to provide for uncertificated Notes in addition to or in place of certificated Notes or to
alter the provisions of this Indenture relating to the form of the Notes (including the related definitions) in a manner that does not materially adversely affect any Holder (as determined in good faith by the Company); 

(3) to comply with Section 5.01; 

(4) to provide for the assumption of the Company’s or any Guarantor’s obligations to the Holders; 

(5) to make any change that would provide any additional rights or benefits to the Holders or that does not adversely affect
the legal rights under this Indenture of any such Holder (as determined in good faith by the Company); 
 (6) to add
covenants for the benefit of the Holders or to surrender any right or power conferred upon the Company or any Guarantor; 

(7) to evidence and provide for the acceptance and appointment under this Indenture of a successor Trustee hereunder pursuant
to the requirements hereof; 

  
 108 

 (8) to provide for the issuance of exchange Notes or private exchange Notes that
are identical to exchange Notes except that they are not freely transferable; 
 (9) to provide for the issuance of
Additional Notes in accordance with this Indenture; 
 (10) to add a Guarantor under this Indenture and to allow a Guarantor
to execute a supplemental indenture and/or guarantee the Notes or to release a Guarantor in accordance with the terms of this Indenture; 

(11) to conform the text of this Indenture, the Guarantees or the Notes to any provisions of the “Description of
Notes” in the Offering Circular to the extent that such provision in such “Description of Notes” was intended to be a verbatim recitation of a provision of this Indenture, Guarantee or Notes (as determined in good faith by the
Company); 
 (12) to make any amendment to the provisions of this Indenture relating to the transfer and legending of Notes
as permitted by this Indenture, including to facilitate the issuance and administration of the Notes; provided, however, that (i) compliance with this Indenture as so amended would not result in Notes being transferred in
violation of the Securities Act or any applicable securities law and (ii) such amendment does not materially and adversely affect the rights of Holders to transfer Notes (in each case, as determined in good faith by the Company); 

(13) to provide for the issuance of the Notes in a manner consistent with the terms of this Indenture; or 

(14) to comply with requirements of the SEC in order to effect or maintain the qualification of this Indenture under the TIA.

 SECTION 9.02 With Consent of Holders. Except as provided below, this Indenture, any Guarantee and the Notes (in each case
with respect to one or more Series of Notes) may be amended or supplemented with the written consent of the Holders of at least a majority in aggregate principal amount of the Notes of the applicable Series then Outstanding, including consents
obtained in connection with a purchase of, or tender offer or exchange offer for, Notes and any existing Default or compliance with any provision of this Indenture or the Notes issued hereunder may be waived with the consent of the Holders of a
majority in aggregate principal amount of the Notes of the applicable Series then Outstanding (including consents obtained in connection with a purchase of or tender offer or exchange offer for the Notes). However, without the consent of each Holder
affected, an amendment or supplement may not, with respect to any Notes of such Series held by a non-consenting Holder: 

(1) make any change in the percentage of the principal amount of such Notes required for amendments or waivers; 

  
 109 

 (2) reduce the principal of or change the fixed final maturity of any such Note
or change the date on which any Notes may be subject to redemption or reduce the redemption price therefor; 
 (3) reduce the
rate of or change the time for payment of interest on any Note of such Series; 
 (4) (A) waive a Default in the payment of
principal of or premium, if any, or interest on the Notes of such Series, except a rescission of acceleration of the Notes by the Holders of a majority in aggregate principal amount of all then Outstanding Notes of such Series, and a waiver of the
Event of Default under Section 6.01(1) or 6.01(2) that resulted from such acceleration, or (B) waive a Default in respect of a covenant or provision contained in this Indenture or any Guarantee which cannot be amended or modified without
the consent of all Holders; 
 (5) make any Dollar Note payable in money other than Dollars or make any Euro Note payable in
money other than Euros; 
 (6) make any change in Section 9.01 or this Section 9.02; 

(7) impair the right of any Holder to receive payment of principal of, premium, if any, or interest on such Holder’s Notes
on or after the due dates therefor or to institute suit for the enforcement of any payment on or with respect to such Holder’s Notes or the Guarantees; or 

(8) make any change to or modify the ranking of the Notes of such Series that would adversely affect the Holders thereof. 

It shall not be necessary for the consent of the Holders under this Section to approve the particular form of any proposed amendment or
supplement, but it shall be sufficient if such consent approves the substance thereof. After an amendment or supplement under this Section becomes effective, the Company shall mail or otherwise deliver to all affected Holders a notice briefly
describing such amendment or supplement. The failure to give such notice to all such Holders, or any defect therein, shall not impair or affect the validity of an amendment or supplement under this Section. 

For purposes of determining whether the Holders of the requisite principal amount of Notes of a Series have taken any action under this
Indenture, the principal amount of Notes shall be deemed to be the principal amount of Notes as of (i) if a record date has been set with respect to the taking of such action, such date or (ii) if no such record date has been set, the date
the taking of such action by the Holders of such requisite principal amount is certified to the Trustee by the Company. 
 SECTION 9.03
Revocation and Effect of Consents and Waivers. A consent to an amendment, supplement or a waiver by a Holder of a Note shall bind the Holder and every subsequent Holder of that Note or portion of the Note that evidences the same debt as the
consenting Holder’s Note, even if notation of the consent or waiver is not made on the Note. However, any such Holder or subsequent Holder may revoke the consent 

  
 110 

 
or waiver as to such Holder’s Note or portion of the Note if the Trustee receives the notice of revocation before the date the amendment, supplement or waiver becomes effective. After an
amendment, supplement or waiver becomes effective, it shall bind every Holder of each Series affected by such amendment, supplement or waiver. 

SECTION 9.04 Notation on or Exchange of Notes. If an amendment changes the terms of a Note, the Trustee may require the Holder of
the Note to deliver it to the Trustee. The Trustee may place an appropriate notation on the Note regarding the changed terms and return it to the Holder. Alternatively, if the Trustee or the Company so determine, the Company in exchange for the Note
shall issue and the Trustee, upon a Company Order, shall authenticate a new Note that reflects the changed terms. Failure to make the appropriate notation or to issue a new Note shall not affect the validity of such amendment. 

SECTION 9.05 Trustee to Sign Amendments. Upon the request of the Company, the Trustee shall sign any amendment, supplement or
waiver authorized pursuant to this Article IX if the amendment, supplement or waiver does not affect the rights, duties or immunities of the Trustee under this Indenture or otherwise. If it does, the Trustee may, but need not, sign it. In signing
any amendment, supplement or waiver the Trustee shall be provided with and shall be fully protected in relying upon an Officer’s Certificate and an Opinion of Counsel, each stating that the execution of such amendment, supplement or waiver is
authorized or permitted by this Indenture and that such amendment, supplement or waiver is enforceable in accordance with its terms, subject to bankruptcy, insolvency, reorganization and other laws of general applicability relating to or affecting
the enforcement of creditors’ rights and to general equity principles. The Trustee shall also be entitled to request indemnity reasonably satisfactory to it in connection with signing an amendment, supplement or waiver or taking any action (or
refraining from taking any action) thereunder or in connection therewith. 
 SECTION 9.06 Payment for Consent. Neither the
Company nor any Affiliate of the Company shall, directly or indirectly, pay or cause to be paid any consideration, whether by way of interest, fee or otherwise, to any Holder for or as an inducement to any consent, waiver or amendment of any of the
terms or provisions of this Indenture or the Notes unless such consideration is offered to be paid to all Holders, ratably, that so consent, waive or agree to amend in the time frame set forth in solicitation documents relating to such consent,
waiver or agreement. The Trustee shall have no duty or obligation with respect to the Company’s obligations under this Section 9.06. 

  
 111 

 ARTICLE X 

GUARANTEES 

SECTION 10.01 Guarantees. 

(a) Each Guarantor hereby jointly and severally, irrevocably and unconditionally guarantees, as a primary obligor and not merely as a surety,
to each Holder and the Trustee and their successors and assigns (i) the full and punctual payment when due, whether at maturity, by acceleration or otherwise, of all obligations of the Company under this Indenture (including obligations to the
Trustee) and the Notes, whether for payment of principal of, premium, if any, or interest on the Notes and all other monetary obligations of the Company under this Indenture and the Notes and (ii) the full and punctual performance within
applicable grace periods of all other obligations of the Company whether for fees, expenses, indemnification or otherwise under this Indenture and the Notes, on the terms set forth in this Indenture by executing this Indenture (all the foregoing
being hereinafter collectively called the “Guaranteed Obligations”). Each Guarantor further agrees that the Guaranteed Obligations may be extended or renewed, in whole or in part, without notice or further assent from each such
Guarantor, and that such Guarantor shall remain bound under this Article X notwithstanding any extension or renewal of any Guaranteed Obligation. 

(b) Each Guarantor waives presentation to, demand of payment from and protest to the Company of any of the Guaranteed Obligations and also
waives notice of protest for nonpayment. Each Guarantor waives notice of any Default under the Notes or the Guaranteed Obligations. 
 (c)
Each Guarantor further agrees that its Guarantee herein constitutes a guarantee of payment, performance and compliance when due (and not a guarantee of collection) and waives any right to require that any resort be had by any Holder or the Trustee
to any security held for payment of the Guaranteed Obligations. 
 (d) Except as expressly set forth in Section 10.02, the obligations
of each Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense of setoff,
counterclaim, recoupment or termination whatsoever or by reason of the invalidity, illegality or unenforceability of the Guaranteed Obligations or otherwise. 

(e) Subject to Section 10.02 and 10.03 hereof, each Guarantor agrees that its Guarantee shall remain in full force and effect until
payment in full of all the Guaranteed Obligations. Each Guarantor further agrees that its Guarantee herein shall continue to be effective or be reinstated, as the case may be, if at any time payment of, or any part thereof, principal of or interest
on any Guaranteed Obligation is rescinded or must otherwise be restored by any Holder or the Trustee upon the bankruptcy or reorganization of the Company or any of its Subsidiaries or otherwise. 

  
 112 

 (f) In furtherance of the foregoing and not in limitation of any other right which any Holder or
the Trustee has at law or in equity against any Guarantor by virtue hereof, upon the failure of the Company to pay the principal of or interest on any Guaranteed Obligation when and as the same shall become due, whether at maturity, by acceleration,
by redemption or otherwise, or to perform or comply with any other Guaranteed Obligation, each Guarantor hereby promises to and shall, upon receipt of written demand by the Trustee, forthwith pay, or cause to be paid, in cash, to the Trustee an
amount equal to the sum of (i) the unpaid principal amount of such Guaranteed Obligations, (ii) accrued and unpaid interest on such Guaranteed Obligations (but only to the extent not prohibited by applicable law) and (iii) all other
monetary obligations of the Company to the Trustee. 
 (g) Each Guarantor agrees that it shall not be entitled to any right of subrogation
in relation to the Trustee in respect of any Guaranteed Obligations guaranteed hereby until payment in full of all Guaranteed Obligations. Each Guarantor further agrees that, as between it, on the one hand, and the Trustee, on the other hand,
(i) the maturity of the Guaranteed Obligations guaranteed hereby may be accelerated as provided in Article VI for the purposes of any Guarantee herein, notwithstanding any stay, injunction or other prohibition preventing such acceleration in
respect of the Guaranteed Obligations guaranteed hereby, and (ii) in the event of any declaration of acceleration of such Guaranteed Obligations as provided in Article VI, such Guaranteed Obligations (whether or not due and payable) shall
forthwith become due and payable by such Guarantor for the purposes of this Section 10.01. 
 (h) Each Guarantor also agrees to pay any
and all fees, costs and expenses (including reasonable attorneys’ fees and expenses) incurred by the Trustee or any Holder in enforcing any rights under this Section 10.01. 

(i) Each Guarantor shall promptly execute and deliver such further instruments and do such further acts as may be reasonably necessary or
proper to carry out more effectively the purpose of this Indenture. 
 SECTION 10.02 Limitation on Liability. Each Guarantor,
and by its acceptance of Notes, each Holder, hereby confirms that it is the intention of all such parties that the Guarantee of such Guarantor not constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent
Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to any Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Guarantors hereby irrevocably agree that, any
term or provision of this Indenture to the contrary notwithstanding, the maximum aggregate amount of the Guaranteed Obligations guaranteed hereunder by any Guarantor shall not exceed the maximum amount that can be hereby guaranteed without rendering
this Indenture, as it relates to such Guarantor, voidable under applicable law relating to fraudulent conveyance or fraudulent transfer or similar laws affecting the rights of creditors generally. Each Guarantor that makes a payment under its
Guarantee shall be entitled upon payment in full of all Guaranteed Obligations under this Indenture to a contribution 

  
 113 

 
from each other Guarantor in an amount equal to such other Guarantor’s pro rata portion of such payment based on the respective net assets of all the Guarantors at the time of such
payment determined in accordance with GAAP. 
 SECTION 10.03 Releases. A Guarantee as to any Guarantor shall be automatically
and unconditionally released and discharged, without further action required on the part of the Guarantor, the Trustee or any Holder of Notes, upon: 

(1) (a) any direct or indirect sale, exchange, transfer or other disposition (by merger, consolidation or otherwise) of
the Capital Stock of such Guarantor, after which the applicable Guarantor is no longer a Restricted Subsidiary, if such sale, exchange, transfer or other disposition is not in violation of the applicable terms of this Indenture; 

(b) the release or discharge of the Indebtedness or guarantee of Indebtedness by such Guarantor that resulted in the creation
of such Guarantee except a release or discharge by or as a result of payment under such guarantee (it being understood that a release subject to a contingent reinstatement will constitute a release for the purposes of this provision); 

(c) the direct or indirect sale, exchange, transfer or other disposition of all or substantially all of the assets of such
Guarantor, in a transaction that is not in violation of the applicable terms of this Indenture, to any Person who is not (either before or after giving effect to such transaction) the Company or a Restricted Subsidiary; 

(d) the release or discharge of such Guarantor from its guarantee, and of all pledges and security, if any, granted by such
Guarantor in connection with the Senior Secured Credit Facilities, except a release or discharge by or as a result of payment under such guarantee (it being understood that a release subject to a contingent reinstatement will constitute a release
for the purposes of this provision); provided that at the time of such release or discharge, such Guarantor is not then a guarantor or an obligor in respect of any other Indebtedness that would require a Guarantee of the Notes under this
Indenture; 
 (e) the proper designation of any Restricted Subsidiary that is a Guarantor as an Unrestricted Subsidiary in
accordance with Section 4.07 and the definition of “Unrestricted Subsidiary”; 
 (f) the merger or
consolidation of any Guarantor with and into the Company or another Guarantor or upon the liquidation of such Guarantor following the transfer of all of its assets to the Company or another Guarantor; or 

(g) the Company exercising its Legal Defeasance option or Covenant Defeasance option with respect to the Notes of such Series
pursuant to Article VIII or the Company’s obligations under this Indenture being discharged with respect to the Notes in accordance with Article VIII; 

  
 114 

 and, in the case of this clause (1), such Guarantor delivering to the Trustee an Officer’s
Certificate and Opinion of Counsel stating that all conditions precedent provided for in this Indenture relating to the release of such Guarantee shall have been complied with; or 

(2) the consent of Holders of a majority in aggregate principal amount of the Outstanding Notes of each applicable Series. 

SECTION 10.04 Successors and Assigns. This Article X shall be binding upon each Guarantor and its successors and assigns and shall
inure to the benefit of the successors and assigns of the Trustee and the Holders and, in the event of any transfer or assignment of rights by any Holder or the Trustee, the rights and privileges conferred upon that party in this Indenture and in
the Notes shall automatically extend to and be vested in such transferee or assignee, all subject to the terms and conditions of this Indenture. 

SECTION 10.05 No Waiver. Neither a failure nor a delay on the part of either the Trustee or the Holders in exercising any right,
power or privilege under this Article X shall operate as a waiver thereof, nor shall a single or partial exercise thereof preclude any other or further exercise of any right, power or privilege. The rights, remedies and benefits of the Trustee and
the Holders herein expressly specified are cumulative and not exclusive of any other rights, remedies or benefits which either may have under this Article X at law, in equity, by statute or otherwise. 

SECTION 10.06 Additional Guarantees. The Company shall cause each Domestic Restricted Subsidiary, other than a Foreign Subsidiary
Holding Company of the Company, that (a) incurs or guarantees any Indebtedness under the Senior Secured Credit Facilities, or (b) guarantees other Indebtedness of the Company or any Guarantor in an aggregate principal amount in excess of
$75 million, to guarantee the Notes. 
 SECTION 10.07 Execution of Supplemental Indenture for Future Guarantors. Each Subsidiary
that is required to become a Guarantor pursuant to Section 10.06 shall promptly execute and deliver to the Trustee a supplemental indenture substantially in the form of Exhibit A hereto pursuant to which such Subsidiary shall become a Guarantor
under this Article X and shall guarantee the Guaranteed Obligations. Concurrently with the execution and delivery of such supplemental indenture, the Company shall deliver to the Trustee an Opinion of Counsel and an Officer’s Certificate each
stating that such supplemental indenture has been duly authorized, executed and delivered by such Subsidiary and that, subject to the application 

  
 115 

 
of bankruptcy, insolvency, moratorium, fraudulent conveyance or transfer and other similar laws relating to creditors’ rights generally and to the principles of equity, whether considered in
a proceeding at law or in equity, the Guarantee of such Guarantor is a valid and binding obligation of such Guarantor, enforceable against such Guarantor in accordance with its terms. 

SECTION 10.08 Non-Impairment. The failure to endorse a Guarantee on any Notes shall not affect or impair the validity thereof.

 SECTION 10.09 Benefits Acknowledged. Each Guarantor acknowledges that it will receive direct and indirect benefits from the
financing arrangements contemplated by this Indenture and that the Guarantee and waivers made by it pursuant to its Guarantee are knowingly made in contemplation of such benefits. 

ARTICLE XI 
 MISCELLANEOUS

 SECTION 11.01 Trust Indenture Act Controls. If this Indenture is qualified under the TIA and any provision of this
Indenture limits, qualifies or conflicts with another provision which is required or deemed to be included in this Indenture by the TIA, the required or deemed provision shall control. 

SECTION 11.02 Notices. Any notice or communication shall be in writing and delivered in person or mailed by first-class mail,
postage prepaid, electronic mail, facsimile transmission or overnight air courier guaranteeing next day delivery addressed as follows: 
 If to the Company:

 The Chemours Company 
 1007 Market Street, 

Wilmington, Delaware 19898 
 Attention: General Counsel 

Email: david.c.shelton@chemours.com 
 with copies for information
purposes only to 
 Skadden, Arps, Slate and Meagher & Flom LLP 

Four Times Square 
 New York, New York 10036 

Attention: Stacy J. Kanter 
 Facsimile: (917) 777-3497 

Email: stacy.kanter@skadden.com 

  
 116 

 If to the Trustee: 

U.S. Bank National Association 
 Corporate Trust Services 

21 South Street 
 Morristown, NJ 07960 

Attention: Stephanie Roche 
 Facsimile: (973) 682-4540 

Email: stephanie.roche@usbank.com 
 The Company
or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications. 
 Any
notice or communication mailed to a Holder shall be mailed by first-class mail (registered or certified, return receipt requested) to the Holder at the Holder’s address as it appears on the registration books of the Registrar and shall be
sufficiently given if so mailed within the time prescribed (or otherwise in accordance with the procedures of DTC, Euroclear or Clearstream, as applicable). 

Notices given by publication or electronic delivery will be deemed given on the first date on which publication or electronic delivery is made
and notices given by first-class mail, postage prepaid, will be deemed given five calendar days after mailing or transmitting. 

Notwithstanding any other provisions of this Indenture or any Notes, where this Indenture or any Note provides for notice of any event
(including any notice of redemption) to a Holder of a Global Note (whether by mail or otherwise), such notice shall be sufficiently given if given to the Depositary for such Note (or its designee) pursuant to the customary procedures of such
Depositary. 
 Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to
other Holders. If a notice or communication is mailed in the manner provided above, it is duly given, whether or not the addressee receives it. 

So long as any Notes are admitted to the Official List and to trading on the Global Exchange Market of the Irish Stock Exchange and the rules
of the Irish Stock Exchange so require, the Company shall deliver, or cause to be delivered, all notices to Holders to the Company Announcements Office of the Irish Stock Exchange. If publication as provided above is not practicable, notice will be
given in such other manner, and shall be deemed to have been given on such date. 
 SECTION 11.03 Communication by Holders with
Other Holders. Holders may communicate pursuant to TIA § 312(b) with other Holders with respect to their rights under this Indenture or the Notes. The Company, the Trustee, the Registrar and anyone else shall have the protection of TIA
§ 312(c). 

  
 117 

 SECTION 11.04 Certificate and Opinion as to Conditions Precedent. Upon any request or
application by the Company to the Trustee to take or refrain from taking any action under this Indenture, the Company shall furnish to the Trustee: 

(1) an Officer’s Certificate stating that all conditions precedent, if any, provided for in this Indenture relating to the
proposed action have been complied with; and 
 (2) an Opinion of Counsel stating that all such conditions precedent have
been complied with. 
 SECTION 11.05 Statements Required in Certificate or Opinion. Each certificate or opinion with respect to
compliance with a covenant or condition provided for in this Indenture shall include: 
 (1) a statement that the individual
making such certificate or opinion has read such covenant or condition (and the related definitions); 
 (2) a brief
statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; 

(3) a statement that, in the opinion of such individual, he or she has made such examination or investigation as is necessary
to enable him or her to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(4) a statement as to whether or not, in the opinion of such individual, such covenant or condition has been complied with.

 SECTION 11.06 Rules by Trustee, Paying Agent and Registrar. The Trustee may make reasonable rules for action by or a meeting
of Holders. The Registrar and the Paying Agent may make reasonable rules for their functions. 
 SECTION 11.07 Legal Holidays.
Unless otherwise provide by Board Resolution, Officer’s Certificate or supplemental indenture hereto for any particular Series, a “Legal Holiday” is a Saturday, a Sunday or a day on which commercial banking institutions are
required to be closed in the State of New York or a place of payment with respect to the Notes. If a payment date is a Legal Holiday, payment shall be made on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the
intervening period. If a Regular Record Date is a Legal Holiday, the record date shall not be affected. 

  
 118 

 SECTION 11.08 Governing Law. THIS INDENTURE AND THE NOTES SHALL BE GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 SECTION 11.09 No Personal Liability of Directors, Officers,
Employees and Stockholders. No present, past or future director, officer, employee, member, partner, incorporator or equityholder of the Company, any Guarantor or any Subsidiary of the Company or any of their respective direct or indirect parent
companies (except for the Company or any Subsidiary in its capacity as obligor or guarantor in respect of the Notes and not in its capacity as equityholder of any Subsidiary Guarantor) shall have any liability for any obligations of the Company or
the Guarantors under the Notes, the Guarantees, this Indenture or for any claim based on, in respect of, or by reason of such obligations or their creation. Each Holder by accepting the Notes waives and releases all such liability. This waiver and
release are part of the consideration for issuance of the Notes. 
 SECTION 11.10 Successors. All agreements of the Company and
the Guarantors in this Indenture and the Notes shall bind its successors. All agreements of the Trustee in this Indenture shall bind its successors. 

SECTION 11.11 Multiple Originals; Electronic Signatures. The parties may sign any number of copies of this Indenture. Each signed
copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Indenture as
to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. 

SECTION 11.12 Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES, THE GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

SECTION 11.13 Table of Contents; Headings. The table of contents, cross-reference sheet and headings of the Articles and Sections
of this Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof. 

  
 119 

 SECTION 11.14 Severability. If any provision in this Indenture is deemed
unenforceable, it shall not affect the validity or enforceability of any other provision set forth herein, or of this Indenture as a whole. 

SECTION 11.15 Submission to Jurisdiction and Venue. ALL JUDICIAL PROCEEDINGS BROUGHT AGAINST ANY PARTY ARISING OUT OF OR RELATING
HERETO, MAY BE BROUGHT IN ANY STATE OR FEDERAL COURT OF COMPETENT JURISDICTION IN THE STATE, COUNTY AND CITY OF NEW YORK. BY EXECUTING AND DELIVERING THIS INDENTURE, EACH PARTY HERETO, FOR ITSELF AND IN CONNECTION WITH ITS PROPERTIES, IRREVOCABLY
SUBMITS TO AND ACCEPTS GENERALLY AND UNCONDITIONALLY THE NONEXCLUSIVE JURISDICTION AND VENUE OF SUCH COURTS; AGREES THAT SERVICE OF ALL PROCESS IN ANY SUCH PROCEEDING IN ANY SUCH COURT MAY BE MADE BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT
REQUESTED, TO THE APPLICABLE PARTY; AGREES THAT SERVICE AS PROVIDED ABOVE IS SUFFICIENT TO CONFER PERSONAL JURISDICTION OVER THE APPLICABLE PARTY IN ANY SUCH PROCEEDING IN ANY SUCH COURT, AND OTHERWISE CONSTITUTES EFFECTIVE AND BINDING SERVICE IN
EVERY RESPECT; AND AGREES EACH OTHER PARTY RETAINS THE RIGHT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR TO BRING PROCEEDINGS AGAINST ANY PARTY IN THE COURTS OF ANY OTHER JURISDICTION HAVING JURISDICTION OVER SUCH PARTY. 

[Signatures on following page] 

  
 120 

 IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed as of the date
first written above. 
  

					
	THE CHEMOURS COMPANY
		
	By:		 /s/ Mark E. Newman

			Name:		Mark E. Newman
			Title:		Senior Vice President and Chief Financial Officer
	
	THE CHEMOURS COMPANY FC, LLC
		
	By:		 /s/ Mark E. Newman

			Name:		Mark E. Newman
			Title:		Senior Vice President and Chief Financial Officer
	
	THE CHEMOURS COMPANY TT, LLC
		
	By:		 /s/ Mark E. Newman

			Name:		Mark E. Newman
			Title:		Senior Vice President and Chief Financial Officer
	
	INTERNATIONAL DIOXCIDE, INC.
		
	By:		 /s/ Mark E. Newman

			Name:		Mark E. Newman
			Title:		Senior Vice President and Chief Financial Officer

 
					
	CHEMFIRST INC.
		
	By:		 /s/ Mark E. Newman

			Name:		Mark E. Newman
			Title:		Senior Vice President and Chief Financial Officer
	
	FIRST CHEMICAL CORPORATION
		
	By:		 /s/ Mark E. Newman

			Name:		Mark E. Newman
			Title:		Senior Vice President and Chief Financial Officer
	
	FIRST CHEMICAL TEXAS, L.P.
	By FT CHEMICAL INC., its general partner
		
	By:		 /s/ Mark E. Newman

			Name:		Mark E. Newman
			Title:		Senior Vice President and Chief Financial Officer
	
	FT CHEMICAL, INC.
		
	By:		 /s/ Mark E. Newman

			Name:		Mark E. Newman
			Title:		Senior Vice President and Chief Financial Officer
	
	FIRST CHEMICAL HOLDINGS, LLC
		
	By:		 /s/ Mark E. Newman

			Name:		Mark E. Newman
			Title:		Senior Vice President and Chief Financial Officer

 
							
	U.S. BANK NATIONAL ASSOCIATION, as Trustee
			
			By:		 /s/ Stephanie Roche

					Name:		Stephanie Roche
					Title:		Vice President
	
	ELAVON FINANCIAL SERVICES LIMITED, UK BRANCH, as Paying Agent with respect to Euro Notes
			
			By:		 /s/ Hamyd Mazrae

					Name:		Hamyd Mazrae
					Title:		Authorised Signatory
			
			By:		 /s/ Laurence Griffiths

					Name:		Laurence Griffiths
					Title:		Authorised Signatory
	
	ELAVON FINANCIAL SERVICES LIMITED, as Registrar and Transfer Agent with respect to Euro Notes
			
			By:		 /s/ Hamyd Mazrae

					Name:		Hamyd Mazrae
					Title:		Authorised Signatory
			
			By:		 /s/ Laurence Griffiths

					Name:		Laurence Griffiths
					Title:		Authorised Signatory

 EXHIBIT A 

FORM OF SUPPLEMENTAL INDENTURE FOR 

ADDITIONAL SUBSIDIARY GUARANTORS 

SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of
[            ], 20[    ], among [    ] (the “Guaranteeing Subsidiary”) a subsidiary of THE CHEMOURS COMPANY, a Delaware corporation
(the “Company”), the other Subsidiary Guarantors (as defined in the Indenture referred to herein), U.S. BANK NATIONAL ASSOCIATION, as trustee under the indenture referred to below (the “Trustee”), ELAVON FINANCIAL
SERVICES LIMITED, UK BRANCH, as paying agent with respect to Euro Notes, and ELAVON FINANCIAL SERVICES LIMITED, as registrar and transfer agent with respect to Euro Notes. 

W I T N E S S E T H 
 WHEREAS,
the Company has heretofore executed and delivered to the Trustee an indenture (as amended or supplemented from time to time, the “Indenture”), dated as of May 12, 2015, among the Company, the Guarantors named therein and the
Trustee, providing for the issuance from time to time of notes (the “Notes”); 
 WHEREAS, the Indenture provides that under
certain circumstances the Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally guarantee all of the Company’s obligations under the Notes
and the Indenture (the “Subsidiary Guarantee”); and 
 WHEREAS, pursuant to Sections 9.01, 10.06 and 10.07 of the
Indenture, the Trustee, the Company and the other Guarantors are authorized and required to execute and deliver this Supplemental Indenture. 

NOW THEREFORE, in consideration of the foregoing and for good and valuable consideration, the receipt of which is hereby acknowledged, the
Guaranteeing Subsidiary, the parties hereto mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows: 

1. Capitalized Terms. Unless otherwise defined in this Supplemental Indenture, capitalized terms used herein without definition shall
have the meanings assigned to them in the Indenture. 
 2. Agreement to be Bound; Guarantee. The Guaranteeing Subsidiary hereby
becomes a party to the Indenture as a Subsidiary Guarantor and as such will have all of the rights and be subject to all of the obligations (including the Guaranteed Obligations) and agreements of a Subsidiary Guarantor under the Indenture. In
furtherance of the foregoing, the Guaranteeing Subsidiary shall be deemed a Subsidiary Guarantor for purposes of Article X of the Indenture, including, without limitation, Section 10.02 thereof. 

  
 A-1 

 3. NEW YORK LAW TO GOVERN. THIS SUPPLEMENTAL INDENTURE SHALL BE
GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 4. Counterparts. The parties may sign any
number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or PDF
transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by
facsimile or PDF shall be deemed to be their original signatures for all purposes. 
 5. Effect of Headings. The Section headings
herein are for convenience only and shall not affect the construction hereof. 
 6. The Trustee. The Trustee shall not be responsible
in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary and the Company.

 7. Ratification of Indenture; Supplemental Indenture Part of Indenture. Except as expressly amended hereby, the Indenture is in
all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of the Indenture for all purposes, and every Holder of Notes heretofore or
hereafter authenticated and delivered shall be bound hereby. 
 [Signature Page Follows]

  
 A-2 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed and attested, all as of the date first above written. 
  

					
	[GUARANTEEING SUBSIDIARY]
			
			By:		  

					Name:
					Title:
	
	THE CHEMOURS COMPANY
		
	By:		  

			Name:
			Title:
	
	THE CHEMOURS COMPANY FC, LLC
		
	By:		  

			Name:
			Title:
	
	THE CHEMOURS COMPANY TT, LLC
		
	By:		  

			Name:
			Title:
	
	INTERNATIONAL DIOXCIDE, INC.
		
	By:		  

			Name:
			Title:

 
			
	CHEMFIRST INC.
		
	By:		  

			Name:
			Title:
	
	FIRST CHEMICAL CORPORATION
		
	By:		  

			Name:
			Title:
	
	FIRST CHEMICAL TEXAS, L.P.
	By FT CHEMICAL, INC., its general partner
		
	By:		  

			Name:
			Title:
	
	FT CHEMICAL, INC.
		
	By:		  

			Name:
			Title:
	
	FIRST CHEMICAL HOLDINGS, LLC
		
	By:		  

			Name:
			Title:

 
			
	U.S. BANK NATIONAL ASSOCIATION, as Trustee
		
	By:		  

			Name:
			Title:
	
	ELAVON FINANCIAL SERVICES LIMITED, UK BRANCH, as Paying Agent with respect to Euro Notes
		
	By:		  

			Name:
			Title:
		
	By:		  

			Name:
			Title:
	
	ELAVON FINANCIAL SERVICES LIMITED, as Registrar and Transfer Agent with respect to Euro Notes
		
	By:		  

			Name:
			Title:
		
	By:		  

			Name:
			Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]